Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 10-K

 

 

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended March 31, 2009

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number: 0-29637

 

 

SELECTICA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   77-0432030

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

1740 Technology Drive Suite 450, San Jose, California 94110-2111

(Address of Principal Executive Offices)

(408) 570-9700

(Registrant’s Telephone Number)

Securities registered under Section 12(b) of the Act:

 

Title of Each Class

  

Name of Each Exchange On Which Registered

Common Stock, $0.0001 par value per share    The NASDAQ Global Market

Securities registered under Section 12(g) of the Act:

None

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act.     Yes   ¨     No   x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes   ¨     No   x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   ¨     No   ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    Yes   ¨     No   x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨   Accelerated filer   ¨
Non-accelerated filer   ¨ (Do not check if a smaller reporting company)   Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   ¨     No   x

As of September 30, 2008, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant, based upon the closing price of $1.01 per share as reported by The NASDAQ Global Market on that date, was $29,009,803.

As of June 22, 2009, the registrant had outstanding 55,583,307 shares of common stock.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement for its fiscal year 2009 Annual Meeting of Stockholders (the “Proxy Statement”) are incorporated herein by reference into Part III of this Annual Report on Form 10-K. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as a part hereof. The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended March 31, 2009.

 

 

 


Table of Contents

SELECTICA, INC.

FORM 10-K ANNUAL REPORT

FOR THE FISCAL YEAR ENDED

MARCH 31, 2009

Table of Contents

 

Part I

Item 1

  

Business

   4

Item 1A

  

Risk Factors

   10

Item 1B

  

Unresolved Staff Comments

   20

Item 2

  

Properties

   20

Item 3

  

Legal Proceedings

   20

Item 4

  

Submission of Matters to a Vote of Security Holders

   21
Part II

Item 5

  

Market for the Registrant’s Common Equity, Related Stockholder Matters and Small Business Issuer Purchases of Equity Securities

   22

Item 6

  

Selected Financial Data

   24

Item 7

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   25

Item 7A

  

Quantitative and Qualitative Disclosures about Market Risk

   32

Item 8

  

Financial Statements and Supplementary Data

   33

Item 9

  

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

   60

Item 9A

  

Controls and Procedures

   60

Item 9B

  

Other Information

   63
Part III

Item 10

  

Directors, Executive Officers and Corporate Governance

   64

Item 11

  

Executive Compensation

   66

Item 12

  

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

   66

Item 13

  

Certain Relationships and Related Transactions, and Director Independence

   66

Item 14

  

Principal Accounting Fees and Services

   66
Part IV

Item 15

  

Exhibits and Financial Statement Schedules

   67
  

SIGNATURES

  

 

2


Table of Contents

Cautionary Statement Pursuant to Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995

The words “Selectica”, “we”, “our”, “ours”, “us”, and the “Company” refer to Selectica, Inc. This Annual Report on Form 10-K contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. In addition, we may make other written and oral communications from time to time that contain such statements. Forward-looking statements include statements as to industry trends and future expectations of ours and other matters that do not relate strictly to historical facts. These statements are often identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue,” and similar expressions or variations. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These forward-looking statements include statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading “Risk Factors” in Item 1A of this Annual Report on Form 10-K (the “10-K” or Report) and in our other Securities and Exchange Commission filings. Furthermore, such forward-looking statements speak only as of the date of this Report. We undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

 

3


Table of Contents

PART I

 

Item 1. Business

OVERVIEW

We deliver flexible, enterprise-class software and services that manage and streamline contract management and sales configuration processes. Our solutions enable companies around the world to automate, optimize, link, track, and report on critical business functions including sourcing, procurement, governance, sales and revenue recognition.

The Selectica Contract Lifecycle Management (“CLM” or “CM”) solution is a contract authoring, analysis, repository and process automation product designed to enhance and automate the management of the entire contract lifecycle. It helps companies take control of their contract management processes by converting from paper-based to electronic repositories and by unlocking multiple layers of critical business data, making it available for the evaluation of risk, the exposure of lost revenue, the evaluation of supplier performance, and other purposes. The solution helps to improve the customer buying experience for sales organizations, improve the control of risk and decrease time spent drafting, monitoring and managing contracts for the corporate counsel’s office and gain access to previously hidden discounts through the exposure and elimination of unfavorable agreements for procurement and sourcing organizations.

The Selectica Sales Configuration (”SCS”) solution consolidates configuration, pricing and quoting functions into a single application platform enabling companies to streamline the opportunity-to-order process for manufacturers, service providers, and financial services companies. Our SCS solution provides a critical link between Customer Relationship Management (CRM) and Enterprise Resource Planning (ERP) systems that helps to simplify and automate the configuration, pricing, and quoting of complex products and services. By empowering customers, internal sales staff, and/or channel partners to generate error-free sales proposals for their unique requirements, we believe our SCS solution helps companies to close sales faster, accelerate revenue generation and enhance customer relationships.

While the SCS and CLM products can interact, providing an integrated configuration to sales contract lifecycle management offering, they are managed as separate product lines given the differing stages of product lifecycle and buyer profiles. In addition to our software solutions, we offer professional implementation and customization. For CLM, on-demand hosting services are offered and for SCS, complex product configuration modeling services.

Selectica was incorporated in California in June 1996 and re-incorporated in Delaware in November 1999. The company’s principal executive offices are located at 1740 Technology Drive, Suite 450, San Jose, California, 95110 and its website is www.selectica.com.

SELECTICA PRODUCTS

Contract Management Solution

Our CLM solution includes the following software modules and services: Selectica Contract Lifecycle Management, Selectica Contract Performance Analytics and Selectica Contract Management Professional Services.

Our CLM solution enables customers to create, manage and analyze contracts in a single, easy to use repository and is offered both on-premise or hosted. We believe that our CLM software offers a high degree of flexibility enabling customers across many departments (e.g., sales, services, procurement, finance, IT, leasing or intellectual property) to model their specific contracting processes and to manage the lifecycle of a contract and

 

4


Table of Contents

its attendant multi-party relationship from creation through closure. We believe our CLM solutions meet the needs of many challenging and dynamic organizations:

 

   

Corporate legal organizations. The General Counsel’s office and other legal organizations can use the contract management solution to transform paper-bound contracts into a secure, centralized, searchable electronic contract repository and gain visibility and control of all corporate agreements.

 

   

Procurement organization. Procurement contract managers can use the contract management solution to expose off-contract spending.

 

   

Sales organization. Sales organizations can use the sales contract management solution to shorten the sales cycle and decrease time to revenue, while potentially protecting the company from inadvertent legal errors.

 

   

Finance organizations. Finance organizations can use the contract management solution to identify and account for non-standard terms and pricing in the revenue cycle while discovering unrealized revenue buried in sales agreements.

 

   

Contract Administration. Contract administrators can use the contract management solution to create visibility into contract obligations not captured by ERP and CRM and empower non-contract professionals to create and execute basic contracts.

We believe our CLM product is differentiated from competitive offerings because it is:

 

   

Adaptable . Adaptable, without sacrificing scalability or speed of implementation. The CLM solution is applicable to both buy and sell-side contracts. Our vertical expertise and advanced sell-side features such as flowdown, workflow and authoring tools help differentiate our CLM solution from its competitors.

 

   

Configurable . Combines the stability of rigid contract management software solutions with the flexibility of custom solutions by allowing companies to configure and update the product without expensive services and engineering support.

 

   

Flexible . Available On-Demand (SaaS) Hosted and Enterprise (On-Site / behind-the-firewall) deployment options using the same application platform.

 

   

Industry Customizable . Customizable for a broad array of contract types including procurement, sales, governance, healthcare provider, intellectual property, IT, equipment leasing, employee, real estate, partnership, supplier and services agreements.

 

   

Rapid Deployment . Our Contract Performance Management solution is delivered in an average of 90 days or less, which we believe is shorter than the average deployment times for many competitive software solutions.

 

   

Extensive Analytics and Reporting Capabilities . Enables detailed contract analysis and performance management by combining both structured and unstructured information stored in its contract repository.

The Contract Performance Analytics module is an add-on to the CLM product that enables multidimensional analyses across multiple data sources including contract information, and presents its analyses using Microsoft Excel or any other industry-standard reporting engine. This tool is an easy-to-use XML-based tool that enables the combination of information external to the contract management system with structured and unstructured contract information into multidimensional data repositories for more advanced analyses.

Our Contract Performance Analytics has web service integration to CLM to get scheduled updates from the contract management database, bringing in structured and unstructured data. The Analytics product can also append data from multiple sources regardless if the data resides in XML, legacy relational databases, or flat files. Thus, the Analytics tool becomes a data mart for reporting solutions to present the data in an organized fashion.

 

5


Table of Contents

Contract Management Professional Services

We offer a range of services to ensure that the Contract Management process and Contract Analytics solutions meet users’ requirements. Our Contract Management Professional Services team takes a best-practice, collaborative approach, applying their extensive experience with contract management and Selectica solutions. We provide these services using both our in-house expertise and that of third parties experienced in our solution acting under our direction. As of June 15, 2009, the CLM Professional Services organization had 13 employees.

Sales Configuration Solution

Our SCS solution guides users through the buying process, offering only valid options and features at each step. As a result, limited training is required for the sales force or channel partners, and customers can easily find and configure the solutions they seek. Unlike many competitive solutions, SCS enables virtually unlimited product configuration, pricing and quoting flexibility and provides tight integration with existing applications down to the bill of materials. We believe our configuration solution helps organizations reduce sales cycles and increase productivity through faster product development, easier product updates, automated sales processes (making self-service kiosks possible even for complex products and services) and seamless integration with existing Product Lifecycle Management (PLM), Inventory Management, Manufacturing and ERP systems, thus helping to ensure order accuracy.

LOGO

Our SCS products were designed to automate configuration for the largest, most complex product and services offerings. We believe that benefits of Selectica’s configuration solution include:

 

   

Increased Revenue. By enabling context-driven cross-sell and up-sell options, companies can increase incremental revenue. Additionally, the configuration solution enables users to combine lines of business to capture higher spend on a per customer basis.

 

   

Increased Channel Sales. By equipping channel partners with our easy-to-use, web-based, graphical interface to more easily sell complex products and services, companies can boost channel revenue.

 

   

Faster Time to Cash. By configuring complex products and services in minutes, rather than days or weeks, organizations can close deals more quickly and accelerate revenue generation.

 

   

Improved Margin. By incorporating pricing/margin during the configuration process, companies can create a configuration that meets user’s objectives at the lowest price for the company, which can improve margins.

 

   

Decreased Cost. By preventing rework and cancellations due to incorrect orders, companies can save money.

 

   

Customer Satisfaction. Our configuration solution ensures quote and order accuracy.

 

6


Table of Contents
   

Flexibility. Our configuration solution can accommodate both sales configurations and manufacturing configurations, enabling our solution to be deployed to sales organizations, manufacturing organizations, or both. The configuration solution can also allow a very large number of SKU’s or offerings and a very large number of users.

We believe key technical differentiators of SCS from our competition include:

 

   

Declarative Constraint Engine (DCE). The DCE describes relationships among product features and components, allowing business logic to be modeled with simple declarative statements rather than complex programming. This approach also helps to simplify model processing and allows for a faster configuration process, even for highly complex products.

 

   

Efficient Modeling. Flexible modeling tools, easy-to-use wizards, automated business logic creation, and repositories of business logic help shorten the time required for development teams to deliver advanced capabilities and customize or update SCS-based applications.

 

   

Development Studio. SCS’s Development Studio’s Model Builder is a rich modeling tool that allows graphical modeling of products and services which are submitted to the Selectica Knowledge Base. A model profiler is also available for inspecting and measuring runtime execution of models.

 

   

Updates by non-technical personnel. In most organizations, business-critical information is stored in repositories, such as relational databases and other applications, and is updated very frequently. The SCS architecture allows changes in business-critical information to be automatically reflected in the application.

 

   

Flexible and Scalable Deployment. SCS is Java-based and can be deployed on a wide range of server hardware and web application servers, such as JBoss, Weblogic or Websphere. We have also introduced a laptop-based version of the configuration engine for real-time configuration at remote customer locations.

We also offer a Pricing Module which can integrate with SCS or third party applications to enable enterprises to efficiently manage pricing by seamlessly integrating marketing and selling pricing management processes. Efficiencies in price management can help companies realize greater profit margins and decrease SKU proliferation. We believe SCS delivers the ability to view, model, and dynamically change all aspects of an enterprise’s pricing management and execution processes.

SCS Professional Services

We offer comprehensive consulting, training and implementation services and ongoing customer support and maintenance for our SCS products. Generally, we charge our customers for these services on a time and materials basis, with training services billed upon delivery. Customer support and maintenance typically is charged as a percentage of license fees and can be renewed annually at the election of our customers based on available support offerings. Our in-house services organization also educates third-party system integrators on the use of our software to assist them in providing services to our customers. As of June 15, 2009, our SCS services organization consisted of 5 employees.

Employees

At June 15, 2009, following a reduction in headcount, we had a total of 56 employees, all located in the United States. 55 of our employees are full time and 1 is part time. Of the total, 12 are engaged in research and development, 18 are engaged in professional services, 16 are engaged in sales and marketing, and 10 are engaged in general & administration. See Note 16 to Notes to Consolidated Financial Statements. None of our employees are represented by a labor union and we consider our relations with our employees to be good.

 

7


Table of Contents

Sales and Marketing

We sell our CM products primarily through our direct sales force along with strategic and OEM partners. Our SCS products are sold primarily through partnership relationships such as an existing relationship with IBM Global Services. As of June 15, 2009, our sales team consisted of 11 employees and our marketing team consisted of 5 employees.

Our CM direct sales force is complemented by business partners, supported by telesales and system engineering resources. We have developed programs to attract and retain high quality, motivated sales representatives that have the necessary technical skills and consultative sales experience. We have also developed specific partner relationships to expand our solutions and domain expertise into various targeted markets. We believe that the cultivation and integration of these support networks assists in both the establishment and enhancement of customer relationships.

Our marketing department is engaged in revenue-centered, sales-support and awareness-building activities, such as lead generation programs, web marketing, product management, public relations, advertising, speaking programs, seminars, sales collateral creation and production, direct mail, and event hosting.

Research and Development

To date, we have invested substantial resources in research and development. At June 15, 2009, we had 12 full-time engineers and technical writing specialists that primarily work on product development, documentation, quality assurance and testing. For the fiscal years ended March 31, 2009 and 2008, we incurred approximately $4.2 million and $5.0 million, respectively on research and development.

Enhancements to our existing products are released periodically to add new features, improve functionality and incorporate feedback and suggestions from our customers. These updates are usually provided as part of a separate maintenance agreement sold with the product license. We expect that enhancements to our existing products will be developed internally.

International Operations

On March 31, 2009 we sold the equity interest of our U.S. parent company in our wholly owned foreign subsidiary in India. The subsidiary had formerly provided development and professional services resources for our Sales Configuration group as well as acted as an interface to an outsourcing partner in India for development services for both of our product lines. As of the date of sale, the subsidiary had ceased to perform those functions and employed three people solely in administrative capacities. The sale was for cash consideration of $4.3 million ($1.0 million of which was held in escrow and released in early June 2009) and $0.4 million of forgiveness of intercompany debt. As of March 31, 2009, we no longer have any employees or operations outside the United States but do business with a number of non-US based companies.

Competition

The contract management and sales configuration markets continue to be subject to rapid change. Competitors vary in size and in the scope and breadth of the products and services offered. We encounter competition primarily from (i) publicly-held and private software companies that offer integrated solutions or specific contract management and/or sales configuration solutions, (ii) information systems departments of potential or current customers that internally develop custom software, and (iii) professional services organizations.

We believe that the principal competitive factors affecting our market include product reputation, functionality, ease-of-use, ability to integrate with other products and technologies, quality, performance, price, customer service and support, and the vendors’ reputation. Although we believe that our products currently

 

8


Table of Contents

compete favorably with regard to such factors, we cannot assure you that we can maintain our competitive position against current and potential competitors. Increased competition may result in price reductions, less beneficial contract terms, reduced gross margins and loss of market share, any of which could materially and adversely affect our business, operating results and financial condition.

Many of our competitors have significantly greater resources and broader alliance and customer relationships than we do. In addition, many of our competitors have extensive knowledge of our industry. Current and potential competitors have established, or may establish, cooperative relationships among themselves or with third parties to offer a single solution and increase the ability of their products to address customer needs. Furthermore, our competitors may combine with each other and other companies may enter our markets by acquiring or entering into strategic relationships with our competitors. Our competitors may also bundle their products in a manner that may discourage users from purchasing our products. Current and potential competitors may establish cooperative relationships with each other or with third parties, or adopt aggressive pricing policies to gain or maintain market share. Competitive pressures may require us to reduce the prices of our products and services. We may not be able to maintain or expand our sales if competition increases and we are unable to respond effectively.

Intellectual Property and Other Proprietary Rights

We rely on a combination of trademark, trade secret and copyright law and contractual restrictions to protect the proprietary aspects of our technology. These legal protections afford only limited protection for our technology. We currently hold six patents and five pending patents in the United States. In addition, we have various trademarks registered or pending registration in various jurisdictions. Our trademark and patent applications might not result in the issuance of any trademarks or patents. Our patents or any future issued patents or trademarks might be invalidated or circumvented or otherwise fail to provide us any meaningful protection. We seek to protect the source code for our software, documentation and other written materials under trade secret and copyright laws. We license our software pursuant to license agreements, which impose certain restrictions on the licensee’s ability to utilize the software. We also seek to avoid disclosure of our intellectual property by requiring employees and consultants with access to our proprietary information to execute confidentiality agreements. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or to obtain and use information that we regard as proprietary. In addition, the laws of many countries do not protect our proprietary rights to as great an extent as do the laws of the United States. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets and to determine the validity and scope of the proprietary rights of others. Our failure to adequately protect our intellectual property could have a material adverse effect on our business and operating results.

 

9


Table of Contents

AVAILABLE INFORMATION

We file annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy and information statements and amendments to reports filed or furnished pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended. The public may read and copy these materials at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. The public may obtain information on the operation of the public reference room by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website (www.sec.gov) that contains reports, proxy and information statements and other information regarding Selectica, Inc. and other companies that file materials with the SEC electronically. You may also obtain copies of reports filed with the SEC, free of charge, on our website at www.selectica.com.

 

Item 1A. Risk Factors

Set forth below and elsewhere in this annual report on Form 10-K, and in the other documents we file with the SEC, are risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward-looking statements contained in this annual report on Form 10-K . Prospective and existing investors are strongly urged to carefully consider the various cautionary statements and risks set forth in this annual report and our other public filings.

We have a history of significant losses and may incur significant losses in the future.

We incurred net losses of approximately $8.4 million and $23.9 million for the fiscal years ended March 31, 2009 and 2008, respectively. We had an accumulated deficit of approximately $249.2 million as of March 31, 2009. We may continue to incur significant losses in the future for a number of reasons, including uncertainty as to the level of our future revenues and the timing and impact of our cost reduction efforts. We plan to continue to pursue opportunities to align research and development, sales and marketing, and general and administrative expenses in absolute dollars over the next year in order to better balance expense levels with projected revenues, including potentially voluntarily delisting from The Nasdaq Global Market and deregistering under the Securities Exchange Act of 1934 (the “Exchange Act”). We will need to generate significant increases in our revenues to achieve and maintain profitability, particularly given the current small size of our business relative to the costs associated with being a public reporting company. If our revenue fails to grow or grows more slowly than we currently anticipate or our operating expenses exceed our expectations, our losses will significantly increase which would significantly harm our business and operating results.

We do not know the impact of current economic conditions on our customers and our business.

The United States and world economies currently face a number of economic challenges, including the availability of credit for businesses and consumers. The financial markets have been dramatically and adversely affected and many companies are either cutting back expenditures or delaying plans to add additional personnel or systems. If these conditions continue or worsen, the ability of our customers to pay for or obtain funding to pay for our products and services may be adversely affected which would then have a significant adverse impact on our ability to generate revenues and cash flow and may cause us to sustain further losses.

We are increasingly dependent on our CM business.

For the first time in the fiscal year ended March 31, 2009, revenues from our CM business exceeded revenues from our SC business. As a result, we are increasingly dependent on our CM business and our business and operating results will be harmed if we are unable to successfully grow our CM business in the future.

Our business could be seriously harmed as a result of recent management changes or if we lose the services of our key personnel. We currently do not have a chief executive officer.

We have recently experienced a number of management changes, including the recent appointment of Jason Stern as our Senior Vice President, Operations for Contract Management on June 10, 2009. All members of our

 

10


Table of Contents

management team have been with us for a limited period of time. There can be no assurance that they will be effective in their roles or that they will not take some time before they achieve desired levels of performance. The loss of services of one or more members of our management team could seriously harm our business. We currently do not have a chief executive officer, which could harm our business, and anticipate hiring a chief executive officer later in the year. There can be no assurance that we will be successful in hiring a chief executive officer or that any chief executive officer we hire will not take some time to achieve desired levels of performance.

Our recent restructuring of our business may adversely impact our business and operating results.

We recently restructured our business to better align expenses with revenues and position our business for improved operating performance in the future. As part of the restructuring, we reduced our headcount from 64 at March 31, 2009 to 56 as of June 15, 2009. We expect to record charges of at least $500,000 during the six months ending September 30, 2009, primarily for facilities, severance and related benefits for terminated employees. The restructuring has placed increased demands on our personnel and could adversely affect our ability to attract and retain talent, to develop and enhance our products and services, to service existing customers, to achieve our sales and marketing objectives and to perform our accounting, finance and administrative functions, particularly given that we operating two separate businesses with relatively limited overlap between their sales and marketing, customer service and product development teams. The occurrence of any of these adverse affects could materially harm our business.

We may be subject to a number of risks if we do not maintain effective corporate governance policies and procedures.

We have undertaken a review of our corporate governance policies and procedures. We undertook the review, among other reasons, (i) after determining that it was appropriate to reconsider the legal status of our management structure, (ii) in response to a letter from counsel from a stockholder with whom we are currently in litigation, who expressed concerns regarding our internal controls and requesting that we investigate those concerns, and (iii) to assess our internal controls regarding our accounting for non-routine transactions. As part of the review, our Board of Directors formed a special committee, assisted by independent counsel, to investigate the concerns raised in the letter from our stockholder’s counsel. As a result of the review, we have adopted and are in the process of implementing a number of changes designed to enhance the effectiveness of our corporate governance. We cannot assure that these changes, when implemented, will ensure that our internal controls and procedures will be effective to prevent fraud or other errors in the future. For more information about the review, including additional background on the reasons for the review and the changes to our corporate governance policies and procedures resulting from the review, please see Part II, Item 9A “Controls and Procedures.”

The internal review, including the independent investigation and related activities, has required us to incur substantial expenses, primarily for legal services, and have diverted management’s attention and time from our business. In addition, any failure to maintain effective corporate governance policies and procedures may have caused or could cause us to fail to timely meet our periodic reporting requirements, result in material misstatements or omissions in our financial statements and reports and other documents filed with the SEC, subject us to liability for failure to comply with applicable laws and regulations, including the Sarbanes-Oxley Act of 2002, and result in private litigation, regulatory proceedings or government enforcement actions. The resolution of any such matters, should they arise, may be time consuming and expensive and may distract management from the conduct of our business. Furthermore, if we are subject to adverse findings in litigation, regulatory proceedings or government enforcement actions, we could be required to pay damages or penalties or have other remedies imposed, which could harm our business, financial condition and results of operations and cash flows.

 

11


Table of Contents

We identified a material weakness in our internal control over financial reporting as of March 31, 2009 and concluded that our internal control over financial reporting and our disclosure controls and procedures were not effective as of March 31, 2009. As a result, we may be subject to a number of risks, including increased risks that we have or may not file our financial statements and related reports with the SEC on a timely basis and that there are errors in our reported financial statements and material misstatements in our reports and other documents filed with the SEC.

We are required to evaluate the effectiveness of our internal control over financial reporting and our disclosure controls and procedures as of the end of each fiscal year and to include a management report assessing the effectiveness of these controls in our Annual Report on Form 10-K. Based on its evaluation of our internal control over financial reporting as of March 31, 2009, including the information made available to management regarding the results of our review of our corporate governance policies and procedures, our management identified several control deficiencies and significant deficiencies in our internal control over financial reporting that, when considered in the aggregate, represent a material weakness in our internal control over financial reporting as of March 31, 2009. As a result, our management determined that our internal control over financial reporting and our disclosure controls and procedures were not effective as of March 31, 2009. For a description of these significant deficiencies and additional information about management’s evaluation of our internal control over financial reporting, please see Part II, Item 9A “Controls and Procedures.”

As part of the changes to our corporate governance policies and procedures described above, we have adopted and are in the process of implementing a number of measures designed to remediate the control deficiencies and significant deficiencies identified during our evaluation of our internal control over financial reporting as of March 31, 2009. We cannot assure you that these measures will be sufficient to remediate the deficiencies identified in our evaluation or that we will not identify additional deficiencies or material weaknesses in the future. The absence of effective internal control over financial reporting and disclosure controls and procedures increases the risk that we have not, or may in the future not, file our financial statements and related reports with the SEC on a timely basis, that there may be errors in our financial statements or material misstatements or omissions in our related reports and documents filed with the SEC. The occurrence of any of these events could expose us to private litigation, regulatory proceedings or government enforcement actions and undermine investor confidence in our reported financial information. The resolution of any such matters, should they arise, may be time consuming and expensive and may distract management from the conduct of our business. Furthermore, if we are subject to adverse findings in litigation, regulatory proceedings or government enforcement actions, we could be required to pay damages or penalties or have other remedies imposed, which could harm our business, financial condition and results of operations and cash flows.

We have relied and expect to continue to rely on orders from a relatively small number of customers for a substantial portion of our revenues, and the loss of any of these customers would significantly harm our business and operating results.

Our revenues are dependent on orders from a relatively small number of customers. Our three largest customers accounted for approximately 33% and 45% of our revenues for the fiscal years ended March 31, 2009 and 2008, respectively. We expect that we will continue to depend upon a relatively small number of customers for a substantial portion of our revenues for the foreseeable future. As a result, if we fail to successfully sell our products and services to one or more large customers in any particular period or a large customer purchases fewer of our products or services, defers or cancels orders, or terminates its relationship with us, our business and operating results would be harmed. In addition, many of our orders are realized at the end of the quarter. As a result of this concentration and timing, our quarterly operating results, including average selling prices, may fluctuate significantly if we are unable to complete one or more substantial sales in any given quarter.

 

12


Table of Contents

Our annual and quarterly revenues and operating results are inherently unpredictable and subject to fluctuations, and as a result, we may fail to meet the expectations of security analysts and investors, which could cause volatility or adversely affect the trading price of our common stock.

We enter into arrangements for the sale of: (1) licenses of software products and related maintenance contracts; (2) services; (3) subscription for on-demand services; and (4) bundled license, maintenance, and services. In instances where maintenance is bundled with a license of software products, the maintenance term is typically one year. For each arrangement, we determine whether evidence of an arrangement exists, delivery has occurred, the fees are fixed or determinable, and collection is probable. If any of these criteria are not met, revenue recognition is deferred until such time as all of the criteria are met.

Our annual and quarterly revenues may fluctuate due to our inability to perform services, achieve specific milestones and obtain formal customer acceptance of specific elements of the overall completion of a project. As we provide such services and products, the timing of delivery and acceptance, changed conditions with the customers and projects could result in changes to the timing of our revenue recognition, and thus, our operating results.

Likewise, if our customers do not renew maintenance services or purchase additional products, our operating results could suffer. Historically, we have derived and expect to continue to derive a significant portion of our total revenue from existing customers who purchase additional products or renew maintenance agreements. Our customers may not renew such maintenance agreements or expand the use of our products. In addition, as we introduce new products, our current customers may not require or desire the features of our new products. If our customers do not renew their subscriptions or maintenance agreements with us or choose not to purchase additional products, our operating results could suffer.

Because we rely on a limited number of customers, the timing of customer acceptance or milestone achievement, or the amount of services we provide to a single customer can significantly affect our operating results or the failure to replace a significant customer. Because expenses are relatively fixed in the near term, any shortfall from anticipated revenues could cause our quarterly operating results to fall below anticipated levels.

We may also experience seasonality in revenues. For example, our annual and quarterly results may fluctuate based upon our customers’ calendar year budgeting cycles. These seasonal variations may lead to fluctuations in our annual and quarterly revenues and operating results.

Our Contract Management customers license our software in a number of ways including perpetual licenses and subscriptions, which may be hosted in our third-party hosting center or on the customer’s own facilities. Historically the bulk of our license revenues have come from perpetual licenses which, if revenue recognition requirements are met, are recognized upon execution or release of contingencies, if any. Any trend towards our customers shifting to subscription licenses, which include maintenance and may include hosting, may affect our short-term financial results.

Based upon the foregoing, we believe that period-to-period comparisons of our results of operations are not necessarily meaningful and that such comparisons should not be relied upon as indications of future performance. In some future period, our operating results may be below the expectations of public market analysts and investors, which could cause volatility or a decline in the price of our common stock.

Our future success depends on our proprietary intellectual property, and if we are unable to protect our intellectual property from potential competitors, our business may be significantly harmed.

We rely on a combination of patent, trademark, trade secret and copyright law and contractual restrictions to protect the proprietary aspects of our technology. These legal protections afford only limited protection for our technology. We currently hold six patents and five pending patents in the United States. In addition, we have various trademarks registered or pending registration in various jurisdictions. Our trademark and patent

 

13


Table of Contents

applications might not result in the issuance of any trademarks or patents. Our patents or any future issued trademarks might be invalidated or circumvented or otherwise fail to provide us any meaningful protection. We seek to protect the source code for our software, documentation and other written materials under trade secret and copyright laws. We license our software pursuant to license agreements, which impose certain restrictions on the licensee’s ability to utilize the software. We also seek to avoid disclosure of our intellectual property by requiring employees and consultants with access to our proprietary information to execute confidentiality agreements. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or to obtain and use information that we regard as proprietary. In addition, the laws of many countries do not protect our proprietary rights to as great an extent as do the laws of the United States. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets and to determine the validity and scope of the proprietary rights of others. Regardless of the outcome, such litigation may require us to incur significant legal expenses and management time. Our failure to adequately protect our intellectual property could have a material adverse effect on our business and operating results.

In addition, we have in the past been subject to claims of third parties that our products and services infringe their intellectual property rights. For example, in October 2007 we agreed to settle a patent infringement lawsuit brought by Versata Enterprises, Inc. and a related party for a $10 million payment in October 2007 and an additional amount of not more than $7.5 million in quarterly payments. It is possible that in the future, other third parties may claim that our current or potential future products infringe their intellectual property rights. Any claims, with or without merit, could be time-consuming, result in costly litigation, divert management’s time from developing our business, cause product shipment delays, require us to enter into royalty or licensing agreements or require us to satisfy indemnification obligations to our customers. Royalty or licensing agreements, if required, may not be available on terms acceptable to us or at all, which could seriously harm our business.

Our lengthy sales cycle for our products makes it difficult for us to forecast revenue and exacerbates the variability of quarterly fluctuations, which could cause our stock price to decline.

The sales cycle of our products has historically averaged between nine to twelve months, and may sometimes be significantly longer. We are generally required to provide a significant level of education regarding the use and benefits of our products, and potential customers tend to engage in extensive internal reviews before making purchase decisions. In addition, the purchase of our products typically involves a significant commitment by our customers of capital and other resources, and is therefore subject to delays that are beyond our control, such as customers’ internal budgetary procedures and the testing and acceptance of new technologies that affect key operations. In addition, because we target large companies, our sales cycle can be lengthier due to the decision process in large organizations. As a result of our products’ long sales cycles, we face difficulty predicting the quarter in which sales to expected customers may occur. If anticipated sales from a specific customer for a particular quarter are not realized in that quarter, our operating results for that quarter could fall below the expectations of financial analysts and investors, which could cause our stock price to decline.

Developments in the market for enterprise software, including our CM and SC solutions, may harm our operating results, which could cause a decline in the price of our common stock.

The market for enterprise software, including CM and SC solutions, is evolving rapidly. In view of changing market trends, including vendor consolidation, the competitive environment growth rate and potential size of the market are difficult to assess. The growth of the market is dependent upon the willingness of businesses and consumers to purchase complex goods and services over the Internet and the acceptance of the Internet as a platform for business applications. In addition, companies that have already invested substantial resources in other methods of Internet selling may be reluctant or slow to adopt a new approach or application that may replace, limit or compete with their existing systems.

 

14


Table of Contents

The rapid change in the marketplace poses a number of concerns. Any decrease in technology infrastructure spending may reduce the size of the market for contract management and sales configuration solutions. Our potential customers may decide to purchase more complete solutions offered by larger competitors instead of individual applications. If the market for contract management and sales configuration solutions is slow to develop, or if our customers purchase more fully integrated products, our business and operating results would be significantly harmed.

We face intense competition, which could reduce our sales, prevent us from achieving or maintaining profitability and inhibit our future growth.

The market for software and services that enable electronic commerce is intensely competitive and rapidly changing. We expect competition to persist and intensify, which could result in price reductions, reduced gross margins and loss of market share. Our principal competition comes from (i) publicly-held and private software companies that offer integrated solutions or specific contract management and/or sales configuration solutions and (ii) internally-developed solutions. Existing and potential competitors include public companies such as Oracle Corporation, Ariba, Open Text and AT&T (through its acquisition of Comergent Technologies) as well as privately held companies such as Upside Software, I-Many, Emptoris and Trilogy/Versata (through its acquisition of Nextance).

Our competitors may intensify their efforts in our market. In addition, other enterprise software companies may offer competitive products in the future. Competitors vary in size, in the scope and breadth of the products and services offered. Although we believe we have advantages over our competitors including the comprehensiveness of our solution, our use of Java technology and our multi-threaded architecture, some of our competitors and potential competitors have significant advantages over us, including:

 

   

a longer operating history;

 

   

preferred vendor status with our customers;

 

   

more extensive name recognition and marketing power; and

 

   

significantly greater financial, technical, marketing and other resources, giving them the ability to respond more quickly to new or changing opportunities, technologies, and customer requirements.

Our competitors may also bundle their products in a manner that may discourage users from purchasing our products. Current and potential competitors may establish cooperative relationships with each other or with third parties, or adopt aggressive pricing policies to gain market share. Competitive pressures may require us to reduce the prices of our products and services. We may not be able to maintain or expand our sales if competition increases, and we are unable to respond effectively.

If we do not keep pace with technological change, including maintaining interoperability of our products with the software and hardware platforms predominantly used by our customers, our products may be rendered obsolete, and our business may fail.

Our industry is characterized by rapid technological change, changes in customer requirements, frequent new product and service introductions and enhancements and emerging industry standards. In order to achieve broad customer acceptance, our products must be compatible with major software and hardware platforms used by our customers. Our products currently operate on the Microsoft Windows NT, Sun Solaris, IBM AIX, J2EE, Linux and Microsoft Windows 2000 Operating Systems. In addition, our products are required to interoperate with electronic commerce applications and databases. We must continually modify and enhance our products to keep pace with changes in these operating systems, applications and databases. Our configuration, pricing and quoting products are complex, and new products and product enhancements can require long development and testing periods. If our products were to be incompatible with a popular new operating system, electronic commerce application or database, our business would be significantly harmed. In addition, the development of

 

15


Table of Contents

entirely new technologies to replace existing software could lead to new competitive products that have better performance or lower prices than our products and could render our products obsolete and unmarketable.

Our failure to meet customer expectations on deployment of our products could result in negative publicity and reduced sales, both of which would significantly harm our business and operating results.

In the past, a small number of our customers have experienced difficulties or delays in completing implementation of our products. We may experience similar difficulties or delays in the future. Deploying our products typically involves integration with our customers’ legacy systems, such as existing databases and enterprise resource planning software as well adding their data to the system. Failing to meet customer expectations on deployment of our products could result in a loss of customers and negative publicity regarding us and our products, which could adversely affect our ability to attract new customers. In addition, time-consuming deployments may also increase the amount of service personnel we must allocate to each customer, thereby increasing our costs and adversely affecting our business and operating result.

If we are unable to maintain our direct sales force, sales of our products and services may not meet our expectations, and our business and operating results will be significantly harmed.

We depend on our direct sales force for a significant portion of our current sales, and our future growth depends in part on the ability of our direct sales force to develop customer relationships and increase sales to a level that will allow us to reach and maintain profitability. If we are unable to retain qualified sales personnel or if newly hired personnel fail to develop the necessary skills or to reach productivity when anticipated, we may not be able to increase sales of our products and services, and our results of operation could be significantly harmed.

If we are unable to manage our professional services organization, we will be unable to provide our customers with technical support for our products, which could significantly harm our business and operating results.

Services revenues, which generated 78% and 71% of our total revenues during the fiscal years ended March 31, 2009 and 2008, respectively, are comprised primarily of revenues from consulting fees, maintenance contracts and training and are important to our business. Services revenues have lower gross margins than license revenues. We generally charge for our professional services on a time and materials rather than a fixed-fee basis. To the extent that customers are unwilling to utilize third-party consultants or require us to provide professional services on a fixed-fee basis, our cost of services revenues could increase and could cause us to recognize a loss on a specific contract, either of which would adversely affect our operating results. If we do not properly manage our costs of professional services, we could adversely affect our operating results. In addition, if we are unable to provide these professional services, we may lose sales or incur customer dissatisfaction, and our business and operating results could be significantly harmed.

If new versions and releases of our products contain errors or defects, we could suffer losses and negative publicity, which would adversely affect our business and operating results.

Complex software products such as ours often contain errors or defects, including errors relating to security, particularly when first introduced or when new versions or enhancements are released. In the past, we have discovered defects in our products and provided product updates to our customers to address such defects. Our products and other future products may contain defects or errors that could result in lost revenues, a delay in market acceptance or negative publicity, each which would significantly harm our business and operating results.

Demand for our products and services will decline significantly if our software cannot support and manage a substantial number of users.

Our strategy requires that our products be highly scalable. To date, only a limited number of our customers have deployed our products on a large scale. If our customers cannot successfully implement large-scale

 

16


Table of Contents

deployments, or if they determine that we cannot accommodate large-scale deployments, our business and operating results would be significantly harmed.

If we become subject to product liability litigation, it could be costly and time consuming to defend and could distract us from focusing on our business and operations.

Since our products are company-wide, mission-critical computer applications with a potentially strong impact on our customers’ sales, errors, defects or other performance problems could result in financial or other damages to our customers. Although our license agreements generally contain provisions designed to limit our exposure to product liability claims, existing or future laws or unfavorable judicial decisions could negate such limitation of liability provisions. Product liability litigation, even if it were unsuccessful, would be time consuming and costly to defend.

Our results of operations will be reduced by charges associated with stock-based compensation, accelerated vesting associated with stock options issued to employees, charges associated with other securities issued by us, and charges related to variable accounting.

We have in the past and expect in the future to incur a significant amount of charges related to securities issuances, which will negatively affect our operating results. We adopted the provisions of SFAS 123R using a modified prospective application effective April 1, 2006. We use the Black-Scholes option pricing model to determine the fair value of our share-based payments and recognize compensation cost on a straight-line basis over the vesting periods. This pronouncement from the FASB provides for certain changes to the method for valuing stock-based compensation. Among other changes, SFAS 123R applies to new awards and to awards that are outstanding which are subsequently modified or cancelled. Compensation expense calculated under SFAS 123R will continue to negatively impact our operating results.

Failure to improve and maintain relationships with systems integrators and consulting firms, which assist us with the sale and installation of our products, would impede the acceptance of our products and the growth of our revenues.

Our strategy has been to rely in part upon systems integrators and consulting firms to recommend our products to their customers and to install and deploy our products. To date, we have had limited success in utilizing these firms as a sales channel or as a provider of professional services. To increase our revenues and implementation capabilities, we must continue to develop and expand our relationships with these systems integrators and consulting firms. If these systems integrators and consulting firms are unwilling to install and deploy our products, we may not have the resources to provide adequate implementation services to our customers, and our business and operating results could be significantly harmed.

Some of our customers are hosted by a third-party provider.

Some of our CM customers’ licenses are hosted by a third-party data center provider under contract to us. Failure of the data center provider to maintain service levels as contracted could result in customer dissatisfaction, customer losses and potential product warranty or performance liabilities.

Our ongoing litigation with Trilogy, Inc. relating to our Rights Agreement could have a material adverse effect on our results of operations and financial condition.

On December 22, 2008, we filed suit in the Court of Chancery of the State of Delaware against Trilogy, Inc. and certain related parties (“Trilogy”) seeking declaratory relief that our Rights Agreement as amended on November 16, 2008 was an appropriate measure to protect a valuable asset of ours—our net operating loss carryforwards and related tax credits—from being limited as to utilization as provided under Section 382 of the Internal Revenue Code (IRC) which could in turn substantially reduce their value to all of our shareholders. We sued Trilogy on December 22, 2008 after (i) we amended our Rights Agreement on November 16, 2008 to reduce

 

17


Table of Contents

the ownership threshold from 15% to 4.99%, with existing 5% or greater shareholders limited to acquiring no more than an additional 0.5% and, (ii) despite the ownership threshold, Trilogy increased its beneficial ownership by 0.51% to 6.71% as announced in its 13(d) filing with the SEC on December 22, 2008. As a result, on January 2, 2009, a special committee of our Board of Directors declared Trilogy as an “Acquiring Person” under the Rights Agreement, and on February 4, 2009 we completed the distribution of 26.8 million shares to all existing shareholders (under the Exchange Provision in the Rights Agreement) other than Trilogy.

On January 16, 2009, the defendants in this action, Trilogy, filed an answer to our complaint and a counterclaim alleging that we, through our Board of Directors, had breached our fiduciary duty in amending the Rights Agreement and that such action favored one group of shareholders over another. We, and our Board of Directors, believe that the action taken on November 16, 2008 was appropriate under the circumstances and in the interest of all our shareholders and therefore the allegations of the counterclaim are without merit. The counterclaim asks for various measures of equitable relief and also includes a claim for punitive or exemplary damages, which are not available in Delaware.

The litigation is currently in the post-trial phase with a decision expected in the third or fourth calendar quarter of 2009, subject to appeal. As the costs of this litigation and related legal work are directly related to the issuance of shares under our rights plan, the costs of the litigation have been charged as issuance costs against the additional paid in capital account on our balance sheet, less a reserve for anticipated recovery from our Director’s and Officer’s insurance policy, which is reflected in prepaid expenses and other current assets on our balance sheet. As of March 31, 2009, the amount charged to additional paid in capital was approximately $2.0 million, and the anticipated recovery from our insurance policy was approximately $1.0 million.

There can be no assurance that we will prevail in our current litigation with Trilogy. In the event that we are not successful in that litigation and Trilogy or any other investor substantially increases its ownership of our common stock, our ability to use our NOLs could be substantially and irrevocably limited by application of the restrictions of Section 382 of the IRC. We could also incur significant costs if the Court orders us to distribute additional shares or undertake other measures to remediate our actions taken against Trilogy. Moreover, even if we are successful, the resolution of the litigation has been expensive, time consuming and distracted management from the conduct of our business.

Anti-takeover defenses that we have in place could prevent or frustrate attempts by stockholders to change our board of directors or the direction of our company.

Provisions of our amended and restated certificate of incorporation and amended and restated bylaws, Delaware law and the stockholder rights agreement adopted by us on February 4, 2003, as subsequently amended and restated on January 2, 2009, may make it more difficult for or prevent a third party from acquiring control of us without approval of our directors. These provisions include:

 

   

providing for a classified board of directors with staggered three-year terms;

 

   

restricting the ability of stockholders to call special meetings of stockholders;

 

   

prohibiting stockholder action by written consent;

 

   

establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at stockholder meetings;

 

   

granting our board of directors the ability to designate the terms of and issue new series of preferred stock without stockholder approval; and

 

   

issuing shareholders rights to purchase additional shares of stock in the event that any person, together with its affiliates and associates, (i) acquires beneficial ownership of 4.99% or more of our outstanding common stock or (ii) commences a tender offer for our shares if upon consummation of the tender offer such person would beneficially own 4.99% or more of the outstanding common stock, subject, in each case, to certain exceptions.

 

18


Table of Contents

These provisions may have the effect of entrenching our board of directors and may deprive or limit your strategic opportunities to sell your shares.

See the immediately preceding risk factor and Item 1, “Legal Proceedings,” of Part II of this report.

Compliance with new regulations dealing with corporate governance and public disclosure may result in additional expenses and require significant management attention.

The Sarbanes-Oxley Act of 2002, as well as new rules implemented by the SEC and The NASDAQ Global Market, has required changes in corporate governance practices of public companies. These rules are increasing our legal and financial compliance costs and causing some management and accounting activities to become more time-consuming and costly. This includes increased levels of documentation, monitoring internal controls, and increased manpower and use of consultants to comply. We have and will continue to expend significant efforts and resources to comply with these rules and regulations and have implemented a comprehensive program of compliance with these requirements and high standards of corporate governance and public disclosure.

We are currently not compliant with NASDAQ listing requirements given that the bid price of our stock is and has been under $1.00 per share for a period exceeding 180 days. However, given the current extraordinary market conditions, NASDAQ has temporarily suspended the applicability of this listing requirement and we have not been notified of any delisting action by NASDAQ. The $1.00 bid price minimum will be reinstated on July 20, 2009 and NASDAQ has not indicated any further suspension of the requirement beyond that date. There cannot be any assurance that any action will be taken by NASDAQ or that our stock will continue to be listed on the NASDAQ Global Market. Such action may make trading in our stock more difficult for investors and impair the liquidity of the stock.

These rules may also make it more difficult and more expensive for us to obtain director and officer liability insurance, and may make us accept reduced coverage or incur substantially higher costs for such coverage. The rules and regulations may also make it more difficult for us to attract and retain qualified executive officers and members of our board of directors, particularly to serve on our Audit Committee.

Restrictions on export of encrypted technology could cause us to incur delays in international product sales, which would adversely impact the expansion and growth of our business.

Our software utilizes encryption technology, the export of which is regulated by the United States government. If our export authority is revoked or modified, if our software is unlawfully exported or if the United States adopts new legislation restricting export of software and encryption technology, we may experience delay or reduction in shipment of our products internationally. Current or future export regulations could limit our ability to distribute our products outside of the United States. While we take precautions against unlawful exportation of our software, we cannot effectively control the unauthorized distribution of software across the Internet.

Unauthorized break-ins or other assaults on our computer systems could harm our business.

Our servers are vulnerable to physical or electronic break-ins and similar disruptions, which could lead to loss of data or public release of proprietary information. In addition, unauthorized persons may improperly access our data. These and other types of attacks could harm us. Actions of this sort may be very expensive to remedy and could adversely affect results of operations.

Changes to accounting standards and financial reporting requirements or tax laws, may affect our financial results.

We are required to follow accounting and financial reporting standards set by governing bodies in the U.S. and other countries where we do business. From time to time, these governing bodies implement new and revised

 

19


Table of Contents

laws and regulations. These new and revised accounting standards, financial reporting and tax laws may require changes to accounting principles used in preparing our financial statements. These changes may have a material impact on our business and financial results. For example, a change in accounting rules can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change became effective. As a result, changes to existing rules or reconsideration of current practices caused by such changes may adversely affect our reported financial results or the way we conduct our business.

Increasing government regulation of the Internet could limit the market for our products and services, or impose greater tax burdens on us or liability for transmission of protected data.

As electronic commerce and the Internet continue to evolve, federal, state and foreign governments may adopt laws and regulations covering issues such as user privacy, taxation of goods and services provided over the Internet, pricing, content and quality of products and services. If enacted, these laws and regulations could limit the market for electronic commerce, and therefore the market for our products and services. Although many of these regulations may not apply directly to our business, we expect that laws regulating the solicitation, collection or processing of personal or consumer information could indirectly affect our business.

 

Item 1B. Unresolved Staff Comments

Not applicable.

 

Item 2. Properties

Facilities

Our headquarters is located in San Jose, California, where we lease approximately 10,500 square feet of commercial space under a term lease that expires on October 31, 2009. We are currently seeking to either renew this lease or find office space elsewhere in the vicinity. Prior to December 2006, our headquarters was located in San Jose, California in an 80,000 square foot commercial office building under a non-cancelable operating lease expiring in December 2009. This facility was subleased in March 2007 to Nuova Systems. We also lease office space in San Francisco, California, with a lease that extends through April 2010.

 

Item 3. Legal Proceedings

Patent Infringement

On October 20, 2006, Versata Software, Inc., formerly known as Trilogy Software Inc., and a related party (collectively, “Versata”) filed a complaint against us in the United States District Court for the Eastern District of Texas, Marshall Division, alleging that we have been and are willfully infringing, directly and indirectly, U.S. Patent Nos. 5,515,524; 5,708,798 and 6,002,854 (collectively, the “Versata Patents”) by making, using, licensing, selling, offering for sale, or importing configuration software and related services (the “Versata Lawsuit”). On October 9, 2007, we reached a settlement on the Versata Lawsuit. Under the terms of the settlement, Selectica paid Versata $10.0 million on October 9, 2007 and agreed to pay an additional amount of not more than $7.5 million in quarterly payments. The quarterly payments are the greater of (i) $200,000 or (ii) amounts calculated based on 10% of revenues from our Sales Configuration Solution’s (“SCS”) products and services and a 50% revenue share of SCS revenue from new Company SCS customers that are currently Versata customers and to whom Versata makes an introduction to Selectica. Both parties entered into mutual releases, releasing any and all claims that they may have against the other occurring before the settlement date.

Rights Agreement

On December 22, 2008, we filed suit in the Court of Chancery of the State of Delaware against Trilogy, Inc. and certain related parties (“Trilogy”) seeking declaratory relief that our Rights Agreement as amended on

 

20


Table of Contents

November 16, 2008 was an appropriate measure to protect a valuable asset of ours—our net operating loss carryforwards and related tax credits—from being limited as to utilization as provided under Section 382 of the Internal Revenue Code (IRC) which could in turn substantially reduce their value to all of our shareholders. We sued Trilogy after (i) we amended our Rights Agreement on November 16, 2008 to reduce the ownership threshold from 15% to 4.99%, with existing 5% or greater shareholders limited to acquiring no more than an additional 0.5% and, (ii) despite the ownership threshold, Trilogy increased its beneficial ownership by 0.51% to 6.71% as announced in its 13(d) filing with the SEC on December 22, 2008. As a result, on January 2, 2009, a special committee of our Board of Directors declared Trilogy as an “Acquiring Person” under the Rights Agreement, and on February 4, 2009 we completed the distribution of 26.8 million shares to all existing shareholders (under the Exchange Provision in the Rights Agreement) other than Trilogy.

On January 16, 2009, the defendants in this action, Trilogy, filed an answer to our complaint and a counterclaim alleging that we, through our Board of Directors, had breached our fiduciary duty in amending the Rights Agreement and that such action favored one group of shareholders over another. We, and our Board of Directors, believe that the action taken on November 16, 2008 was appropriate under the circumstances and in the interest of all our shareholders and therefore the allegations of the counterclaim are without merit. The counterclaim asks for various measures of equitable relief and also includes a claim for punitive or exemplary damages, which are not available in Delaware.

The litigation is currently in the post-trial phase with a decision expected in the third or fourth calendar quarter of 2009, subject to appeal. As the costs of this litigation and related legal work are directly related to the issuance of shares under our rights plan, the costs of the litigation have been charged as issuance costs against the additional paid in capital account on our balance sheet, less a reserve for anticipated recovery from our Director’s and Officer’s insurance policy, which is reflected in prepaid expenses and other current assets on our balance sheet. As of March 31, 2009, the amount charged to additional paid in capital was approximately $2.0 million, and the anticipated recovery from our insurance policy was approximately $1.0 million.

Other

In the future we may be subject to other lawsuits, including claims relating to intellectual property matters or securities laws. Any litigation, even if not successful against us, could result in substantial costs and divert management’s and other resources away from the operations of our business. If successful against us, we could be liable for large damage awards and, in the case of patent litigation, subject to injunctions that significantly harm our business.

 

Item 4. Submission of Matters to a Vote of Security Holders

Not applicable.

 

21


Table of Contents

PART II

 

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Small Business Issuer Purchases of Equity Securities

Our common stock is traded over the counter on The NASDAQ Global Market (“NASDAQ”) under the symbol “SLTC.” Our common stock began trading in March 2000.

As of June 22, 2009, there were approximately 107 holders of record of our common stock. Brokers and other institutions hold many of such shares on behalf of stockholders.

 

     High    Low  

Fiscal 2008

     

First Quarter

   $ 2.00    $ 1.78   

Second Quarter

   $ 1.87    $ 1.45   

Third Quarter

   $ 2.00    $ 1.59   

Fourth Quarter

   $ 1.85    $ 1.25   

Fiscal 2009

     

First Quarter

   $ 1.56    $ 1.30   

Second Quarter

   $ 1.26    $ 1.01   

Third Quarter

   $ 1.09    $ 0.60   

Fourth Quarter

   $ 0.88    $ 0.29 (1) 

 

(1) On January 2, 2009, a special committee of our Board of Directors declared Trilogy as an “Acquiring Person” under the Rights Agreement, and as a result, on February 4, 2009 we completed the distribution of 26.8 million shares to all existing shareholders (under the Exchange Provision in the Rights Agreement) other than Trilogy.

The trading price of our common stock could be subject to wide fluctuations in response to quarterly variations in operating results, announcements of technological innovations or new products by us or our competitors, changes in financial estimates or purchase recommendations by securities analysts and other events or factors. In addition, the stock market has experienced volatility that has affected the market prices of equity securities of many high technology companies and that often has been unrelated to the operating performance of such companies. These broad market fluctuations may adversely affect the market price of our common stock. See “Risk Factors.”

Equity Compensation Plan Information

The following table sets forth as of March 31, 2009, certain information regarding our equity compensation plans.

 

     A    B    C  

Plan category

   Number of
securities to
be issued upon
exercise of
outstanding options
warrants and rights
   Weighted-average
exercise price of
outstanding options
warrants and rights
   Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding securities
reflected in Column A)
 
     (in thousands, except for per share amounts below)  

Equity compensation plans approved by security holders

   4,016    $ 1.24    33,676 (1)(2) 

Equity compensation plans not approved by security holders

   104    $ 1.92    3,588   
                  

Total

   4,120    $ 1.27    37,264   
                  

 

(1) These plans permit the grant of options, stock appreciation rights, shares of restricted stock and stock units.

 

22


Table of Contents
(2) On each January 1, starting in 2001, the number of shares reserved for issuance under our 1999 Equity Incentive Plan will be automatically increased by the lesser of 5% of the then outstanding shares of common stock or 3.6 million shares. On each May 1, starting in 2001, the number of shares reserved for issuance under our 1999 Employee Stock Purchase Plan will be automatically increased by the lesser of 2% of the then outstanding shares of common stock or 2.0 million shares.

Stock Option Plans—Not Required to be Approved by Stockholders

2001 Supplemental Plan

We adopted the 2001 Supplemental Plan (the “Supplemental Plan”) on May 30, 2001; the Supplemental Plan did not require stockholder approval. A total of approximately 5.0 million shares of common stock have been reserved for issuance under the Supplemental Plan. With limited restrictions, if shares awarded under the Supplemental Plan are forfeited, those shares will again become available for new awards under the Supplemental Plan. The Supplemental Plan permits the grant of non-statutory options and shares of restricted stock. Employees and consultants, who are not officers or members of the Board of Directors, are eligible to participate in the Supplemental Plan. Options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the Supplemental Plan have a maximum term of ten years.

The Compensation Committee of the Board of Directors administers the Supplemental Plan and has complete discretion to make all decisions relating to the interpretation and operation of the Supplemental Plan. The Compensation Committee has the discretion to determine which eligible persons are to receive an award, and to determine the type, number, vesting requirements and other features and conditions of each award. The exercise price of options may be paid with: cash, outstanding shares of common stock, the cashless exercise method through a designated broker, a pledge of shares to a broker or a promissory note. The purchase price for newly issued restricted shares may be paid with: cash, a promissory note or the rendering of past or future services. The Compensation Committee may reprice options and may modify, extend or assume outstanding options. The Compensation Committee may accept the cancellation of outstanding options in return for the grant of new options. The new option may have the same or a different number of shares and the same or a different exercise price. If a merger or other reorganization occurs, the agreement of merger or reorganization shall provide that outstanding options and other awards under the Supplemental Plan shall be assumed or substituted with comparable awards by the surviving corporation or its parent or subsidiary, shall be continued by the Company if it is the surviving corporation, shall have accelerated vesting and then expire early or shall be cancelled for a cash payment. If a change in control occurs, awards will become fully exercisable and fully vested if the awards do not remain outstanding, are not assumed by the surviving corporation or its parent or subsidiary and if the surviving corporation or its parent or subsidiary does not substitute its own awards that have substantially the same terms for the awards granted under the Supplemental Plan. If a change in control occurs and a plan participant is involuntarily terminated within 12 months following this change in control, then the vesting of awards held by the participant will accelerate, as if the participant provided another 12 months of service. A change in control includes: a merger or consolidation after which the then-current stockholders own less than 50% of the surviving corporation, a sale of all or substantially all of the assets, a proxy contest that results in replacement of more than one-half of the directors over a 24-month period or an acquisition of 50% or more of the outstanding stock by a person other than a person related to the Company, including a corporation owned by the stockholders. The Board of Directors may amend or terminate the Supplemental Plan at any time. The Supplemental Plan will continue in effect indefinitely unless the Board of Directors decides to terminate the plan earlier.

Dividend Policy

We have never declared or paid any cash dividends on our capital stock. Whether or not a dividend will be paid in the future will be determined by our Board of Directors.

 

23


Table of Contents

Recent Sales of Unregistered Securities

Not applicable.

Use of Proceeds from Sales of Registered Securities

Not applicable.

 

Item 6. Selected Financial Data.

We are a “smaller reporting company” as defined by Regulation S-K and as such, are not required to provide the information contained in this item pursuant to Regulation S-K.

 

24


Table of Contents
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Form 10-K. This discussion contains forward-looking statements reflecting our current expectations and estimates and assumptions concerning events and financial trends that may affect our future operating results or financial position. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the “Forward-Looking Statements” set forth above.

Overview

We provide contract management and sales configuration software solutions that allow enterprises to efficiently manage sell-side business processes. Our solutions include software, on demand hosting, professional services and expertise.

The Selectica Contract Lifecycle Management (“CLM” or “CM”) solution is a contract authoring, analysis, repository and process automation product designed to enhance and automate the management of the entire contract lifecycle. It helps companies take control of their contract management processes by converting from paper-based to electronic repositories and by unlocking multiple layers of critical business data, making it available for the evaluation of risk, the exposure of lost revenue and the evaluation of supplier performance, and other purposes. The solution helps to improve the customer buying experience for sales organizations, improve the control of risk and decrease time spent drafting, monitoring and managing contracts for the corporate counsel’s office and gain access to previously hidden discounts through the exposure and elimination of unfavorable agreements for procurement and sourcing organizations.

The Selectica Sales Configuration (“SCS”) solution consolidates configuration, pricing and quoting functions into a single application platform enabling companies to streamline the opportunity-to-order process for manufacturers, service providers, and financial services companies. Our SCS solution provides a critical link between Customer Relationship Management (CRM) and Enterprise Resource Planning (ERP) systems that helps to simplify and automate the configuration, pricing, and quoting of complex products and services. By empowering customers, internal sales staff, and/or channel partners to generate error-free sales proposals for their unique requirements, we believe our SCS solution helps companies to close sales faster, accelerate revenue generation and enhance customer relationships.

Summary of Operating Results for Fiscal 2009

During the fiscal year ended March 31, 2009, our total revenues increased by 3%, or $0.4 million, to $16.4 million compared with total revenues of $16.0 million for the fiscal year ended March 31, 2008. The results for 2009 also reflected a shift of revenues from being primarily dependent on our SCS products to being primarily dependent on our CLM products. In fiscal 2009, CLM products and service revenues totaled $9.9 million or 60% of total revenues, representing an increase of $4.1 million or 72% over fiscal 2008, whereas our SCS products and service revenues totaled $6.5 million or 40% of total revenues, representing a decrease of $3.7 million or 36% over fiscal 2008. This resulted largely from increased license and professional service revenues for our CM products, reflecting the investments we made in fiscal 2009 to expand our CM business and the decline in license revenues for our SCS products.

During the fiscal year ended March 31, 2009, our net loss declined by 65% or $15.5 million, to $8.4 million compared to a net loss of $23.9 million for the fiscal year ended March 31, 2008. The most significant factors affecting the decline in our net loss are (i) a decline in charges from $16.3 million related to a litigation settlement in the fiscal year ended March 31, 2008, to $92,000 in the fiscal year ended March 31, 2009 (ii) a decline in professional fees related to our stock option investigation from $3.6 million in the fiscal year ended March 31, 2008 to $38,000 in the fiscal year ended March 31, 2009 and (iii) a decline in gross margins in the

 

25


Table of Contents

period ended March 31, 2009 due to the shift in mix between license revenues and service revenues offset by declines in costs for research and development, sales and marketing and restructuring. Service revenues typically have lower margins than license revenues and the shift towards service revenues in the year ended March 31, 2009 resulted in a decline of 8.9% (from 73.8% to 64.9%) in our overall gross margin from the year ended March 31, 2008.

Outlook for Fiscal 2010

We anticipate that our shift in focus from our SCS business to our CM business will continue in fiscal year 2010 and, specifically, that revenues from our CM business will continue to grow in fiscal year 2010, but at a lower rate of growth than in fiscal 2009, while revenues from our SCS business will remain flat or decline modestly. We believe that our success in fiscal year 2010 will depend critically on our ability to (i) manage the continuing shift from our SCS business to our CM business, (ii) increase our CM license revenue , (iii) manage our costs of professional services to increase our margins in that segment of our business, (iv) enhance our management team, (v) execute on our business plan despite a significant reduction in our workforce in the first quarter of fiscal 2010 and (vi) achieve targeted expense reductions. We believe that key risks in fiscal 2010 include (i) the impact of continuing adverse worldwide economic conditions on overall demand for our products, (ii) risks associated with the planned transition of our business, and (iii) the impact of our continuing litigation with Trilogy regarding our shareholder rights plan.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. Our significant accounting policies are described in notes accompanying the consolidated financial statements. The preparation of the consolidated financial statements requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosure of contingent assets and liabilities. Estimates are based on information available as of the date of the financial statements, and accordingly, actual results in future periods could differ from these estimates. Significant judgments and estimates used in the preparation of the consolidated financial statements apply critical accounting policies described in the notes to our consolidated financial statements.

We consider our recognition of revenue, calculation of liabilities and stock-based compensation to be the most critical judgments that are involved in the preparation of the consolidated financial statements.

Results of Operations

Revenues

 

     2009     2008     Change  
     (in thousands, except percentages)  

License

   $ 3,569      $ 4,588      $ (1,019

Percentage of total revenues

     22     29     —     

Services

   $ 12,876      $ 11,415      $ 1,461   

Percentage of total revenues

     78     71     —     

Total revenues

   $ 16,445      $ 16,003      $ 442   

License. License revenues consist of revenue from licensing our software products. Fiscal 2009 license revenue decreased by $1.0 million from the prior year primarily due to the $1.9 million decline in license revenues from our sales configuration business as we increased our focus to our CM products, which produced an increase in CM license revenues of $0.9 million which did not offset the decline in SCS license revenues.

 

26


Table of Contents

Services. Services revenues are comprised of fees from consulting, maintenance, training, subscription revenues and out-of pocket reimbursements. Services revenues for fiscal year 2009 increased $1.5 million, or 13%, from the prior year, primarily due to more consulting revenues provided by new and existing customer agreements in the CM business unit. Maintenance revenues were 44% and 49% of total service revenues for the twelve months ended March 31, 2009, and 2008, respectively.

We expect services revenues to continue to fluctuate in future periods as a percentage of total revenues and in absolute dollars. This will depend on new license revenue and the number and size of new software implementations and follow-on services to our existing customers. We expect maintenance revenue to fluctuate in absolute dollars and as a percentage of services revenues with respect to the number of maintenance renewals, and number and size of new license contracts. In addition, maintenance renewals, although renewed at a 100% rate from existing customers in fiscal 2009, are extremely dependent upon economic conditions, customer satisfaction and the level of need to make changes or upgrade versions of our software by our customers. Fluctuations in revenue are also due to timing of revenue recognition, achievement of milestones, customer acceptance, changes in scope or renegotiated terms, and additional services.

Factors Affecting Operating Results

A small number of customers in our SCS category account for a significant portion of our total revenues. We expect that our revenue will continue to depend upon a limited number of customers. If we were to lose a customer, it would have a significant impact upon future revenue. Customers who accounted for at least 10% of total revenues were as follows:

 

     2009     2008  

Customer A

   18   25

Customer B

   *      12
 

* Revenues were less than 10% of total revenues

We no longer have significant foreign activities. We anticipate that any exposure to foreign currency fluctuations will not be significant.

Cost of Revenues

 

     2009     2008     Change  

Cost of license revenues

   $ 206      $ 255      $ (49

Percentage of license revenues

     6     6     —     

Cost of services revenues

   $ 5,563      $ 3,946      $ 1,617   

Percentage of services revenues

     43     35     —     

Total cost of revenues

   $ 5,769      $ 4,201      $ 1,568   

Cost of License Revenues. Cost of license revenues consists of a fixed allocation of our research and development costs. During the fiscal year 2009, license costs were $0.2 million. We expect cost of license revenues to maintain a relatively consistent level in absolute dollars in fiscal year 2010.

Cost of Services Revenues. Cost of services revenues is comprised mainly of salaries and related expenses of our services organization plus certain allocated corporate expenses. During fiscal 2009, these costs increased by approximately $1.6 million primarily due to the increase in investments in our CM professional services staff as well as an increase in the use of third-party consultants. This increase was partially offset by a decrease during fiscal 2009 of approximately $0.7 million from the SCS business unit due to a decrease of 10 headcount in SCS professional services.

We expect cost of service revenues to fluctuate as a percentage of service revenues.

 

27


Table of Contents

Gross Margin

 

     2009     2008  

Gross margin, license revenues

   94   94

Gross margin, services revenues

   57   65

Gross margin, total revenues

   65   74

Gross Margin—Gross margins represent gross profit as a percentage of revenue. Gross margins in fiscal 2009 and 2008 were affected by the factors discussed above under “Revenues” and “Cost of Revenues”.

Gross Profit

Gross profit was $10.7 million, or 65% of revenues, in fiscal 2009 compared with $11.8 million, or 74% of revenues, in fiscal 2008. The decline in gross profit during fiscal year 2009 was due to the change in mix to a greater percentage of revenue being from services, which have lower margins, and an increase in our cost of services revenue due to the increase in investments in our CM professional services staff as well as an increase in the use of third-party consultants.

SCS gross profit was $4.9 million, or 75% of revenues, in fiscal 2009 compared with $7.9 million, or 77% of revenues, in fiscal 2008. The decrease was due to a $1.9 million reduction in license revenues and higher relative professional services revenues which operate at lower margins.

CM gross profit was $5.7 million, or 58% of revenues, in fiscal 2009 compared with $3.9 million, or 67% of revenues, in fiscal 2008. The increase in gross profit during fiscal year 2009 was due to increased license revenues while margins decreased due to the increase in development expenditures and investments in our CM professional services staff as well as an increase in the use of third-party consultants to complete historic fixed-price arrangements to assure customer satisfaction.

We expect that our overall gross margins will continue to fluctuate due to the timing of service and license revenue recognition and will continue to be adversely affected by lower margins associated with service revenues. The impact on our gross margin will depend on the mix of services we provide, whether the services are performed by our in-house staff or third party consultants, and the overall utilization rates of our professional services organization. In addition, gross margins may be lower as a result of the shift and increased investment we have made to our CM business which, in the short term may have lower gross margins than our SCS business depending on the relationship of professional service revenues to license or subscription revenues.

Operating Expenses

 

     2009     2008     Change  

Total research and development

   $ 4,218      $ 5,045      $ (827

Percentage of total revenues

     26     32     —     

Research and Development. Research and development expenses consist mainly of salaries and related costs of our engineering, quality assurance, technical publications efforts, and certain allocated expenses. The decrease in research and development expenses of $0.8 million in fiscal 2009 compared to fiscal year 2008 was attributable primarily to reductions in headcount and decreases in costs for facilities, overhead and benefits. We expect research and development expenditures to increase modestly in absolute dollars over the next several years as we continue development in our CM products and integrate with tools provided by third parties.

 

     2009     2008     Change  

Sales and marketing

   $ 6,307      $ 6,664      $ (357

Percentage of total revenues

     38     42     —     

 

28


Table of Contents

Sales and Marketing. Sales and marketing expenses consist primarily of salaries and related costs for our sales and marketing organization, sales commissions, expenses for travel and entertainment, trade shows, public relations, collateral sales materials, advertising and certain allocated expenses. In fiscal 2009, sales and marketing expenses decreased $0.4 million primarily due to decreases in expenditures in our SCS product line and the implementation of a new team in our CM product line which was fully in place only for the second half of fiscal 2009. We expect modest reductions in sales and marketing expenses in fiscal 2010 compared to fiscal 2009 both in absolute dollars and as a percentage of total revenues.

 

     2009     2008     Change  

General and administrative

   $ 5,522      $ 5,427      $ 95   

Percentage of total revenues

     34     34     —     

Professional fees related to stock option investigation

   $ 38      $ 3,596      $ (3,558

Percentage of total revenues

     0.2     22     —     

Litigation settlement

   $ 92      $ 16,275      $ (16,183

Percentage of total revenues

     0.6     101     —     

General and Administrative, Professional fees related to stock option investigation, and litigation settlement. General and administrative expenses consist mainly of personnel and related costs for general corporate functions, including finance, accounting, legal, human resources, bad debt expense and certain allocated expenses. General and administrative expenses increased $0.1 million in fiscal 2009 compared with fiscal 2008 due to increased expenditures for outside contractors, and payments to our board members who assumed more active roles as a result of not having a full time CEO, offset partially by internal efficiencies. We incurred approximately $38,000 in professional fees related to the stock option investigation in fiscal 2009, compared to $3.6 million in fiscal year 2008 in professional fees related to the stock option investigation. We incurred approximately $92,000 in litigation settlement expenses related to the Versata lawsuit as the majority of those expenses were incurred in the prior year (See Footnote 8 to the Consolidated Financial Statements). We incurred approximately $16.3 million in legal settlement costs related to the Versata lawsuit in the prior year. We expect modest reductions in general and administrative expenses in fiscal 2010 compared to fiscal 2009 both in absolute dollars and as a percentage of total revenues.

Restructuring. Restructuring expenses consist primarily of personnel reductions and excess facility charges related to our cost realignment initiatives. The restructuring accrual and the related utilization for the fiscal year ended March 31, 2009 were (in thousands):

 

     Severance and
Benefits
    Excess
Facilities
    Total  

Balance, March 31, 2008

   $ 126      $ 2,705      $ 2,831   

Additional accruals

     661        (143     518   

Amounts paid in cash

     (735     (1,812     (2,547

Loan to sublessee

     —          463        463   
                        

Balance, March 31, 2009

   $ 52      $ 1,213      $ 1,265   
                        

During fiscal year 2009, we reduced certain executive headcount and revised our excess facility accrual related to our corporate headquarters relocation in the amount of $0.7 million and $0.3 million, respectively. Based on a reduction of headcount in the first quarter of fiscal 2010, we expect to record restructuring charges of at least $500,000 in fiscal 2010.

Other income (expense), net

 

     2009     2008    Change  

Other income (expense), net

   $ (2,122   $ 381    $ (2,503

 

29


Table of Contents

Other income (expense), net consists primarily of expenses from the impact of foreign currency remeasurement, primarily from our Indian subsidiary (which was sold on March 31, 2009) as well as interest expense associated with our note payable to Versata. In fiscal 2009, other income (expense), net decreased $2.5 million primarily due to unfavorable foreign exchange rate movements against the U.S. dollar that occurred prior to our adopting a hedging program in December 2008. Subsequent to the sale of our Indian subsidiary, our foreign exchange exposure has been substantially eliminated.

Interest Income

 

     2009    2008    Change  

Interest income

   $ 983    $ 2,477    $ (1,494

Interest income consists primarily of interest earned on cash balances and short-term investments. Interest income decreased in fiscal year 2009 due to lower cash balances and interest rates. We anticipate that interest income in fiscal 2010 will decline relative to fiscal 2009 as a result of lower cash balances and lower interest rates.

Provision for Income Taxes

We incurred income taxes of approximately $157,000 for fiscal year 2009 and approximately $361,000 for fiscal year 2008. As of March 31, 2009, we had federal and state net operating loss carryforwards of approximately $166.5 million and $87.3 million, respectively. As of March 31, 2009, we also had federal and state research and development tax credit carryforwards of approximately $3.1 million and $4.3 million, respectively.

The fiscal 2009 and 2008 tax provisions vary from the expected provision or benefit at the U.S. federal statutory rate due to the recording of valuation allowances against our U.S. operating loss and the effects of different tax rates in our foreign jurisdictions. Given our history of operating losses and our inability to achieve profitable operations, it is difficult to accurately forecast how results will be affected by the realization of net operating loss carryforwards.

SFAS No. 109 provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based upon the weight of available evidence, which includes our historical operating performance and the reported cumulative net losses in all prior years, we have provided a full valuation allowance against our net deferred tax assets. We will continue to evaluate the realizability of the deferred tax assets on a quarterly basis.

In addition, the Housing and Economic Recovery Act of 2008 (“Act”), signed into law in July 2008 and modified under the Economic Stimulus Act of 2009, allows taxpayers to claim refundable AMT or research and development credit carryovers if they forego bonus depreciation on certain qualified fixed assets placed in service from the period between April 2008 through December 2009. We estimated and recognized the credit based on fixed assets placed into service through the twelve months ended March 31, 2009. During the twelve months ended March 31, 2009 we recorded a net income tax benefit of $13,756 for a U.S. federal refundable credit as provided by the Act.

Liquidity and Capital Resources

 

     2009     2008  
     (in thousands)  

Cash, cash equivalents and short-term investments

   $ 23,452      $ 35,213   

Working capital

   $ 20,180      $ 30,762   

Net cash used for operating activities

   $ (8,002   $ (22,162

Net cash provided by investing activities

   $ 10,470      $ 15,014   

Net cash used for financing activities

   $ (2,808   $ (484

 

30


Table of Contents

Our primary sources of liquidity consisted of approximately $23.5 million in cash, cash equivalents and short-term investments as of March 31, 2009 compared to approximately $35.2 million in cash, cash equivalents and short-term investments as of March 31, 2008.

Net cash used in operating activities was $8.0 million for the twelve months ended March 31, 2009, resulting primarily from our net loss of $8.4 million, a $3.3 million increase in accounts receivable and a $1.6 million increase in prepaid expenses and other current assets. These decreases in cash flows from operating activities were partially offset by a $1.9 million increase in deferred revenues and a $2.7 million increase in accounts payable.

Net cash used in operating activities was $22.2 million for the twelve months ended March 31, 2008, resulting primarily from our net loss of approximately $23.9 million. Adjustments for non-cash expenses include a net non-cash charge for litigation settlement of $6.1 million, stock based compensation expenses of $1.5 million, depreciation and amortization of approximately $0.7 million, a decrease in accounts payable of approximately $2.5 million and a decrease in accrued liabilities of approximately $3.8 million.

Net cash provided by investing activities was $10.5 million for the twelve months ended March 31, 2009, resulting primarily from $8.2 million of net proceeds of short-term investments, and $2.6 million in net proceeds from the sale of our Indian subsidiary, which was completed on March 31, 2009.

Net cash provided by investing activities was $15.0 million for the twelve months ended March 31, 2008, which was primarily due to net proceeds from the maturity of short-term investments.

As a result of current adverse financial market conditions, investments in some financial instruments may pose risks arising from liquidity and credit concerns. Although we believe our current investment portfolio has very little risk of impairment, we cannot predict future market conditions or market liquidity and can provide no assurance that our investment portfolio will remain unimpaired.

Net cash used in financing activities was $2.8 million for the twelve months ended March 31, 2009, resulting primarily from $2.0 million in costs to defend our Rights Agreement, as well as $0.8 million of payments on our note payable to Versata.

Net cash used in financing activities was $0.5 million for the twelve months ended March 31, 2008, which was primarily due to $0.2 million in payments on our note payable to Versata and $0.3 million used to purchase treasury stock.

We expect to incur significant operating costs for the foreseeable future. We expect to fund our operating costs, as well as our future capital expenditures and liquidity needs, from a combination of available cash balances and internally generated funds. We have no outside debt, and do not have any plans to enter into borrowing arrangements. As a result, our net cash flows will depend heavily on the level of future sales, changes in deferred revenues, our ability to manage costs and ongoing legal proceedings.

We believe our cash, cash equivalents, and short-term investment balances as of March 31, 2009 should be adequate to fund our operations through at least March 31, 2010. However, given the significant changes in our business and results of operations in the last 12 months, the fluctuation in cash and investment balances may be greater than presently anticipated. See “Risk Factors.” After the next 12 months, we may find it necessary to obtain additional funds. In the event additional funds are required, we may not be able to obtain additional financing on favorable terms or at all.

 

31


Table of Contents

Contractual Obligations

The following table summarizes our outstanding contractual obligations as of March 31, 2009 and the effect those obligations are expected to have on our liquidity and cash flows in future periods (in thousands):

 

     Payments Due by Period

Contractual Obligations

   Total    Less than
1 Year
   1-3 Years    3-5 years    More than
5 Years

Operating lease—real estate, net

   $ 1,472    $ 1,464    $ 8    $ 0    $ 0

Other

     41      18      18      3      2
                                  

Total

   $ 1,513    $ 1,482    $ 26    $ 3    $ 2
                                  

Our contractual obligations and commercial commitments at March 31, 2009 were approximately $1.5 million. We had no significant commitments for capital expenditures as of March 31, 2009.

We do not anticipate any significant capital expenditures, un-planned payments due on long-term obligations, or other contractual obligations. However, management is continuing to review the Company’s cost structure to minimize expenses and use of cash as it implements its planned business model changes. This activity may result in additional restructuring charges for severance and other benefits.

Off-balance sheet arrangements

We have no off-balance sheet arrangements or transactions with unconsolidated limited purpose entities, nor do we have any undisclosed material transactions or commitments involving related persons or entities.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

We are a “smaller reporting company” as defined by Regulation S-K and as such, are not required to provide the information contained in this item pursuant to Regulation S-K.

 

32


Table of Contents
Item 8. Financial Statements and Supplementary Data.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm

   34

Consolidated Balance Sheets as of March 31, 2009 and 2008

   35

Consolidated Statements of Operations—Years ended March 31, 2009 and 2008

   36

Consolidated Statements of Stockholders’ Equity—Years ended March 31, 2009 and 2008

   37

Consolidated Statements of Cash Flows—Years ended March 31, 2009 and 2008

   38

Notes to Consolidated Financial Statements

   39

 

33


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders

Selectica, Inc.

We have audited the accompanying consolidated balance sheets of Selectica, Inc. (the “Company”) as of March 31, 2009 and 2008, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the two years in the period ended March 31, 2009. In connection with our audits of the consolidated financial statements, we have also audited the financial statement schedule listed in Item 15b. These consolidated financial statements and related financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal controls over financial reporting. An audit includes consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Selectica, Inc. at March 31, 2009 and March 31, 2008, and the consolidated results of their operations and their cash flows for each of the two years in the period ended March 31, 2009, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the consolidated financial statements taken as a whole, presents fairly, in all material aspects, the information set forth therein.

/ S / A RMANINO M C K ENNA LLP

San Ramon, California

July 7, 2009

 

34


Table of Contents

SELECTICA, INC.

CONSOLIDATED BALANCE SHEETS

 

     March 31,  
     2009     2008  
    

(in thousands,

except par value)

 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 23,256      $ 22,137   

Short-term investments

     196        13,076   

Accounts receivable, net of allowance for doubtful accounts of $373 and $0, as of March 31, 2009 and 2008, respectively

     5,598        1,330   

Prepaid expenses and other current assets

     2,485        919   

Total current assets

     31,535        37,462   
                

Property and equipment, net

     1,060        2,185   

Intangible assets

     7        102   

Other assets

     665        491   
                

Total assets

   $ 33,267      $ 40,240   
                

Liabilities and Stockholders’ Equity

    

Current liabilities:

    

Current portion of note payable to Versata

   $ 786      $ 786   

Accounts payable

     3,133        518   

Current portion of accrual for restructuring liability

     1,265        1,937   

Accrued payroll and related liabilities

     720        740   

Other accrued liabilities

     1,520        735   

Deferred revenues

     3,931        1,984   
                

Total current liabilities

     11,355        6,700   

Accrual for restructuring liability, net of current portion

     —          924   

Note payable to Versata, net of current portion

     4,588        5,113   

Other long-term liabilities

     48        245   
                

Total liabilities

     15,991        12,982   
                

Commitments and contingencies (See Notes 7 and 8)

    

Stockholders’ equity:

    

Preferred stock, $0.0001 par value:

    

Authorized: 25,000 shares at March 31, 2009 and 2008; None issued and outstanding

     —          —     

Common stock, $0.0001 par value:

    

Authorized: 150,000 shares at March 31, 2009 and 2008, respectively
Issued: 66,892 and 40,041 shares at March 31, 2009 and 2008, respectively Outstanding: 55,546 and 28,695 shares at March 31, 2009 and 2008, respectively

     4        4   

Additional paid-in capital

     299,383        300,939   

Accumulated deficit

     (249,205     (240,783

Accumulated other comprehensive income, net of income taxes

     —          4   

Treasury stock at cost—11,346 shares at March 31, 2009 and 2008, respectively

     (32,906     (32,906
                

Total stockholders’ equity

     17,276        27,258   
                

Total liabilities and stockholders’ equity

   $ 33,267      $ 40,240   
                

The accompanying notes are an integral part of these consolidated financial statements.

 

35


Table of Contents

SELECTICA, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

     Fiscal Years Ended March 31,  
                 2009                             2008              
     (in thousands, except per share amounts)  

Revenues:

    

License

   $ 3,569      $ 4,588   

Services

     12,876        11,415   
                

Total revenues

     16,445        16,003   

Cost of revenues:

    

License

     206        255   

Services

     5,563        3,946   
                

Total cost of revenues

     5,769        4,201   
                

Gross profit

     10,676        11,802   
                

Operating expenses:

    

Research and development

     4,218        5,045   

Sales and marketing

     6,307        6,664   

General and administrative

     5,522        5,427   

Restructuring

     675        1,193   

Professional fees related to stock option investigation

     38        3,596   

Litigation settlement

     92        16,275   
                

Total operating expenses

     16,852        38,200   
                

Loss from operations

     (6,176     (26,398

Other income (expense), net

     (2,122     381   

Loss on sale of subsidiary

     (950     —     

Interest income

     983        2,477   
                

Loss before provision for income taxes

     (8,265     (23,540

Provision for income taxes

     157        361   
                

Net loss

   $ (8,422   $ (23,901
                

Basic and diluted net loss per share

   $ (0.26   $ (0.84
                

Weighted-average shares of common stock used in computing basic and diluted net loss per share

     32,828        28,457   
                

The accompanying notes are an integral part of these consolidated financial statements.

 

36


Table of Contents

SELECTICA, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands)

 

    Common Stock   Additional
Paid-In
Capital
    Accumulated
Deficit
    Accumulated
Other
Comprehensive
Income (Loss),
net of taxes
    Treasury Stock     Total
Stockholders’
Equity
    Comprehensive
Loss
 
  Shares   Amount         Shares     Amount      

Balance at March 31, 2007

  39,596   $ 4   $ 299,476      $ (216,889   $ (18   (11,189   $ (32,660   $ 49,913     

Exercise of stock options by employees, net of repurchase

  92     —       —          —          —        —          —          —       

Issuance of restricted stock

  353     —       —          —          —        (157     (246     (246  

Stock-based compensation expense

  —       —       1,463        —          —        —          —          1,463     

Comprehensive loss:

                 

Other comprehensive gain, net of taxes

  —       —       —          7        22      —          —          29      $ 29   

Net loss

  —       —       —          (23,901     —        —          —          (23,901     (23,901
                       

Total comprehensive loss

                  $ (23,872
                                                               

Balance at March 31, 2008

  40,041     4     300,939        (240,783     4      (11,346     (32,906     27,258     
                                                         

Stock-based compensation expense

  —       —       452        —          —        —          —          452     

Proceeds from sales of shares through employee stock purchase plan

  56     —       26        —          —        —          —          26     

Issuance of additional common shares under Rights Agreement (see Note 8)

  26,795     —       —          —          —        —          —          —       

Common stock issuance costs, net (see Note 8)

  —       —       (2,034     —          —        —          —          (2,034  

Comprehensive loss:

                 

Other comprehensive loss, net of taxes

  —       —       —          —          (4   —          —          (4   $ (4

Net loss

  —       —       —          (8,422     —        —          —          (8,422     (8,422
                       

Total comprehensive loss

                  $ (8,426
                                                               

Balance at March 31, 2009

  66,892   $ 4   $ 299,383      $ (249,205   $ —        (11,346   $ (32,906   $ 17,276     
                                                         

The accompanying notes are an integral part of these consolidated financial statements.

 

37


Table of Contents

SELECTICA, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     Fiscal Years Ended March 31,  
             2009                     2008          
     (in thousands)  

Operating activities:

    

Net loss

   $ (8,422   $ (23,901

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation

     394        449   

Amortization

     95        207   

Non-cash charge for litigation settlement

     —          6,118   

Loss on sale of subsidiary

     950        —     

Loss (gain) on disposition of property and equipment

     97        (20

Stock-based compensation expense

     452        1,469   

Changes in assets and liabilities:

    

Accounts receivable (net)

     (3,268     448   

Prepaid expenses and other current assets

     (1,615     (352

Other assets

     (180     40   

Accounts payable

     2,651        (2,496

Accrual for restructuring liability

     (1,585     (2,835

Accrued payroll and related liabilities

     6        (180

Other accrued and long-term liabilities

     475        (841

Deferred revenues

     1,948        (268
                

Net cash used for operating activities

     (8,002     (22,162
                

Investing activities:

    

Proceeds from sale of subsidiary, net of cash contributed

     2,639        —     

Purchase of capital assets

     (361     (558

Proceeds from disposition of property and equipment

     19        22   

Proceeds from sale of restricted investments

     —          150   

Purchase of short-term investments

     (9,169     (55,272

Proceeds from maturities of short-term investments

     17,342        69,663   

Proceeds from maturities of long-term investments

     —          1,009   
                

Net cash provided by investing activities

     10,470        15,014   
                

Financing activities:

    

Payments on note payable to Versata

     (800     (238

Common stock issuance costs, net (See Note 8)

     (2,034     —     

Purchase of treasury stock

     —          (246

Proceeds from issuance of common stock under stock option and stock purchase plans

     26        —     
                

Net cash used for financing activities

     (2,808     (484
                

Effect of exchange rate changes on cash

     1,459        (396

Net increase (decrease) in cash and cash equivalents

     1,119        (8,028

Cash and cash equivalents at beginning of the period

     22,137        30,165   
                

Cash and cash equivalents at end of the period

   $ 23,256      $ 22,137   
                

Supplemental disclosure of cash flow information:

    

Income taxes paid

   $ 106      $ 927   

Supplemental disclosure of non-cash financing activities:

    

Change in unrealized gain (loss) on available for sales securities

   $ (4   $ 22   

The accompanying notes are an integral part of these consolidated financial statements.

 

38


Table of Contents

SELECTICA, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. Organization and Operations

Selectica, Inc. (the Company or Selectica) was incorporated in the State of California on June 6, 1996 and subsequently reincorporated in the State of Delaware on January 19, 2000. The Company was originally organized to provide configuration, pricing management and quoting solutions for automating customers’ opportunity to order process. In May 2005, the Company purchased Determine Software, Inc. and entered the contract management software business.

 

2. Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include all accounts of the Company and those of its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

Foreign Currency Transactions

Foreign currency transactions at foreign operations are measured using the U.S. dollar as the functional currency. Accordingly, monetary accounts (principally cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities) are remeasured into the U.S. dollar using the foreign exchange rate at the balance sheet date. Operational accounts and non-monetary balance sheet accounts are remeasured at the rate in effect at the date of a transaction. The impact of foreign currency remeasurement is reported in current operations, and was approximately a $1.4 million charge to earnings prior to the Company’s adoption of its hedging program in December 2008. The impact of foreign currency remeasurement was immaterial in the prior year.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments, long-term investments, restricted investments, and accounts receivable. The Company places its short-term, long-term and restricted investments in high-credit quality financial institutions. The Company is exposed to credit risk in the event of default by these institutions to the extent of the amount recorded on the balance sheet. The Company’s cash balances periodically exceed the FDIC insured amounts. Investments are not protected by FDIC insurance. Restricted investments include corporate bonds and term deposits. As of March 31, 2009, the Company only has short-term investments in a certificate of deposit. Accounts receivable are derived from revenue earned from customers primarily located in the United States. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral. The Company maintains reserves for potential credit losses, and historically, such losses have not been significant.

Cash Equivalents and Short-term Investments

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of money market funds, certificates of deposits, and commercial paper. Debt securities with maturities less than one year are available-for-sale and are

 

39


Table of Contents

classified as short-term investments. All of the Company’s short-term investments were classified as available-for-sale as of the balance sheet dates presented and, accordingly, are reported at fair value with unrealized gains and losses recorded net of tax as a component of accumulated other comprehensive income in stockholders’ equity. Fair values of cash equivalents approximated original cost due to the short period of time to maturity. The cost of securities sold is based on the specific identification method. The Company’s investment policy limits the amount of credit exposure to any one issuer of debt securities.

The Company monitors its investments for impairment on a quarterly basis and determines whether a decline in fair value is other-than-temporary by considering factors such as current economic and market conditions, the credit rating of the issuers, the length of time an investment has been below the Company’s carrying value, and the Company’s ability and intent to hold the investment to maturity. If a decline in fair value, caused by factors other than changes in interest rates, is determined to be other-than-temporary, an adjustment is recorded and charged to operations.

Accounts Receivable and Allowance for Doubtful Accounts

The Company evaluates the collectibility of its accounts receivable based on a combination of factors. When the Company believes a collectibility issue exists with respect to a specific receivable, the Company records an allowance to reduce that receivable to the amount that it believes to be collectible. In making the evaluations, the Company will consider the collection history with the customer, the customer’s credit rating, communications with the customer as to reasons for the delay in payment, disputes or claims filed by the customer, warranty claims, non-responsiveness of customers to collection calls, and feedback from the responsible sales contact. In addition, the Company will also consider general economic conditions, the age of the receivable and the quality of the collection efforts.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on estimated useful lives. The estimated useful lives for computer software and equipment is three years, furniture and fixtures is five years, and leasehold improvements is the shorter of the applicable lease term or estimated useful life.

Revenue Recognition

We enter into arrangements for the sale of: (1) licenses of software products and related maintenance contracts; (2) bundled license, maintenance, and services; (3) services; and (4) subscription for licenses, maintenance and/or other services. In instances where maintenance is bundled with a license of software products, the maintenance term is typically one year.

For each arrangement, the Company determines whether evidence of an arrangement exists, delivery has occurred, the fees are fixed or determinable, and collection is probable. If any of these criteria are not met, revenue recognition is deferred until such time as all of the criteria are met.

Arrangements consisting of license and maintenance only. For those contracts that consist solely of license and maintenance, the Company recognizes license revenues based upon the residual method after all elements other than maintenance have been delivered as prescribed by Statement of Position (“SOP”) “Modification of SOP No. 97-2 Software Revenue Recognition, with Respect to Certain Transactions ” (“SOP 98-9”). The Company recognizes maintenance revenues over the term of the maintenance contract because vendor-specific objective evidence of fair value for maintenance exists. Under the residual method, the fair value of the undelivered elements is deferred and the remaining portion of the arrangement fee is recognized as revenue. If vendor specific objective evidence does not exist to allocate the total fee to all undelivered elements of the arrangement, revenue is deferred until the earlier of the time at which (1) such evidence does exist for the

 

40


Table of Contents

undelivered elements, or (2) all elements are delivered. If unspecified future products are given over a specified term, the Company recognizes license revenue ratably over the applicable period. The Company recognizes license fees from resellers as revenue when the above criteria have been met and the reseller has sold the subject licenses through to the end-user.

Arrangements consisting of license, maintenance and other services. Services revenues can consist of maintenance, training and/or consulting services. Consulting services include a range of services including installation of off-the-shelf software, customization of the software for the customer’s specific application, data conversion and building of interfaces to allow the software to operate in customized environments.

In all cases, the Company assesses whether the service element of the arrangement is essential to the functionality of the other elements of the arrangement. In this determination the Company focuses on whether the software is off-the-shelf software, whether the services include significant alterations to the features and functionality of the software, whether the services involve the building of complex interfaces, the timing of payments and the existence of milestones. Often the installation of the software requires the building of interfaces to the customer’s existing applications or customization of the software for specific applications. As a result, judgment is required in the determination of whether such services constitute “complex” interfaces. In making this determination the Company considers the following: (1) the relative fair value of the services compared to the software; (2) the amount of time and effort subsequent to delivery of the software until the interfaces or other modifications are completed; (3) the degree of technical difficulty in building of the interface and uniqueness of the application; (4) the degree of involvement of customer personnel; and (5) any contractual cancellation, acceptance, or termination provisions for failure to complete the interfaces. The Company also considers the likelihood of refunds, forfeitures and concessions when determining the significance of such services.

In those instances where the Company determines that the service elements are essential to the other elements of the arrangement, the Company accounts for the entire arrangement under the percentage of completion contract method in accordance with the provisions of SOP 81-1, “ Accounting for Performance of Construction Type and Certain Production Type Contracts ” (“SOP 81-1”). The Company follows the percentage of completion method if reasonably dependable estimates of progress toward completion of a contract can be made. The Company estimates the percentage of completion on contracts utilizing hours and costs incurred to date as a percentage of the total estimated hours and costs to complete the project. Recognized revenues and profits are subject to revisions as the contract progresses to completion. Revisions in profit estimates are charged to income in the period in which the facts that give rise to the revision become known. The Company also accounts for certain arrangements under the completed contract method, when the terms of acceptance and warranty commitments preclude revenue recognition until all uncertainties expire. To date, when the Company has been primarily responsible for the implementation of the software, where the services have been considered essential to the functionality of the software products, license and services revenues have been recognized in accordance with SOP 81-1.

For those contracts that include contract milestones or acceptance criteria, the Company recognizes revenue as such milestones are achieved or as such acceptance occurs.

For those contracts with unspecified future products and services which are not essential to the functionality of the other elements of the arrangement, license revenue is recognized by the subscription method over the length of time that the unspecified future product is available to the customer.

In some instances the acceptance criteria in the contract require acceptance after all services are complete and all other elements have been delivered. In these instances the Company recognizes revenue based upon the completed contract method after such acceptance has occurred.

For those arrangements for which the Company has concluded that the service element is not essential to the other elements of the arrangement, the Company determines whether the services are available from other

 

41


Table of Contents

vendors, do not involve a significant degree of risk or unique acceptance criteria, and whether the Company has sufficient experience in providing the service to be able to separately account for the service. When services qualify for separate accounting, the Company uses vendor-specific objective evidence of fair value for the services and the maintenance to account for the arrangement using the residual method, regardless of any separate prices stated within the contract for each element.

Vendor-specific objective evidence of fair value of services is based upon hourly rates. As previously noted, the Company enters into contracts for services alone, and such contracts are based on a time and materials basis. Such hourly rates are used to assess the vendor-specific objective evidence of fair value in multiple element arrangements.

In accordance with SOP 97-2, “ Software Revenue Recognition ” (“SOP 97-2”), vendor-specific objective evidence of fair value of maintenance is determined by reference to the price the customer will be required to pay when it is sold separately (that is, the renewal rate). Each license agreement offers additional maintenance renewal periods at a stated price. Maintenance contracts are typically one year in duration.

Arrangements consisting of consulting services. Consulting services consist of a range of services including installation of off-the-shelf software, customization of the software for the customer’s specific application, data conversion and building of interfaces to allow the software to operate in customized environments. Consulting services may be recognized based on customer acceptance in the form of customer-signed timesheets, invoices, cash received, or customer-signed acceptance as defined in the master service agreement.

Contract Management (CM) Arrangements. CM arrangements generate revenue from three principal sources: (1) perpetual licenses and related maintenance; (2) subscription revenues, which are comprised of subscription fees from customers accessing the Company’s on-demand application service, and from customers purchasing additional support beyond the standard support that is included in the basic subscription fee; and (3) related consulting services, consisting primarily of integration and training fees. Because the Company provides its application as a service, the Company follows the provisions of Securities and Exchange Commission Staff Accounting Bulletin (“SAB”) No. 101, Revenue Recognition in Financial Statements , as amended by SAB No. 104, Revenue Recognition . Consulting services, when sold with subscription and support offerings, are accounted for separately when these services have stand-alone value to the customer, and there is objective and reliable evidence of fair value of the undelivered elements. In these circumstances, consulting service revenues are recognized as the services are rendered for time and material contracts, and when the milestones are achieved and accepted by the customer for fixed price contracts. Training revenues are recognized after the services are performed.

In determining whether the consulting services can be accounted for separately from subscription revenues, the Company considers the following factors for each consulting agreement: availability of the consulting services from other vendors, whether objective and reliable evidence for fair value exists for the undelivered elements, the nature of the consulting services, the timing of when the consulting contract was signed in comparison to the subscription arrangement, and the contractual dependence of the subscription service on the customer’s satisfaction with the consulting work. If a consulting arrangement does not qualify for separate accounting, we initially defer all revenue under the arrangement and then, when all consulting services have been delivered, we recognize the consulting and subscription revenues ratably over the remaining term of the subscription contract. In these situations we defer the costs of the consulting arrangement and amortize those costs over the same time period as the consulting revenue is recognized.

 

42


Table of Contents

Customer Concentrations

A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years:

 

     Fiscal Years Ended March 31,  
       2009         2008    

Customer A

   18   25 %

Customer B

   *      12
 
  * Revenues were less than 10% of total revenues.

Customers who accounted for at least 10% of gross accounts receivable were as follows:

 

     Fiscal Years Ended March 31,  
       2009         2008    

Customer A

   13   15

Customer B

   *      15

Customer C

   *      15

Customer D

   *      12

Customer E

   *      10

Customer F

   11   *   

Customer G

   21   *   
 
  * Accounts receivable was less than 10% of total accounts receivable.

Warranties and Indemnifications

The Company generally provides a warranty for its software product to its customers and accounts for its warranties under Statements of Financial Accounting Standards (“SFAS”) No. 5, “ Accounting for Contingencies ” (SFAS 5). The Company’s products are generally warranted to perform substantially in accordance with the functional specifications set forth in the associated product documentation for a period of 90 days. In the event there is a failure of such warranties, the Company generally is obligated to correct the product to conform to the product documentation or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product or service. The Company has not provided for a warranty accrual as of March 31, 2009 and 2008. To date, the Company has not refunded any amounts in relation to the warranty.

The Company generally agrees to indemnify its customers against legal claims that the Company’s software infringes certain third-party intellectual property rights and accounts for its indemnification under SFAS 5. In the event of such a claim, the Company is obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of the infringement, the Company agrees to modify or replace the infringing product, or, if those options are not reasonably possible, to refund the purchase price of the software. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers. As such, the Company has not provided for an indemnification accrual as of March 31, 2009 and 2008.

Advertising Expense

The cost of advertising is expensed as incurred. Advertising expense for the years ended March 31, 2009 and 2008 was approximately $117,000 and $113,000, respectively.

 

43


Table of Contents

Development Costs

Software development costs incurred prior to the establishment of technological feasibility are included in research and development expenses. The Company defines establishment of technological feasibility as the completion of a working model. Software development costs incurred subsequent to the establishment of technological feasibility through the period of general market availability of the products are capitalized, if material, after consideration of various factors, including net realizable value. To date, software development costs that are eligible for capitalization have not been material and have been expensed.

Accumulated Other Comprehensive Income or Loss

SFAS No. 130 “ Reporting Comprehensive Income ” (“SFAS 130”) establishes standards for reporting and displaying comprehensive net income or loss and its components in stockholders’ equity. However, it has no impact on the Company’s net loss as presented in its financial statements. There was no accumulated other comprehensive income or loss at March 31, 2009. For the fiscal year ended March 31, 2008, accumulated other comprehensive income or loss was comprised of net unrealized gains on available for sale securities of approximately $4,000.

Stock-Based Compensation

Beginning April 1, 2006, the Company adopted the provisions of, and accounts for stock-based compensation in accordance with, SFAS No. 123 (revised 2004) “ Share-Based Payment ” (“SFAS 123R”) and Securities and Exchange Commission Staff Accounting Bulletin No. 107 (“SAB 107”). The Company elected the modified-prospective method, under which prior periods are not revised for comparative purposes. The Company currently uses the Black-Scholes option-pricing model to determine the fair value of stock options and employee stock purchase plan rights and compensation cost is recognized as expense over the requisite service period.

The Company estimates the fair value of each stock option on the date of grant using a Black-Scholes option-pricing model, consistent with the provisions of SFAS 123R, SAB 107 and the Company’s prior period pro forma disclosures of net loss, including stock-based compensation (determined under a fair value method as prescribed by SFAS No. 123) to determine the fair value of stock options and employee stock purchase plan shares. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by the stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the awards, actual and projected employee stock option exercise behaviors, risk-free interest rate and expected dividends.

The Company estimates the expected term of options granted by calculating the average term from the Company’s historical stock option exercise experience. The Company estimates the volatility of its stock options by using historical volatility in accordance with SAB 107. The Company believes its historical volatility is representative of its estimate of expectations of the expected term of its equity instruments. The Company bases the risk-free interest rate used in the option-pricing model on U.S. Treasury zero-coupon issues with remaining terms similar to the expected term on the options. The Company does not anticipate paying any cash dividends in the foreseeable future and therefore uses an expected dividend yield of zero in the option-pricing model. The Company is required to estimate forfeitures at the time of grant and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company uses historical experience to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. All share-based payment awards are amortized on a straight-line basis over the requisite service periods of the awards, which are the vesting periods.

If factors change and the Company employs different assumptions for estimating stock-based compensation expense in future periods or if it decides to use a different option-pricing model, the future periods may differ significantly from what has been recorded in the current period and could materially affect operating income (loss), net income (loss) and net income (loss) per share.

 

44


Table of Contents

The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable, characteristics not present in our option grants and employee stock purchase plan shares. Existing option-pricing models, including the Black-Scholes option-pricing and binomial lattice models, may not provide reliable measures of the fair values of our stock-based compensation. Consequently, there is a risk that the Company’s estimates of the fair values of its stock-based compensation awards on the grant dates may bear little resemblance to the actual values realized upon the exercise, expiration, early termination or forfeiture of those stock-based payments in the future. Certain stock-based payments, such as employee stock options, may expire worthless or otherwise result in zero intrinsic value as compared to the fair values originally estimated on the grant date and reported in our financial statements. Alternatively, value may be realized from these instruments that are significantly higher than the fair values originally estimated on the grant date and reported in the Company’s financial statements. There is no market-based mechanism or other practical application to verify the reliability and accuracy of the estimates stemming from these option-pricing models, nor is there a means to compare and adjust the estimates to actual values.

The effect of recording stock-based compensation for each of the periods presented was as follows:

 

     Fiscal Years Ended
March 31,
     2009    2008

Stock-based compensation expense by category is as follows:

     

Cost of revenues

   $ 85,000    $ 27,000

Research and development

     172,000      374,000

Sales and marketing

     63,000      184,000

General and administrative

     132,000      884,000
             

Impact on net loss

   $ 452,000    $ 1,469,000
             

1999 Employee Stock Purchase Plan (“ESPP”)

The price paid for the Company’s common stock purchased under the ESPP is equal to 85% of the lower of the fair market value of the Company’s common stock at the beginning of each offering period or at the end of each offering period. The compensation expense in connection with the ESPP for the fiscal year ended March 31, 2009 and 2008 was $36,000 and $19,000, respectively. During the fiscal years ended March 31, 2009 and 2008, there were 56,070, and zero shares issued, respectively, under the ESPP at a weighted average purchase price of $0.4675 and $0 per share, respectively.

Geographic Information:

International revenues are attributable to countries based on the location of the customers. For the fiscal year ended March 31, 2009, 6% of sales were from international locations. For the fiscal years ended March 31, 2009 and 2008, sales to international locations were derived primarily from Canada, India, New Zealand, Switzerland and the United Kingdom.

 

     Fiscal Years Ended
March 31,
 
     2009     2008  

International revenues

   6   13

Domestic revenues

   94   87
            

Total revenues

   100   100
            

For the fiscal years ended March 31, 2009 and 2008, there were no sales to a specific international customer that accounted for 10% of total revenues.

 

45


Table of Contents

For the year ended March 31, 2009, the Company did not hold long-lived assets outside of the United States as a result of the sale of the Indian subsidiary that occurred on March 31, 2009 (Note 15). For the year ended March 31, 2008, the Company held long-lived assets outside of the United States with a net book value of approximately $1.0 million. The assets were located in India.

Treasury Stock

From time to time, the Company’s Board of Directors has approved common stock repurchase programs allowing management to repurchase shares of its common stock in the open market. In December 2005, the Board of Directors approved a stock buyback program to repurchase up to $25.0 million worth of stock in the open market subject to certain criteria as determined by the Board. The Board also dissolved the previous stock buyback program initiated in May 2003.

There were no stock repurchases during fiscal 2009 or 2008.

All repurchases have been made in compliance with Rule 10b 5-1 under the Securities Exchange Act of 1934, as amended. The Company values the repurchased Treasury Stock at the market value of the day of the transaction. The Company has no plans to resell any of the current Treasury Stock shares held. The Company records the repurchase of Treasury Stock at cost using the par value method.

Recent Accounting Pronouncements

In April 2009, the FASB issued FSP No. FAS 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly, which provides additional guidance for estimating fair value in accordance with SFAS No. 157, Fair Value Measurements (SFAS 157). This FSP states that a significant decrease in the volume and level of activity for the asset or liability when compared with normal market activity is an indication that transactions or quoted prices may not be determinative of fair value because there may be increased instances of transactions that are not orderly in such market conditions. Accordingly, further analysis of transactions or quoted prices is needed, and a significant adjustment to the transactions or quoted prices may be necessary to estimate fair value. This FSP is effective for the Company beginning the first quarter of fiscal 2010. The Company does not expect the impact of the adoption of this FSP to be material on its consolidated financial statements.

In April 2009, the FASB issued FSP No. FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value of Financial Instruments, which requires disclosures about the fair value of the Company’s financial instruments for which it is practicable to estimate that value, whether recognized or not recognized in the balance sheets, in the interim reporting periods as well as in the annual reporting periods. In addition, the FSP requires disclosures of the methods and significant assumptions used to estimate the fair value of those financial instruments. This FSP is effective for the Company beginning the first quarter of fiscal 2010. The Company does not expect the impact of the adoption of this FSP to be material on its consolidated financial statements.

In April 2009, the FASB issued FSP No. FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-Than-Temporary Impairments, which establishes a new method of recognizing and reporting other-than-temporary impairments of debt securities and requires additional disclosures related to debt and equity securities. This FSP does not change existing recognition and measurement guidance related to other-than-temporary impairments of equity securities. This FSP is effective for the Company beginning the first quarter of fiscal 2010. The Company does not expect the impact of the adoption of this FSP to be material on its consolidated financial statements.

 

46


Table of Contents
3. Cash, Cash Equivalents, Investments and Fair Value Measurements

Cash, cash equivalents, and short-term investments consisted of the following:

 

     Unrealized
     Cost    Gain    Loss     Market
     (in thousands)

March 31, 2009:

          

Cash and cash equivalents:

          

Cash

   $ 6,636    $ —      $ —        $ 6,636

Money market fund

     16,620      —        —          16,620
                            
   $ 23,256    $ —      $ —        $ 23,256
                            

Short-term investments:

          

(due in less than 12 months)

          

Certificate of deposit

   $ 196    $ —      $ —        $ 196
                            

March 31, 2008:

          

Cash and cash equivalents:

          

Cash

   $ 2,418    $ —      $ —        $ 2,418

Money market fund

     5,320      —        —          5,320

Commercial paper

     9,592         —          9,592

Certificate of deposit

     4,807      —        —          4,807
                            
   $ 22,137    $ —      $ —        $ 22,137
                            

Short-term investments:

          

(due in less than 12 months)

          

Commercial paper

   $ 10,461    $ —      $ (2   $ 10,459

Corporate notes & bonds

     2,457      6      —          2,463

Certificate of deposit

     154      —        —          154
                            
   $ 13,072    $ 6    $ (2   $ 13,076
                            

The fair value of cash equivalents, based on quoted market prices, is substantially equal to their carrying value as of March 31, 2009 and 2008.

Fair Value Measurements

The following table summarizes the Company’s financial assets measured at fair value on a recurring basis in accordance with SFAS No. 157 as of March 31, 2009 (in thousands):

 

Description

   Balance as of
March 31, 2009
   Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
   Significant Other
Observable Inputs
(Level 2)

Cash equivalents:

        

Money market fund

   $ 16,620    $ 16,620    $ —  

Short-term investments:

        

Certificates of deposit

     196      —        196
                    
   $ 16,816    $ 16,620    $ 196
                    

The Company’s financial assets and liabilities are valued using market prices on both active markets (Level 1) and less active markets (Level 2). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily-available pricing sources for comparable instruments. As of March 31, 2009, the Company did not

 

47


Table of Contents

have any assets or liabilities without observable market values that would require a high level of judgment to determine fair value (Level 3).

 

4. Property and Equipment

Property and equipment consist of the following:

 

     March 31,  
     2009     2008  
     (in thousands)  

Computers and software

   $ 2,760      $ 8,128   

Furniture and equipment

     651        1,584   

Leasehold improvements

     498        869   

Land and building

     —          1,225   

Automobile

     —          36   
                
     3,909        11,842   

Less: accumulated depreciation

     (2,849     (9,657
                

Total property and equipment, net

   $ 1,060      $ 2,185   
                

Depreciation expense related to property and equipment was approximately $394,000 and $449,000 for the years ended March 31, 2009 and 2008, respectively. The decrease in net property and equipment in the fiscal year ended March 31, 2009 was due primarily to the sale of the Company’s Indian subsidiary which was completed on March 31, 2009. See Note 15 of Notes to Consolidated Financial Statements.

 

5. Accrued and Other Liabilities

As of March 31, 2009 and 2008, liabilities consisted of the following:

 

     2009    2008
     (in thousands)

Accrued Payroll

     

Accrued salaries

   $ 57    $ 203

Accrued vacation

     400      299

Accrued bonus

     —        71

Accrued commissions

     235      77

Accrued benefits

     28      90
             

Total

   $ 720    $ 740
             
     2009    2008
     (in thousands)

Other Accrued Liabilities

     

Other payables

     923      249

Accrued sales tax

     23      53

Accrued taxes and accounting

     574      433
             

Total

   $ 1,520    $ 735
             

Deferred Revenue

     

Deferred revenue hosting

   $ 34    $ 6

Deferred revenue consulting

     32      188

Deferred revenue subscription

     818      708

Deferred revenue maintenance

     3,047      1,082
             

Total

   $ 3,931    $ 1,984
             

 

48


Table of Contents
     2009    2008
     (in thousands)

Other Long-Term Liabilities

     

Long-term deferred revenue

   $ 48    $ 234

Lease obligation

     —        11
             

Total

   $ 48    $ 245
             

 

6. Intangible Assets

As of March 31, 2009 and 2008, intangible assets are as follows:

 

     2009     2008  
     (in thousands)  

Cost

   $ 801      $ 801   

Accumulated amortization

     (794     (699
                

Net

   $ 7      $ 102   

These intangible assets will be fully amortized in the first quarter of fiscal year 2010. Amortization for the years ended March 31, 2009 and 2008 was approximately $95,000 and $207,000, respectively.

 

7. Operating Lease Commitments

The Company leases office space and office equipment under non-cancelable operating lease agreements that expire at various dates through 2013. Aggregate future minimum annual payments under these lease agreements, which have non-cancelable lease terms, as of March 31, 2009, along with sublease rental income commitments are as follows:

 

     Amount
     (in thousands)
     Offices    Equipment    Sublease Income     Total

2010

   $ 2,008    $ 18    $ (544   $ 1,482

2011

     8      18      —          26

2012

     —        3      —          3

2013

     —        2      —          2
                            

Total future minimum payments

   $ 2,016    $ 41    $ (544   $ 1,513
                            

Rental expenses for office space and equipment were approximately $544,000 and $559,000 for the years ended March 31, 2009 and 2008, respectively.

 

8. Litigation

Patent Infringement

On October 20, 2006, Versata Software, Inc., formerly known as Trilogy Software Inc., and a related party (collectively, “Versata”) filed a complaint against the Company in the United States District Court for the Eastern District of Texas, Marshall Division, alleging that the Company has been and is willfully infringing, directly and indirectly, U.S. Patent Nos. 5,515,524; 5,708,798 and 6,002,854 (collectively, the “Versata Patents”) by making, using, licensing, selling, offering for sale, or importing configuration software and related services. On October 9, 2007 Selectica Inc. and Versata Software Inc. reached a settlement of a patent lawsuit. Selectica paid Versata $10.0 million on October 9, 2007 and agreed to pay an additional amount of not more than $7.5 million in quarterly payments. The quarterly payments are based on 10% of revenues from the Company’s

 

49


Table of Contents

Configuration, Pricing or Quoting (SCS or Sales Configuration Segment) products and services and a 50% revenue share of SCS revenue from new Company SCS customers that are currently Versata customers and to whom Versata makes an introduction to Selectica. The Company agreed that its quarterly payments will be the greater of the sum calculated by the percentages of SCS revenues or $200,000. Both parties entered into mutual releases releasing any and all claims that they may have against the other occurring before the settlement date. At March 31, 2009, the present value of the amount owed to Versata was approximately $5.4 million.

Rights Agreement

On December 22, 2008, the Company filed suit in the Court of Chancery of the State of Delaware against Trilogy, Inc. and certain related parties (“Trilogy”) seeking declaratory relief that the Company’s Rights Agreement as amended on November 16, 2008 was an appropriate measure to protect a valuable asset – the Company’s net operating loss carryforwards and related tax credits – from being limited as to utilization as provided under Section 382 of the Internal Revenue Code which could in turn substantially reduce their value to all of the Company’s shareholders. The Company sued Trilogy after amending its Rights Agreement on November 16, 2008 to reduce the ownership threshold from 15% to 4.99%, with existing 5% or greater shareholders limited to acquiring no more than an additional 0.5% and, despite the ownership threshold, Trilogy increased its beneficial ownership by 0.51% to 6.71% as announced in its 13(d) filing with the SEC on December 22, 2008. As a result, on January 2, 2009, a special committee of the Company’s Board of Directors declared Trilogy as an “Acquiring Person” under the Rights Agreement, and as a result, on February 4, 2009 the Company completed the distribution of 26.8 million shares to all existing shareholders (under the Exchange Provision in the Rights Agreement) other than Trilogy. On January 16, 2009, the defendants in this action, Trilogy/Versata, filed an answer to the Company’s complaint and a counterclaim alleging that the Company, through its Board of Directors, had breached its fiduciary duty in amending the Rights Agreement and that such action favored one group of shareholders over another. The Company, and its Board of Directors, believes that the action taken on November 16, 2008 was appropriate under the circumstances and in the interest of all the Company’s shareholders and therefore the allegations of the counterclaim are without merit. The counterclaim asks for various measures of equitable relief and also includes a claim for punitive or exemplary damages, which are not available in Delaware. The litigation is currently in the post-trial phase with a decision expected in the third or fourth calendar quarter of 2009, subject to appeal. As the costs of this litigation and related legal work are directly related to the issuance of shares under the Company’s rights plan, the costs of the litigation have been charged as issuance costs against the additional paid in capital account on the Company’s balance sheet, less a reserve for anticipated recovery from the Company’s Director’s and Officer’s insurance policy, which is reflected in prepaid expenses and other current assets on the Company’s balance sheet. As of March 31, 2009, the amount charged to additional paid in capital was approximately $2.0 million, and the anticipated recovery from the Company’s insurance policy was approximately $1.0 million.

 

9. Stockholders’ Equity (Deficit)

Common Stock Reserved for Future Issuance

At March 31, 2009, shares of common stock reserved for future issuance were as follows:

 

     (in thousands)

Stock option plans:

  

Outstanding

   2,588

Reserved for future grants

   28,640

Employee Stock Purchase Plan

   8,624
    

Total common stock reserved for future issuance

   39,852
    

Preferred Stock

The Company is authorized to issue 25 million shares of preferred stock at a par value of $0.0001 per share. There was no preferred stock issued and outstanding at March 31, 2009 and 2008.

 

50


Table of Contents

The Board of Directors has the authority, without action by the stockholders, to designate and issue the preferred stock in one or more series and to fix the rights, preferences, privileges, and related restrictions, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any series or the designation of the series.

Stock Option Plans—Approved by Stockholders

1996 Plan

The Company adopted the 1996 Stock Plan as amended and restated March 28, 2001 (the “1996 Plan”). A total of approximately 16.3 million shares of common stock have been reserved under the 1996 Plan. With limited restrictions, if shares awarded under the 1996 Plan are forfeited, those shares will again become available for new awards under the 1996 Plan. The 1996 Plan permits the grant of options, stock appreciation rights, shares of restricted stock, and stock units. The types of options include incentive stock options that qualify for favorable tax treatment for the optionee under Section 422 of the Internal Revenue Code of 1986, and nonstatutory stock options not designed to qualify for favorable tax treatment. Employees, non-employee members of the board and consultants are eligible to participate in the 1996 Plan. Incentive stock options are granted at an exercise price of not less than 100% of the fair market value per share of the common stock on the date of grant, and nonstatutory stock options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the 1996 Plan have a maximum term of ten years.

1999 Equity Incentive Plan

The Company adopted the 1999 Equity Incentive Plan (the “1999 Plan”) on November 18, 1999. A total of 4.4 million shares of common stock were initially reserved for issuance under the 1999 Plan. On each January 1, starting in 2001, the number of shares reserved for issuance will be automatically increased by the lesser of 5% of the then outstanding shares of common stock or 3.6 million. With limited restrictions, if shares awarded under the 1999 Plan are forfeited, those shares will again become available for new awards under the 1999 Plan. The 1999 Plan permits the grant of options, stock appreciation rights, shares of restricted stock, and stock units. The types of options include incentive stock options that qualify for favorable tax treatment for the optionee under Section 422 of the Internal Revenue Code of 1986 and nonstatutory stock options not designed to qualify for favorable tax treatment. Employees, non-employee members of the Board of Directors and consultants are eligible to participate in the 1999 Plan. Each eligible participant is limited to being granted options or stock appreciation rights covering no more than 660,000 shares per fiscal year, except in the first year of employment where the limit is 1,320,000 shares. Incentive stock options are granted at an exercise price of not less than 100% of the fair market value per share of the common stock on the date of grant, and nonstatutory stock options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the 1999 Plan have a maximum term of ten years.

1999 Employee Stock Purchase Plan

On November 18, 1999, the Company’s Board of Directors approved the adoption of the 1999 Employee Stock Purchase Plan (the “Purchase Plan”) and the Company’s stockholders have approved of the Purchase Plan. A total of 2.0 million shares of common stock were initially reserved for issuance under the Purchase Plan. On each May 1, starting in 2001, the number of shares reserved for issuance will be automatically increased by the lesser of 2% of the then outstanding shares of common stock or 2.0 million shares.

The Compensation Committee of the Board of Directors administers this plan. The Purchase Plan is intended to qualify under Section 423 of the Internal Revenue Code. The Purchase Plan permits eligible

 

51


Table of Contents

employees to purchase common stock through payroll deductions, which may not exceed 15% of an employee’s cash compensation, at a purchase price equal to the lower of 85% of the fair market value of the Company’s common stock at the beginning of each offering period or at the end of each purchase period. Employees who work more than five months per year and more than twenty hours per week are eligible to participate in the Purchase Plan. Stockholders who own more than 5% of the Company’s outstanding common stock are excluded from participating in the Purchase Plan. Each eligible employee cannot purchase more than 2,500 shares per purchase date (5,000 shares per year) and, generally, cannot purchase more than $25,000 of stock per calendar year. Eligible employees may begin participating in the Purchase Plan at the start of an offering period. Each offering period lasts 24 months and consists of four consecutive purchase periods of six months duration. Two overlapping offering periods start on May 1 and November 1 of each calendar year. Employees may end their participation in the Purchase Plan at any time. Participation ends automatically upon termination of employment. The Board of Directors may amend or terminate the Purchase Plan at any time. If not terminated earlier, the Purchase Plan has a term of twenty years. If the Board of Directors increases the number of shares of common stock reserved for issuance under the Purchase Plan, other than any share increase resulting from the formula described in the previous paragraph, it must seek the approval of the Company’s stockholders.

2001 Supplemental Plan

The Company adopted the 2001 Supplemental Plan (the “Supplemental Plan”) on April 4, 2001, and the Supplemental Plan did not require stockholder approval. A total of approximately 5.0 million shares of common stock have been reserved for issuance under the Supplemental Plan. With limited restrictions, if shares awarded under the Supplemental Plan are forfeited, those shares will again become available for new awards under the Supplemental Plan. The Supplemental Plan permits the grant of non-statutory options and shares of restricted stock. Employees and consultants, who are not officers or members of the Board of Directors, are eligible to participate in the Supplemental Plan. Options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the Supplemental Plan have a maximum term of ten years.

Activity under all equity plans is as follows:

 

     Shares
Available for
Grant
    Options Outstanding
     Number of
Shares
    Exercise Price
Per Share
   Weighted-
Average
Exercise
Price Per
Share
     (in thousands except for per share amounts)

Balance at March 31, 2007

   21,071      6,991      $ 0.84 – $31.74    $ 1.61

Increase in shares reserved

   2,849      —          

Options granted

   (2,648   2,648      $ 0.75 – $  0.95    $ 0.91

Options cancelled

   4,707      (4,707   $ 0.85 – $31.74    $ 1.58

Options expired

   (154   —          

Restricted stock awards granted

   (1,534       
                 

Balance at March 31, 2008

   24,291      4,932      $ 0.75 – $31.74    $ 1.25

Increase in shares reserved

   3,362      —          

Options granted

   (610   610      $ 0.36 – $  0.73    $ 0.51

Options cancelled

   2,954      (2,954   $ 0.73 – $31.74    $ 1.09

Restricted stock awards issued

   (1,357       
                 

Balance at March 31, 2009

   28,640      2,588      $ 0.36 – $31.74    $ 1.27
                 

 

52


Table of Contents

Options outstanding and exercisable at March 31, 2009 were in the following exercise price ranges:

 

     Options Outstanding    Options Vested

Range of Exercise

Prices Per Share

   Number of
Shares
   Weighted-
Average
Remaining
Contractual
Life (Years)
   Number of
Shares
   Weighted-
Average
Exercise
Price Per Share

$0.36 – $0.72

   530,000    7.00    5,000    $ 0.72

$0.73 – $0.91

   400,000    8.41    192,707    $ 0.87

$0.92 – $1.22

   559,125    8.57    216,561    $ 0.95

$1.23 – $1.71

   636,000    6.21    588,535    $ 1.58

$1.72 – $26.35

   462,892    3.47    462,871    $ 2.49
                     

$0.36 – $26.35

   2,558,017    6.73    1,465,674    $ 1.68
               

The weighted average term for exercisable options is 5.96 years. The intrinsic value is calculated as the difference between the market value as of March 31, 2009 and the exercise price of the shares. The market value of the Company’s common stock as of March 31, 2009 was $0.41 as reported by the NASDAQ National Market. The aggregate intrinsic value of stock options outstanding at March 31, 2009 was $7,400 and none of the intrinsic value was related to exercisable options.

The following table summarizes values for options granted during the respective years:

 

     Fiscal Years Ended
March 31,
     2009    2008(1)

Weighted average grant date fair value

   $ 109,959    $ 795,531

Intrinsic value of options exercised

     —        —  

Fair value of shares vesting during the year

   $ 202,639    $ 1,397,923

 

(1) In the fiscal year ended March 31, 2008, there were no participants in the Company’s employee stock purchase plan.

The fair value of rights granted under the employee stock purchase plan were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

 

     Fiscal Years Ended
March 31,
 
     2009     2008  

Risk-free interest rate

     2.19     0.00

Dividend yield

     0.00     0.00

Expected volatility

     41.49     0.00

Expected term in years

     1.24        —     

Weighted average fair value at grant date

   $ 0.26      $ —     

The fair value of options granted under employee stock options were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

 

     Fiscal Years Ended
March 31,
 
     2009     2008  

Risk-free interest rate

     1.75     3.72

Dividend yield

     0.00     0.00

Expected volatility

     50.25     34.34

Expected option life in years

     3.26        3.91   

Weighted average fair value at grant date

   $ 0.18      $ 0.58   

 

53


Table of Contents

Equity Compensation Plan Information

The table below demonstrates the number of options issued and the number of options available for issuance, respectively, under the Company’s current equity compensation plans as of March 31, 2009:

 

     Number of Securities
to be Issued upon Exercise

of Outstanding
Options, and Rights
   Weighted-Average
Exercise Price Per
Share of Outstanding
Options and Rights
   Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
     (in thousands, except for per share amount)

Plans Approved by Stockholders

        

1996 Stock Plan

   207    $ 1.94    2,746

1999 Equity Incentive Plan

   2,277    $ 1.18    22,306

Plans Not Required to be Approved by Stockholders

        

2001 Supplemental Plan

   104    $ 1.92    3,588
            

Total

   2,588       28,640
            

All vested shares granted under all Plans are exercisable; however, shares exercised but not vested under the 1996 Stock Plan are subject to repurchase.

 

10. Computation of Basic and Diluted Net Loss Per Share

Basic and diluted net loss per common share is presented in conformity with SFAS No. 128, “ Earnings per Share ” (“SFAS 128”), for all periods presented. In accordance with SFAS 128, basic and diluted net loss per share has been computed using the weighted-average number of shares of common stock outstanding during the period. The diluted net loss per share is equivalent to the basic net loss per share because the Company has experienced losses in all periods presented and thus no potential common shares from the exercise of stock options have been included in the net loss per share calculation.

The following common stock equivalents were excluded from the net loss per share computation:

 

     Fiscal Years Ended
March 31,
         2009            2008    
     (In thousands)

Options excluded due to the exercise price exceeding the average fair market value of the Company’s common stock during the period

   2,248    2,181

Options excluded for which the exercise price was less than the average fair market value of the Company’s common stock during the period but were excluded as inclusion would decrease the Company’s net loss per share

   340    329
         

Total common stock equivalents excluded from diluted net loss per common share

   2,588    2,510
         

 

54


Table of Contents
11. Income Taxes

The provision for income taxes is based upon loss before income taxes as follows:

 

     Fiscal Years Ended
March 31,
 
     2009     2008  
     (in thousands)  

Domestic pre-tax loss

   $ (4,682   $ (24,066

Foreign pre-tax income (loss)

     (3,583     527   
                

Total pre-tax loss

   $ (8,265   $ (23,539
                
     Fiscal Years Ended
March 31,
 
     2009     2008  
     (in thousands)  

Federal tax at statutory rate

   $ (2,810   $ (8,004

Computed state tax

     934        (1,251

Computed foreign tax

     1,557        275   

Losses not benefited

     270        9,238   

Change in tax reserve

     12        —     

Non-deductible expenses

     321        190   

Research and development tax credits

     (127     (88
                

Income tax provision

   $ 157      $ 361   
                

The components of the provision for income taxes are as follows:

 

     Fiscal Years Ended
March 31,
     2009    2008
     (in thousands)

Current:

     

US

   $ 15    $ 196

Foreign

     142      165
             

Income tax provision

     157      361

Deferred:

     

Federal

     —        —  

State

     —        —  
             

Income tax provision

   $ 157    $ 361
             

Financial Accounting Standards Board Statement No. 109 provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based on the weight of available evidence, which includes the Company’s historical operation performance and the reported cumulative net losses in all prior years, the Company has provided a full valuation allowance against its net deferred tax assets.

 

55


Table of Contents

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows (in thousands):

 

     March 31,  
     2009     2008  
     (in thousands)  

Deferred tax assets:

    

Net operating loss carryforwards

   $ 61,649      $ 53,544   

Intangible assets

     16,063        15,789   

Tax credit carryforwards

     4,519        2,776   

Reserves and accruals

     1,227        1,572   

Depreciation

     (17     61   

Stock compensation

     326        658   

Deferred revenue

     132        180   
                

Total net deferred tax asset

     83,899        74,580   

Valuation allowance

     (83,899     (74,580
                

Net deferred tax assets

   $ —        $ —     
                

Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance change by $9.3 million and ($8.2 million) during 2009 and 2008 respectively.

As of March 31, 2009, the Company had federal and state operating loss carryforwards of approximately $166.5 million and $87.3 million, respectively. As of March 31, 2009, the Company also had federal and state research and development tax credit carryforwards of $3.1 and $4.3 million, respectively.

The federal net operating loss and credit carryforwards begin to expire in 2012 through 2029, if not utilized. The state net operating loss carryforwards begin to expire in 2011 through various dates, if not utilized. The state tax credit carryforwards have no expiration date.

The Internal Revenue Code limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in the stock ownership of a company. In the event the Company has had a change in ownership, utilization of the carryforwards could be restricted.

Based on its most recently performed study, the Company has concluded it has not had a prior ownership change, as defined by Section 382 of the Internal Revenue Code (IRC), which could limit the future realization of its net operating loss carryforwards since June 1999. Based on this recent study, the Company believes that the application of Section 382 will not result in the forfeiture of any net operating loss carryforward for federal income tax purposes and any net operating loss carryforward for California income tax purposes. Please note the net operating loss carryforwards above take into account this belief. Applicable taxing authorities could disagree if and when an income tax return is filed that utilizes some or all of these net operating loss carryforwards.

In addition, based on this recent study, the Company has concluded that none of the federal and California research tax credit carryforwards, respectively, would be subject to forfeiture due to Section 382 ownership changes under IRC Section 383 and/or possible credit amount reduction upon audit, but as noted above this is subject to review by the applicable taxing authority. Please note the research and development tax credit carryforwards above take into account this reduction.

On April 1, 2007, the Company adopted FASB Interpretation No. 48 (“FIN 48”), “Accounting for Uncertainty in Income Taxes.” FIN 48 clarifies the accounting for uncertainty in income taxes and prescribes a recognition threshold, measurement attribute for the financial statement recognition and measurement of a tax

 

56


Table of Contents

position taken, or expected to be taken, in a tax return. Under FIN 48, the Company is required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods and disclosure. The Company policy is to record interest and penalties related to unrecognized tax benefits in income tax expense.

The implementation of FIN 48 did not have a material impact on the Company’s financial statements. At March 31, 2009, there was no material increase in the liability for unrecognized tax benefits.

At March 31, 2009, the Company has accrued $130,000 of income tax expense and $40,000 of interest and penalties due to Selectica India Private Ltd.’s branch operations within the U.S. resulting in an increase on the Company’s effective tax rate. In addition at March 31, 2009, the Company had $1.82 million of unrecognized tax benefits of which was netted against deferred tax assets with a full valuation allowance or other fully reserved amounts, and if recognized there will be no effect on the Company’s effective tax rate. The Company does not have any tax positions for which it is reasonably possible that the total amount of gross unrecognized tax benefits will increase or decrease within 12 months of the year.

A reconciliation of the beginning and ending unrecognized tax benefit amounts for fiscal year 2009 are as follows (in thousands):

 

     Amount

Balance at April 1, 2008

   $ 1,564

Increases related to current year tax positions

     256
      

Balance at March 31, 2009

   $ 1,820
      

The Company’s Federal, state, and foreign tax returns are subject to examination by the tax authorities from 1997 to 2008 due to net operating losses and tax carryforwards unutilized from such years.

 

12. 401(k) Benefit Plan

Effective February 1998, the Company adopted a tax-deferred savings plan, the Selectica 401(k) Plan (the 401(k) Plan), for the benefit of qualified employees. The 401(k) Plan is designed to provide employees with an accumulation of funds at retirement. Qualified employees may elect to make contributions to the 401(k) Plan on a monthly basis. The 401(k) Plan does not require the Company to make any contributions. No contributions were made by the Company for the years ended March 31, 2009 and 2008. Administrative expenses relating to the 401(k) Plan are insignificant.

 

13. Restructuring

On June 30, 2008, the Company entered into a Separation Arrangement (“Separation Agreement”) with its former CEO, Robert Jurkowski. Pursuant to the terms of the Separation Agreement, Mr. Jurkowski’s employment with the Company terminated on June 30, 2008. Mr. Jurkowski also resigned as a member of the Company’s Board of Directors effective June 30, 2008. Under the Separation Agreement, Mr. Jurkowski received a payment of $45,000 representing his target bonus for the first quarter of fiscal 2009 and also a payment of $180,000 equal to six months of his base salary on July 10, 2008. The Company will also continue to pay Mr. Jurkowski payments equal to six months of his base salary and health insurance premiums for himself and his dependents until June 30, 2009. These amounts have been accrued for as of June 30, 2008. Mr. Jurkowski’s outstanding issuances of restricted stock were cancelled and a $400,823 non-cash stock-based compensation expense reduction was recorded in the Company’s statements of operations for the quarter ended June 30, 2008.

 

57


Table of Contents

The restructuring accrual and the related utilization for the fiscal years ended March 31, 2009 and 2008, respectively were (in thousands):

 

     Severance and
Benefits
    Excess
Facilities
    Total  

Balance, March 31, 2007

   $ 103      $ 5,740      $ 5,843   

Additional accruals

     300        436        736   

Amounts paid in cash

     (277     (2,974     (3,251

Loan to sublessee

     —          (497     (497
                        

Balance, March 31, 2008

     126        2,705        2,831   

Additional accruals

     661        (143     518   

Amounts paid in cash

     (735     (1,812     (2,547

Loan to sublessee

     —          463        463   
                        

Balance, March 31, 2009

   $ 52      $ 1,213      $ 1,265   
                        

 

14. Segment Information

SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information” (SFAS 131), requires disclosures of certain information regarding operating segments, products and services, geographic areas of operation and major customers. SFAS 131 reporting is based upon the “management approach”. This requires management to organize the Company’s operating segments for which separate financial information is: (i) available and (ii) evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance.

Selectica offers comprehensive consulting, training and implementation services and ongoing customer support and maintenance, to support its software applications. The business is focused towards delivering software and services under two operating segments (1) contract management, and (2) sales configuration.

The Selectica Contract Lifecycle Management (“CLM” or “CM”) solution is a contract authoring, analysis, repository and process automation component designed to enhance and automate the management of the entire contract lifecycle. It helps companies take control of their contract management processes by converting from paper-based to electronic repositories and by unlocking multiple layers of critical business data, making it available for the evaluation of risk, the exposure of lost revenue and the evaluation of supplier performance, and other purposes. The solution helps to improve the customer buying experience for sales organizations, improve the control of risk and decrease time spent drafting, monitoring and managing contracts for the corporate counsel’s office and gain access to previously hidden discounts through the exposure and elimination of unfavorable agreements for procurement and sourcing organizations.

The Selectica Sales Configuration (“SCS”) solution consolidates configuration, pricing and quoting functions into a single application platform enabling companies to streamline the opportunity-to-order process for manufacturers, service providers, and financial services companies. The Company’s SCS solution provides a critical link between Customer Relationship Management (CRM) and Enterprise Resource Planning (ERP) systems that helps to simplify and automate the configuration, pricing, and quoting of complex products and services. By empowering customers, internal sales staff, and/or channel partners to generate error-free sales proposals for their unique requirements, the Company believes its SCS solution helps companies to close sales faster, accelerate revenue generation and enhance customer relationships.

 

58


Table of Contents

The Company evaluates performance and allocates resources based on segment revenue and segment operating income (loss). Segment operating income (loss) is comprised of income before unallocated selling, general and administrative expenses, interest income and interest and other income. Segment information for total assets, capital expenditures and depreciation is not presented as such information is not used in measuring segment performance or allocating resources between segments.

 

     Fiscal Years Ended
March 31,
 
     2009     2008  
     (in thousands)  

Sales Configuration Solutions:

    

Net Revenues

   $ 6,552      $ 10,248   

Cost of Sales

     1,625        2,321   
                

Gross Profit

     4,927        7,927   
                

Income from Operations

     2,134        4,246   
                

Contract Management Solutions:

    

Net Revenues

     9,893        5,755   

Cost of Sales

     4,144        1,880   
                

Gross Profit

     5,749        3,875   
                

Loss from Operations

     (1,983     (4,715
                

Unallocated Corporate Expenses

     6,327        (25,929

 

15. Sale of Indian Subsidiary

On March 31, 2009, the Company sold the equity interest of its U.S. parent company in its wholly owned foreign subsidiary in India. The subsidiary had formerly provided development and professional services resources for the Sales Configuration group as well as acted as an interface to an outsourcing partner in India for development services for both product lines. The sale was for a cash consideration of $4.3 million ($1.0 million of which was held in escrow and released in early June 2009) and $0.4 million of forgiveness of intercompany debt. The Company recorded a net $0.9 million loss on sale, which included a non-cash charge of $2.6 million due to the liquidation of the subsidiary, on its consolidated statements of operations for the fiscal year ended March 31, 2009.

 

16. Subsequent Event

On June 10, 2009, the Company announced that, following a review of its business operations, it has implemented a re-alignment and restructuring, reducing headcount from 64 at March 31, 2009 to 56 as of June 15, 2009. The Company expects to record charges of at least $0.5 million in the six months ending September 30, 2009.

 

59


Table of Contents
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

 

Item 9A. Controls and Procedures.

Controls and Procedures

Review of Corporate Governance Policies and Procedures

Background . In early 2009, we began a review of certain of our corporate governance policies and procedures, including policies and procedures that impact our disclosure controls and procedures and our internal control over financial reporting (collectively, our “internal controls”).

There were three interrelated reasons for initiating this review. First, our Board of Directors determined that it was appropriate to reconsider the legal status of our management structure due to the length of time following the appointment of Jim Thanos and Brenda Zawatski as Co-Chairs of our Board in July 2008 without the appointment of a CEO. Second, we received a letter from counsel for a stockholder of the Company with whom we are currently in litigation in April 2009 expressing concern regarding possible weaknesses in our internal controls and procedures. Third, our Audit Committee undertook a review of our internal controls regarding our accounting for certain non-routine transactions.

Management Structure . On June 30, 2008, Jim Thanos and Brenda Zawatski were appointed Co-Chairs of our Board of Directors, following the departure of our former chief executive officer on the same day. As originally contemplated, Mr. Thanos and Ms. Zawatski would, in their capacity as non-employee directors, devote additional time on an interim basis to overseeing operational matters until we appointed a successor chief executive officer. On August 1, 2008, our Board determined to compensate Mr. Thanos and Ms. Zawatski at the rate of $250 per hour in cash, subject to a maximum of eight hours per day, for time spent providing operational assistance beyond the time spent on normal Board matters. Pursuant to this arrangement, Mr. Thanos and Ms. Zawatski received $164,125 and $274,273 in cash, respectively, in the fiscal year ended March 31, 2009, but no equity compensation. These amounts exclude cash and equity compensation paid to them pursuant to our regular compensation program for non-employee directors of our Board of Directors.

The responsibilities of Mr. Thanos and Ms. Zawatski have evolved over time to the point that collectively, they are acting in a capacity similar to that of a chief executive officer, largely because we deferred efforts to hire a new chief executive officer after deciding to evaluate strategic alternatives in July, 2008. As a result of their greater involvement in operational matters for a longer time period than initially anticipated, we have determined to disclose their fiscal year 2009 compensation and compensation arrangements as if they were “named executive officers” of the Company in Item 11 of this Annual Report on Form 10-K (the “Annual Report”). As more fully disclosed below, we have also (i) determined that Mr. Thanos and Ms. Zawatski are not “independent” directors within the meaning of applicable rules of the SEC and The Nasdaq Global Stock Market, (ii) accepted their resignations as members of the Audit Committee, Compensation Committee and Nominating Committee of our Board of Directors to ensure that all members of these committees are independent, and (iii) determined that Ms. Zawatski and Mr. Thanos certify our Annual Report and our Quarterly Reports for the quarters ended June 30, September 30, and December 31, 2008 (the “Quarterly Reports”).

Stockholder Letter. On or about April 7, 2009, our Board of Directors received a letter from counsel to a stockholder of the Company expressing concern regarding certain of our internal controls and compliance matters and requesting that we investigate those concerns. The Company is currently involved in litigation with the stockholder. In response to the letter, on April 8, 2009, the Board of Directors formed a special committee of our Board of Directors (the “Special Committee”), assisted by independent legal counsel, to investigate each of the matters raised in the letter and to report to our Board of Directors. As a result of the investigation, which is substantially complete, pending confirmation of certain additional information, the Special Committee recommend that our Board of Directors enhance our corporate governance policies and procedures to, among other things, ensure that we comply with applicable regulatory and legal requirements.

 

60


Table of Contents

Changes in Corporate Governance Policies and Procedures. On June 28, 2009, as a result of the review described above, including the recommendations of the Special Committee described above and of our Audit Committee, our Board of Directors adopted a number of changes designed to enhance the effectiveness of our corporate governance policies and procedures, including our internal controls. Among other things, our Board of Directors:

 

  1. Determined that Jim Thanos and Brenda Zawatski are not “independent” directors within the meaning of applicable rules of the SEC and The Nasdaq Global Market, which led to them resigning as members of the Audit, Compensation and Nominating committees;

 

  2. Determined that Jim Thanos and Brenda Zawatski are acting together in a capacity similar to that of a chief executive officer of the Company and therefore should certify the Annual Report and the Quarterly Reports;

 

  3. Amended the charters of our Audit Committee and Compensation Committee to enhance their responsibilities and authority, including additional policies and procedures as summarized herein;

 

  4. Reconstituted the Nominating Committee as the Nominating/Corporate Governance Committee and granted it responsibility and authority to, among other things, oversee corporate governance policies and procedures, including compliance with applicable regulatory and legal requirements;

 

  5. Adopted Corporate Governance Guidelines setting forth specific guidelines with respect to our Board of Directors’ composition, responsibilities, meetings, committees, and review of management and with respect to stockholder communications;

 

  6. Adopted policies and procedures for related party transactions, as contemplated by item 404(b) of Regulation S-K;

 

  7. Adopted policies and procedures to ensure that there is sufficient time to review (i) our annual and quarterly business plans before we publicly disclose guidance regarding our forecast financial results and (ii) all earnings announcements and other financial releases and related disclosure before they are released to the public;

 

  8. Adopted policies and procedures for increased scrutiny and review of the accounting for significant non-routine transactions and transactions requiring increased levels of management judgment;

 

  9. Adopted a requirement that all officers and directors of the Company receive additional training in the Company’s corporate governance policies and procedures, including the responsibilities of the committees of our Board of Directors, our insider trading policy and our Regulation FD communications compliance policy; and

 

  10. Adopted a requirement that our management prepare a detailed annual calendar of all meetings of our Board of Directors and its committees, including the specific matters to be addressed at those meetings, to ensure that all corporate governance policies and procedures are complied with on an annual basis .

Accounting for Non-Routine Transactions . As previously reported in our Form 8-K for the quarter ended September 30, 2008, following the appointment of our current Chief Financial Officer in September 2008, we initiated a review of our internal control over financial reporting. As a result of the review, our management determined that we had a material weakness in our internal control over financial reporting as of September 30, 2008 due to the combined effect of several significant deficiencies. Among the items identified by our management was the improper reporting of a non-routine compensation expense in a prior accounting period. In addition, on April 6, 2009, we disclosed the sale of our Indian subsidiary along with the expected accounting treatment of that transaction. As a result of additional work by our management, we determined that our disclosure was incomplete and filed a report on Form 8-K reporting that the original disclosure should not be relied upon. On June 10, 2009, we subsequently disclosed the full accounting treatment of the sale. As a result of these transactions, our Audit Committee recommended changes in our internal controls over financial reporting designed to ensure that our accounting for non-routine transactions receives appropriate levels of management scrutiny, review and judgment. As summarized above, these proposed changes have been adopted by our Board of Directors.

 

61


Table of Contents

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining internal controls over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Internal control over financial reporting means a process designed by, or under the supervision of, our principal executive and principal financial officers (or persons performing similar functions), and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer; (ii) provide reasonable assurances that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Our management, including the Co-Chairs of our Board of Directors and our Chief Financial Officer, evaluated the effectiveness of our internal control over financial reporting as of March 31, 2009 based on the guidelines established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

Based upon our evaluation of internal control over financial reporting as of March 31, 2009, including the information made available to management regarding the results of our review of certain of our corporate governance policies and procedures, as summarized above, our management identified control deficiencies and significant deficiencies in our internal control over financial reporting as of that date. These control deficiencies and significant deficiencies relate primarily to the need to implement changes described above under Review of Corporate Governance Policies and Procedures. Although none of these internal control deficiencies or significant deficiencies was considered material individually, when considered in the aggregate, our management determined that these control deficiencies and significant deficiencies together represent a material weakness in our internal control over financial reporting. As a result, our management concluded that our internal control over financial reporting was not effective as of March 31, 2009 and that additional steps were needed to provide assurance that effective controls could be maintained in the future.

A control deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a control deficiency, or combination of control deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the company’s financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

Our management believes that the steps taken by our Board of Directors, as summarized above, when fully implemented should be sufficient to remediate the material weakness. We plan to monitor implementation of the steps taken by our Board of Directors and to evaluate whether these steps are sufficient.

This 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this 10-K.

 

62


Table of Contents

Evaluation of Disclosure Controls and Procedures

Management is responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act ). Disclosure controls and procedures means controls and other procedures that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified by the rule and forms of the Securities and Exchange Commission (the “SEC”). Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our management, including the Co-Chairs of our Board of Directors and our Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures for each fiscal quarter during the period ended March 31, 2009. Based on its evaluation, our management concluded that our disclosure controls and procedures were not effective as of March 31, 2009, because of the need to implement the changes described above under Review of Corporate Governance Policies and Procedures and the material weakness in our internal control over financial reporting described above.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting in the quarter ended March 31, 2009 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. However, as noted above, we have made a number of material changes to our corporate governance policies and procedures in the quarter ending June 30, 2009, that are designed to enhance our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including our principal executive officer and principal financial officer (or persons performing those functions), do not expect that our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Item 9B. Other Information.

None.

 

63


Table of Contents

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

Directors

The following table sets forth, as of June 29, 2009, the names and certain information concerning our directors:

 

Name

   Age   

Position

   Director
Since
   End of
Term

Brenda Zawatski

   48    Co-Chair of the Board    2005    2009

Jim Thanos

   60    Co-Chair of the Board    2007    2011

James Arnold, Jr. (1)(2)(3)

   52    Director    2003    2010

Lloyd Sems (1)(2)(3)

   38    Director    2008    2010

Alan Howe (1)(2)(3)

   47    Director    2009    2009

 

(1) Member of the Audit Committee

 

(2) Member of the Compensation Committee

 

(3) Member of the Nominating/Corporate Governance Committee

Brenda Zawatski has served as a director since November 2005 and as Co-Chair of the Board since June 30, 2008. Ms. Zawatski was the vice president of sales and marketing for Pillar Data Systems from January 2006 to July 2007. Prior to joining Pillar, Ms. Zawatski was the vice president of sales and general manager of Information Lifecycle Management Solutions at StorageTek. Previously, Ms. Zawatski served as vice president of Product and Solutions Marketing for VERITAS Software. Prior to her move to VERITAS, Ms. Zawatski held significant roles at IBM as vice president, Tivoli Storage Software; vice president, Removable Media Storage Solutions; and director of S/390 Enterprise Systems. Ms. Zawatski holds a bachelor’s of science degree in Accounting and Computer Science from Penn State University.

Jim Thanos was appointed Co-Chair of the Board on June 30, 2008, and has served as a director since October 2007. Since June 2002, Mr. Thanos has served on advisory boards and provided consulting services to a variety of companies. From June 2000 to June 2002, Mr. Thanos served as Executive Vice President and General Manager of Worldwide Field Operations at Broadvision. Previously, Mr. Thanos held senior sales management roles for Aurum Software, Harvest Software, and Metaphor Inc. Mr. Thanos also serves on the Board of Directors of SupportSoft, a provider of software and services for technology problem resolution. Mr. Thanos holds a B.A. in behavioral sciences from The Johns Hopkins University in Baltimore, Maryland.

James Arnold, Jr. has served as chairman and financial expert of the Board’s Audit Committee since 2003. Mr. Arnold has served as Senior Vice President since 2004 and was Chief Financial Officer of Nuance Communications from 2004 to 2008. Prior to joining Nuance Communications, Mr. Arnold served as Corporate Vice President and Corporate Controller of Cadence Design Systems. Prior to joining Cadence, Mr. Arnold held a number of senior finance positions, including Chief Financial Officer, at Informix Corp.—now known as Ascential Software Corporation. From 1995 to 1997, Mr. Arnold served as Corporate Controller for Centura Software Corporation. Mr. Arnold worked in public accounting at Price Waterhouse LLP from 1983 to 1995, where he provided consulting and auditing services. Mr. Arnold received a bachelor’s degree in finance from Delta State University in Cleveland, Mississippi and an M.B.A. from Loyola University in New Orleans, Louisiana.

Lloyd Sems was elected to the Board of Directors of the Company on June 2, 2008, and serves as chairman of the Board’s Nominating/Corporate Governance Committee. Since October 2003, he served as President of Sems Capital, LLC and of Capital Edge, LLC, both of which he founded. Previously, Mr. Sems served as Director of Research and Portfolio Manager for Watchpoint Asset Management. Mr. Sems holds a Bachelor of Science degree in Business Administration and Finance from Albright College.

 

64


Table of Contents

Alan Howe was elected to the Board on January 12, 2009 and serves as chairman of the Board’s Compensation Committee. Mr. Howe has extensive operational experience as well as involvement with many aspects of corporate finance and business development. He is co-founder and managing partner of Broadband Initiatives, LLC, a boutique corporate advisory and consulting firm. He served as vice president of strategic and wireless business development for Covad Communications, Inc., a national broadband telecommunications company. Prior to that, Mr. Howe was chief financial officer and vice president of corporate development of Teletrac, Inc., and director of corporate development for Sprint PCS. Mr. Howe is a member of the board of directors of Proxim Wireless Corporation, Alliance Semiconductor Corporation, Crossroads Systems, Inc., LCC International, Anacomp Inc., and Dyntek, Inc. Mr. Howe holds a B.A. in business administration from the University of Illinois and an M.B.A. from the Indiana University Kelley Graduate School of Business.

Executive Officers

The following table sets forth, as of June 29, 2009, the names and certain information concerning our executive officers who do not also serve as directors:

 

Name

   Age   

Position

Richard Heaps

   56    Chief Financial Officer, General Counsel and Secretary

Jason Stern

   39    Senior Vice President, Operations of the Contract Management Business

Richard Heaps was appointed the Company’s Chief Financial Officer and General Counsel on September 8, 2008. Since 2001, Mr. Heaps served as managing director of The Management Group, LLC, a financial and strategic management advisory practice focused on early-stage technology companies. Prior to that, Mr. Heaps served as CFO and COO of Clarent Corporation and CFO and General Counsel of Centura Software. He also has held various positions at Unisoft, Oracle and Dataquest. Mr. Heaps has a J.D. and M.B.A. from Stanford University and a B.A. from Yale University. Mr. Heaps is an active member of the State Bar of California.

Jason Stern was appointed Senior Vice President of Operations of the Company’s Contract Management Business on June 10, 2009, and did not serve as an executive officer of the Company in fiscal year 2009. From March 2008 to June 2009, Mr. Stern served as the Company’s Vice President of Products and Business Development for Contract Management Solutions and from January 2007 to March 2008, was Vice President of Solutions. Prior to joining the Company in November of 2006, Mr. Stern was the Vice President of Product Management for I-many, a contract management software and services company. With more than 10 years of experience in enterprise software product management, Mr. Stern also spent four years at Oracle, an enterprise software company, managing products for CRM, Call Center, and Finance. Mr. Stern has a B.A. from UCLA and an M.B.A. from the University of Southern California.

In June 2009, we determined that Jim Thanos and Brenda Zawatski are acting together in capacity similar to that of a chief executive officer by virtue of service as Co-Chair of the Board.

The information required by this item regarding our directors and corporate governance matters is included under the captions “Corporate Governance and Board of Directors Matters” and “Proposals to be Voted On—Proposal Number 1—Election of Directors” in Selectica’s Proxy Statement for its fiscal year 2010 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended March 31, 2009 (the “2010 Proxy Statement”) and is incorporated herein by reference. The information required by this item regarding delinquent filers pursuant to Item 405 of Regulation S-K is included under the heading “Section 16(a) Beneficial Ownership Reporting Compliance” in the 2010 Proxy Statement and is incorporated herein by reference. The information required by this item regarding our procedures by which Stockholders may recommend nominees to the Board of Directors pursuant to Item 407(c)(3) of Regulation S-K is included under the heading “Stockholder Communication with the Board of Directors” in the 2010 Proxy Statement and is incorporated herein by reference.

 

65


Table of Contents
Item 11. Executive Compensation.

The information required by this item is included under the captions “Director Compensation” and “Executive Compensation” in the fiscal year 2010 Proxy Statement and incorporated herein by reference.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item is included under the captions “Common Stock Ownership of Certain Beneficial Owners and Management” and “Executive Compensation—Equity Compensation Plan Information” in the fiscal year 2010 Proxy Statement and is incorporated herein by reference.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by this item is included under the captions “Certain Relationships and Related Transactions” and “Corporate Governance—Independence of Directors” in the fiscal year 2010 Proxy Statement and is incorporated herein by reference.

 

Item 14. Principal Accounting Fees and Services.

The information required by this item is included under the caption “Independent Public Accountants” in the fiscal year 2010 Proxy Statement and is incorporated herein by reference.

 

66


Table of Contents

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

The following documents are filed as part of this report:

(a) Financial Statements : See Index to Consolidated Financial Statements in Part II, Item 8.

(b) Financial Statement Schedule :

Schedule II—Valuation and Qualifying Accounts and Reserves

All other schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.

Schedule II: Valuation and Qualifying Accounts

Accounts Receivable Allowance for Doubtful Accounts

The following describes activity in the accounts receivable allowance for doubtful accounts for the years ended March 31, 2009 and 2008, respectively:

 

       Balance at
Beginning
of Period
   Additions to
Costs and
Expenses
   Write
Offs
    Reversal
Benefit to
Revenue
    Balance
at End of
Period

Allowance for doubtful accounts:

            

Fiscal year ended March 31, 2008

   $ 121    $ —      $ (81   $ (40   $ —  

Fiscal year ended March 31, 2009

   $ —      $ 373    $ —        $ —        $ 373

(c) Exhibits : See the Exhibit Index immediately following the signature page of this Annual Report on Form 10-K.

 

67


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Jose, State of California, on the day of July 8, 2009.

 

SELECTICA, INC.

Registrant

/ S /    B RENDA Z AWATSKI        

Brenda Zawatski
Co-Chair

/ S /    J IM T HANOS        

Jim Thanos
Co-Chair

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Brenda Zawatski and Richard Heaps, and each of them, his or her true and lawful attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any amendments to this report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact or their substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/ S /    B RENDA Z AWATSKI        

Brenda Zawatski

  

Co-Chair

  July 8, 2009

/ S /    J IM T HANOS        

Jim Thanos

   Co-Chair   July 8, 2009

/ S /    R ICHARD H EAPS        

Richard Heaps

   Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), General Counsel and Secretary   July 8, 2009
Directors:     

/ S /    J AMIE A RNOLD        

Jamie Arnold

   Director   July 8, 2009

/ S /    B RENDA Z AWATSKI        

Brenda Zawatski

   Director   July 8, 2009

/ S /    L LOYD S EMS        

Lloyd Sems

   Director   July 8, 2009

/ S /    J IM T HANOS        

Jim Thanos

   Director   July 8, 2009

/ S /    A LAN H OWE        

Alan Howe

   Director   July 8, 2009


Table of Contents

EXHIBIT INDEX

 

Exhibit
No.
  

Description

  3.1(1)    The Second Amended and Restated Certificate of Incorporation.
  3.2(3)    Certificate of Designation of Series A Junior or Participating Preferred Stock.
  3.3(3)    Amended and Restated Bylaws.
  3.4(12)    Certificate of Designation of Series B Junior or Participating Preferred Stock.
  4.1    Reference is made to Exhibits 3.1, 3.2, 3.3 and 3.4.
  4.2(1)    Form of Registrant’s Common Stock certificate.
  4.3(1)    Amended and Restated Investor Rights Agreement, dated June 16, 1999.
  4.4(9)    Transfer Agent Agreement between Registrant and Wells Fargo Corporation, as Transfer Agent, dated February 13, 2007
  4.5(12)    Amended and Restated Rights Agreement between Registrant and Computershare Trust Company, N.A., as Rights Agent, dated January 2, 2009.
  4.6(13)    Amendment dated as of January 26, 2009, to the Amended and Restated Rights Agreement between Registrant and Computershare Trust Company, N.A. as Rights Agent, dated January 2, 2009.
  4.7(17)    Amendment 2, dated as of May 8, 2009, between Registrant and Wells Fargo Bank, N.A., as Rights Agent, to the Amended and Restated Rights Agreement between Registrant and Computershare Trust Company, N.A., dated January 2, 2009, as amended,
10.1(1)    Form of Indemnification Agreement.
10.2(1)*    1996 Stock Plan.
10.3(1)    Lease between John Arrillaga Survivors Trust and the Richard T. Perry Separate Property Trust as Landlord and the Registrant as Tenant, dated October 1, 1999.
10.4(2)*    Employment Agreement between the Registrant and Stephen Bennion, dated as of January 1, 2003.
10.5(5)    Sublease Agreement between Selectica Incorporated and Nuova Systems, dated March 6, 2007
10.6(6)*    Employment Agreement between the Registrant and Stephen Bennion, dated August 9, 2006.
10.7(9)*    Employment Agreement between the Registrant and Bill Roeschlein, dated September 11, 2006.
10.8(9)*    Employment Agreement between the Registrant and Steve Goldner, dated September 27, 2006.
10.9(9)*    Employment Agreement between the Registrant and Terry Nicholson, dated September 27, 2006.
10.10(3)    Warrant to Purchase Common Stock issued to Sales Technologies Limited, dated April 4, 2001.
10.11(3)    Licensed Works Agreement between the Registrant and International Business Machines Corporation, dated December 11, 2002.
10.12(3)    Licensed Works Agreement Statement of Work between the Registrant and International Business Machines Corporation, dated December 11, 2002.
10.13(3)    Professional Services Agreement between the Registrant and GE Medical Services, dated June 28, 2002.
10.14(3)    Major Account License Agreement between the Registrant and GE Medical Systems, dated June 28, 2002.
10.15(3)    Amendment #1 to Major Account License Agreement between the Registrant and GE Medical Systems.


Table of Contents
Exhibit
No.
  

Description

10.16(3)    Amendment #2 to Major Account License Agreement between the Registrant and GE Medical Systems, dated October 8, 2002.
10.17(3)    Amendment #3 to Major Account License Agreement between the Registrant and GE Medical Systems, dated March 31, 2003.
10.18(3)    Amendment #1 to Professional Services Agreement between Registrant and GE Medical Services, dated August 27, 2002.
10.19(3)    Amendment #2 to Professional Services Agreement between Registrant and GE Medical Services, dated March 3, 2003.
10.20(9)*    Company Compensation Plan for Non Employee Directors, dated August 1, 2006.
10.21(7)    Letter Agreement between Registrant and Sanjay Mittal, dated July 21, 2006.
10.22(6)    Separation Agreement between Registrant and Vince Ostrosky, dated August 9, 2006.
10.23(4)*    1999 Equity Incentive Plan Stock Option Agreement.
10.24(4)*    1999 Equity Incentive Plan Stock Option Agreement (Initial Grant to Directors).
10.25(4)*    1999 Equity Incentive Plan Stock Option Agreement (Annual Grant to Directors).
10.26(4)    Selectica UK Limited Major Account License Agreement, dated December 5, 2003.
10.27(4)    Amendment Agreement between MCI WorldCom, Limited and Selectica UK Limited, dated December 23, 2004.
10.28(8)    Notice of Delisting, dated June 19, 2007.
10.29(10)    Separation Agreement between Registrant and Stephen Bennion, dated October 23, 2007.
10.30(11)    Severance Agreement between Registrant and William Roeschlein, dated September 27, 2006.
10.31(11)    Severance Agreement between Registrant and Michael Shaw, dated January 14, 2008.
10.32(11)*    Employment Agreement between the Registrant and Robert Jurkowski, dated August 21, 2007.
10.33(11)*    Offer Letter between Registrant and Michael Shaw, dated January 9, 2008.
10.34(15)*    Employment Agreement between the Registrant and Richard Heaps, dated September 5, 2008.
10.35(15)    Severance Agreement between the Registrant and Richard Heaps, dated September 4, 2008.
10.36(16)    Share Purchase Agreement between the Registrant and DAX Partners, L.P., dated March 31, 2009.
10.37*    1999 Employee Stock Purchase Plan, as amended and restated February 1, 2008.
10.38*    1999 Equity Incentive Plan, as amended and restated August 1, 2006.
10.39*    Form of Stock Unit Agreement for issuance of restricted stock units pursuant to the Registrant’s 1999 Equity Incentive Plan to plan participants, including named executive officers.
10.40*    Registrant Compensation Program for Non-Employee Directors effective January 2, 2009.
10.41*    Registrant Compensation Program for Non-Employee Directors effective May 20, 2009.
10.42    Registrant Master Software License Agreement with CA, Inc., dated February 13, 2009.
10.43    Settlement, Release and License Agreement between Registrant and Versata Software Inc., a corporation f/k/a Trilogy Software, Inc., dated October 5, 2007.
10.44*    Summary of Registrant’s Board Co-Chairs Compensation Arrangement.
21.1    Subsidiaries.


Table of Contents
Exhibit
No.
  

Description

23.1    Consent of Independent Registered Public Accounting Firm.
24.1    Power of Attorney (contained in the signature page to this Annual Report on Form 10-K).
31.1**    Certification of Co-Chair Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2**    Certification of Co-Chair Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.3**    Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**    Certification of Co-Chair Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**    Certification of Co-Chair Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.3**    Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1(14)    Trust Agreement, dated January 27, 2009, between Registrant and Wilmington Trust Company, as trustee.

 

(1) Previously filed in the Company’s Registration Statement (No. 333-92545) declared effective on March 9, 2000.

 

(2) Previously filed in the Company’s report on Form 10-Q filed on February 14, 2003.

 

(3) Previously filed in the Company’s report on Form 10-K filed on June 30, 2003.

 

(4) Previously filed in the Company’s report on Form 10-K filed on June 29, 2006.

 

(5) Previously filed in the Company’s report on Form 8-K filed on March 27, 2008.

 

(6) Previously filed in the Company’s report on Form 8-K on August 15, 2007.

 

(7) Previously filed in the Company’s report on Form 8-K on July 27, 2007.

 

(8) Previously filed in the Company’s report on Form 8-K on June 22, 2008.

 

(9) Previously filed in the Company’s report on Form 10-K on October 3, 2007

 

(10) Previously filed in the Company’s report on Form 8-K on October 23, 2007.

 

(11) Previously filed in the Company’s report on Form 10-KSB filed on June 10, 2008.

 

(12) Previously filed in the Company’s report on Form 8-K on January 2, 2009.

 

(13) Previously filed in the Company’s report on Form 8-K on January 28, 2009.

 

(14) Previously filed in the Company’s report on Form 8-K filed on February 4, 2009.

 

(15) Previously filed in the Company’s report on Form 10-Q filed on February 17, 2009.

 

(16) Previously filed in the Company’s report on Form 8-K filed on April 6, 2009.

 

(17) Previously filed in the Company’s report on Form 8-K filed on April 28, 2009.

 

* Represents a management agreement or compensatory plan.

 

** This certification is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Selectica, Inc. specifically incorporates it by reference.

Exhibit 10.37

S ELECTICA , I NC .

1999 E MPLOYEE S TOCK P URCHASE P LAN

(A S A MENDED AND R ESTATED E FFECTIVE F EBRUARY  1, 2008)


TABLE OF CONTENTS

 

     Page

SECTION 1. PURPOSE OF THE PLAN

   1

SECTION 2. ADMINISTRATION OF THE PLAN

   1

(a) Committee Composition

   1

(b) Committee Responsibilities

   1

SECTION 3. STOCK OFFERED UNDER THE PLAN

   1

(a) Authorized Shares

   1

(b) Anti-Dilution Adjustments

   1

(c) Reorganizations

   2

SECTION 4. ENROLLMENT AND PARTICIPATION

   2

(a) Offering Periods

   2

(b) Enrollment

   2

(c) Duration of Participation

   2

(d) Transition Rule

   2

SECTION 5. EMPLOYEE CONTRIBUTIONS

   3

(a) Commencement of Payroll Deductions

   3

(b) Amount of Payroll Deductions

   3

(c) Reducing Withholding Rate or Discontinuing Payroll Deductions

   3

(d) Increasing Withholding Rate

   3

SECTION 6. WITHDRAWAL FROM THE PLAN

   3

(a) Withdrawal

   3

(b) Re-Enrollment After Withdrawal

   3

SECTION 7. CHANGE IN EMPLOYMENT STATUS

   4

(a) Termination of Employment

   4

(b) Leave of Absence

   4

(c) Death

   4

SECTION 8. PLAN ACCOUNTS AND PURCHASE OF SHARES

   4

(a) Plan Accounts

   4

(b) Purchase Price

   4

(c) Number of Shares Purchased

   4

(d) Available Shares Insufficient

   5

(e) Issuance of Stock

   5

(f) Tax Withholding

   5

(g) Unused Cash Balances

   5

(h) Stockholder Approval

   5

 

i


SECTION 9. LIMITATIONS ON STOCK OWNERSHIP

   5

(a) Five Percent Limit

   5

(b) Dollar Limit

   6

SECTION 10. RIGHTS NOT TRANSFERABLE

   6

SECTION 11. NO RIGHTS AS AN EMPLOYEE

   7

SECTION 12. NO RIGHTS AS A STOCKHOLDER

   7

SECTION 13. SECURITIES LAW REQUIREMENTS

   7

SECTION 14. AMENDMENT OR DISCONTINUANCE

   7

(a) General Rule

   7

(b) Impact on Purchase Price

   7

SECTION 15. DEFINITIONS

   8

(a) Board

   8

(b) Code

   8

(c) Committee

   8

(d) Company

   8

(e) Compensation

   8

(f) Corporate Reorganization

   8

(g) Eligible Employee

   8

(h) Exchange Act

   8

(i) Fair Market Value

   8

(j) Offering Period

   9

(k) Participant

   9

(l) Participating Company

   9

(m) Plan

   9

(n) Plan Account

   9

(o) Purchase Price

   9

(p) Stock

   9

(q) Subsidiary

   9

 

ii


S ELECTICA , I NC .

1999 E MPLOYEE S TOCK P URCHASE P LAN

SECTION 1. PURPOSE OF THE PLAN.

The Board adopted the Plan effective as of March 9, 2000, and amended it from time to time thereafter. The Board most recently amended and restated the Plan effective as of February 1, 2008. The purpose of the Plan is to provide Eligible Employees with an opportunity to increase their proprietary interest in the success of the Company by purchasing Stock from the Company on favorable terms and to pay for such purchases through payroll deductions. The Plan is intended to qualify for favorable tax treatment under section 423 of the Code.

SECTION 2. ADMINISTRATION OF THE PLAN.

(a) Committee Composition . The Committee shall administer the Plan. The Committee shall consist exclusively of one or more members of the Board, who shall be appointed by the Board.

(b) Committee Responsibilities . The Committee shall interpret the Plan and make all other policy decisions relating to the operation of the Plan. The Committee may adopt such rules, guidelines and forms as it deems appropriate to implement the Plan. The Committee’s determinations under the Plan shall be final and binding on all persons.

SECTION 3. STOCK OFFERED UNDER THE PLAN.

(a) Authorized Shares . The number of shares of Stock available for purchase under the Plan shall be 1,000,000 (subject to adjustment pursuant to Subsection (b) below). On May 1 of each year from 2001 through 2007, and on February 1 of each year after 2007, the aggregate number of shares of Stock available for purchase during the life of the Plan shall automatically increase by a number equal to the lowest of:

(i) 2% of the total number of Common Shares then outstanding;

(ii) 1,000,000 Common Shares (subject to adjustment pursuant to Subsection (b) below); or

(iii) The number determined by the Board.

(b) Anti-Dilution Adjustments . The aggregate number of shares of Stock offered under the Plan, the number of shares of Stock set forth in Subsection (a)(ii) above, the 5,000-share limitation described in Section 8(c) and the price of shares that any Participant has elected to purchase shall be adjusted proportionately for any increase or decrease in the number


of outstanding shares of Stock resulting from a subdivision or consolidation of shares or the payment of a stock dividend, any other increase or decrease in such shares effected without receipt or payment of consideration by the Company, the distribution of the shares of a Subsidiary to the Company’s stockholders, or a similar event.

(c) Reorganizations . Any other provision of the Plan notwithstanding, immediately prior to the effective time of a Corporate Reorganization, the Offering Period then in progress shall terminate and shares shall be purchased pursuant to Section 8, unless the Plan is continued or assumed by the surviving corporation or its parent corporation. The Plan shall in no event be construed to restrict in any way the Company’s right to undertake a dissolution, liquidation, merger, consolidation or other reorganization.

SECTION 4. ENROLLMENT AND PARTICIPATION.

(a) Offering Periods . While the Plan is in effect, two Offering Periods shall commence in each calendar year. The Offering Periods shall consist of the six-month periods commencing on each February 1 and August 1. However, the Committee may determine that the first Offering Period applicable to the Eligible Employees of a new Participating Company shall commence on any date specified by the Committee, provided that an Offering Period shall in no event be longer than 27 months.

(b) Enrollment . In the case of any individual who qualifies as an Eligible Employee on the first day of an Offering Period, he or she may elect to become a Participant on such day by filing the prescribed enrollment form with the Company. The enrollment form shall be filed at the prescribed location at least 15 days prior to such day.

(c) Duration of Participation . Once enrolled in the Plan, a Participant shall continue to participate in the Plan until he or she:

(i) Reaches the end of the Offering Period in which his or her employee contributions were discontinued under Section 5(c) or 9(b);

(ii) Is deemed to withdraw from the Plan under Subsection (b) above;

(iii) Withdraws from the Plan under Section 6(a); or

(iv) Ceases to be an Eligible Employee.

A Participant whose employee contributions were discontinued automatically under Section 9(b) shall automatically resume participation at the beginning of the earliest Offering Period ending in the next calendar year, if he or she then is an Eligible Employee. In all other cases, a former Participant may again become a Participant, if he or she then is an Eligible Employee, by following the procedure described in Subsection (c) above.

(d) Transition Rule . Any provision of the Plan as in effect prior to February 1, 2008, notwithstanding, each Participant who was enrolled in the Plan on January 31,

 

2


2008, shall cease to be enrolled in any Offering Period that commenced prior to February 1, 2008. Such Participant shall automatically be enrolled in the new Offering Period commencing on February 1, 2008.

SECTION 5. EMPLOYEE CONTRIBUTIONS.

(a) Commencement of Payroll Deductions . A Participant may purchase shares of Stock under the Plan solely by means of payroll deductions. Payroll deductions shall commence as soon as reasonably practicable after the Company has received the prescribed enrollment form.

(b) Amount of Payroll Deductions . An Eligible Employee shall designate on the prescribed enrollment form the portion of his or her Compensation that he or she elects to have withheld for the purchase of Stock. Such portion shall be a whole percentage of the Eligible Employee’s Compensation, but not less than 1% nor more than 15%.

(c) Reducing Withholding Rate or Discontinuing Payroll Deductions . If a Participant wishes to reduce his or her rate of payroll withholding, such Participant may do so by filing a new enrollment form with the Company at the prescribed location at any time. The new withholding rate shall be effective as soon as reasonably practicable after the Company has received such form. The new withholding rate may be 0% or any whole percentage of the Participant’s Compensation, but not more than his or her old withholding rate. No Participant shall make more than two elections under this Subsection (c) during any Offering Period. (In addition, employee contributions may be discontinued automatically pursuant to Section 9(b).)

(d) Increasing Withholding Rate . If a Participant wishes to increase his or her rate of payroll withholding, such Participant may do so by filing a new enrollment form with the Company at the prescribed location at any time. The new withholding rate may be effective on the first day of any Offering Period, provided that the Participant has filed the enrollment form with the Company at the prescribed location at least 15 days prior to the first day of such Offering Period. The new withholding rate may be any whole percentage of the Participant’s Compensation, but not less than 1% nor more than 15%. An increase in a Participant’s rate of payroll withholding may not take effect during an Offering Period.

SECTION 6. WITHDRAWAL FROM THE PLAN.

(a) Withdrawal . A Participant may elect to withdraw from the Plan by filing the prescribed form with the Company at the prescribed location at any time before the last day of an Offering Period. As soon as reasonably practicable thereafter, payroll deductions shall cease and the entire amount credited to the Participant’s Plan Account shall be refunded to him or her in cash, without interest. No partial withdrawals shall be permitted.

(b) Re-Enrollment After Withdrawal . A former Participant who has withdrawn from the Plan shall not be a Participant until he or she re-enrolls in the Plan under Section 4(c). Re-enrollment may be effective only at the commencement of an Offering Period.

 

3


SECTION 7. CHANGE IN EMPLOYMENT STATUS.

(a) Termination of Employment . Termination of employment as an Eligible Employee for any reason, including death, shall be treated as an automatic withdrawal from the Plan under Section 6(a). (A transfer from one Participating Company to another shall not be treated as a termination of employment.)

(b) Leave of Absence . For purposes of the Plan, employment shall not be deemed to terminate when the Participant goes on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by the Company in writing. Employment, however, shall be deemed to terminate 90 days after the Participant goes on a leave, unless a contract or statute guarantees his or her right to return to work. Employment shall be deemed to terminate in any event when the approved leave ends, unless the Participant immediately returns to work.

(c) Death . In the event of the Participant’s death, the amount credited to his or her Plan Account shall be paid to a beneficiary designated by him or her for this purpose on the prescribed form or, if none, to the Participant’s estate. Such form shall be valid only if it was filed with the Company at the prescribed location before the Participant’s death.

SECTION 8. PLAN ACCOUNTS AND PURCHASE OF SHARES.

(a) Plan Accounts . The Company shall maintain a Plan Account on its books in the name of each Participant. Whenever an amount is deducted from the Participant’s Compensation under the Plan, such amount shall be credited to the Participant’s Plan Account. Amounts credited to Plan Accounts shall not be trust funds and may be commingled with the Company’s general assets and applied to general corporate purposes. No interest shall be credited to Plan Accounts.

(b) Purchase Price . The Purchase Price for each share of Stock purchased at the close of an Offering Period shall be the lower of:

(i) 85% of the Fair Market Value of such share on the last trading day before the commencement of such Offering Period; or

(ii) 85% of the Fair Market Value of such share on the last trading day in such Offering Period.

(c) Number of Shares Purchased . As of the last day of each Offering Period, each Participant shall be deemed to have elected to purchase the number of shares of Stock calculated in accordance with this Subsection (c), unless the Participant has previously elected to withdraw from the Plan in accordance with Section 6(a). The amount then in the Participant’s Plan Account shall be divided by the Purchase Price, and the number of shares that results shall be purchased from the Company with the funds in the Participant’s Plan Account. The foregoing notwithstanding, no Participant shall purchase more than 5,000 shares of Stock with respect to any Offering Period nor more than the amounts of Stock set forth in Sections 3(a) and 9(b). The Committee may determine with respect to all Participants that any fractional share, as calculated under this Subsection (c), shall be (i) rounded down to the next lower whole share or (ii) credited as a fractional share.

 

4


(d) Available Shares Insufficient . In the event that the aggregate number of shares that all Participants elect to purchase during an Offering Period exceeds the maximum number of shares remaining available for issuance under Section 3, then the number of shares to which each Participant is entitled shall be determined by multiplying the number of shares available for issuance by a fraction. The numerator of such fraction is the number of shares that such Participant has elected to purchase, and the denominator of such fraction is the number of shares that all Participants have elected to purchase.

(e) Issuance of Stock . The shares of Stock purchased by a Participant under the Plan may be registered in the name of such Participant, or jointly in the name of such Participant and his or her spouse as joint tenants with the right of survivorship or as community property (with or without the right of survivorship). The Committee may require that such shares must be held for the Participant’s benefit by a broker designated by the Committee until the expiration of the holding period described in section 423(a)(1) of the Code. (The preceding sentence shall apply whether or not the Participant is required to pay income tax in the United States.)

(f) Tax Withholding . To the extent required by applicable federal, state, local or foreign law, a Participant shall make arrangements satisfactory to the Company for the satisfaction of any withholding tax obligations that arise in connection with the Plan. The Company shall not be required to issue any shares of Stock under the Plan until such obligations are satisfied.

(g) Unused Cash Balances . An amount remaining in the Participant’s Plan Account that represents the Purchase Price for any fractional share shall be carried over in the Participant’s Plan Account to the next Offering Period. Any amount remaining in the Participant’s Plan Account that represents the Purchase Price for whole shares that could not be purchased by reason of Subsection (c) above, Section 3 or Section 9(b) shall be refunded to the Participant in cash, without interest.

(h) Stockholder Approval . Any other provision of the Plan notwithstanding, no shares of Stock shall be purchased under the Plan unless and until the Company’s stockholders have approved the adoption of the Plan.

SECTION 9. LIMITATIONS ON STOCK OWNERSHIP.

(a) Five Percent Limit . Any other provision of the Plan notwithstanding, no Participant shall be granted a right to purchase Stock under the Plan if such Participant, immediately after his or her election to purchase such Stock, would own stock possessing more than 5% of the total combined voting power or value of all classes of stock of the Company or any parent or Subsidiary of the Company. For purposes of this Subsection (a), the following rules shall apply:

(i) Ownership of stock shall be determined after applying the attribution rules of section 424(d) of the Code;

 

5


(ii) Each Participant shall be deemed to own any stock that he or she has a right or option to purchase under this or any other plan; and

(iii) Each Participant shall be deemed to have the right to purchase 5,000 shares of Stock under this Plan with respect to each Offering Period.

(b) Dollar Limit . Any other provision of the Plan notwithstanding, no Participant shall purchase Stock with a Fair Market Value in excess of the following limit:

(i) In the case of Stock purchased during an Offering Period that commenced in the current calendar year, the limit shall be equal to (A) $25,000 minus (B) the Fair Market Value of the Stock that the Participant previously purchased in the current calendar year (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company).

(ii) In the case of Stock purchased during an Offering Period that commenced in the immediately preceding calendar year, the limit shall be equal to (A) $50,000 minus (B) the Fair Market Value of the Stock that the Participant previously purchased (under this Plan and all other employee stock purchase plans of the Company or any parent or Subsidiary of the Company) in the current calendar year and in the immediately preceding calendar year.

For purposes of this Subsection (b), the Fair Market Value of Stock shall be determined in each case as of the beginning of the Offering Period in which such Stock is purchased. Employee stock purchase plans not described in section 423 of the Code shall be disregarded. If a Participant is precluded by this Subsection (b) from purchasing additional Stock under the Plan, then his or her employee contributions shall automatically be discontinued and shall automatically resume at the beginning of the earliest Offering Period ending in the next calendar year (if he or she then is an Eligible Employee).

SECTION 10. RIGHTS NOT TRANSFERABLE.

The rights of any Participant under the Plan, or any Participant’s interest in any Stock or moneys to which he or she may be entitled under the Plan, shall not be transferable by voluntary or involuntary assignment or by operation of law, or in any other manner other than by beneficiary designation or the laws of descent and distribution. If a Participant in any manner attempts to transfer, assign or otherwise encumber his or her rights or interest under the Plan, other than by beneficiary designation or the laws of descent and distribution, then such act shall be treated as an election by the Participant to withdraw from the Plan under Section 6(a).

 

6


SECTION 11. NO RIGHTS AS AN EMPLOYEE.

Nothing in the Plan or in any right granted under the Plan shall confer upon the Participant any right to continue in the employ of a Participating Company for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Participating Companies or of the Participant, which rights are hereby expressly reserved by each, to terminate his or her employment at any time and for any reason, with or without cause.

SECTION 12. NO RIGHTS AS A STOCKHOLDER.

A Participant shall have no rights as a stockholder with respect to any shares of Stock that he or she may have a right to purchase under the Plan until such shares have been purchased on the last day of the applicable Offering Period.

SECTION 13. SECURITIES LAW REQUIREMENTS.

Shares of Stock shall not be issued under the Plan unless the issuance and delivery of such shares comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations promulgated thereunder, state securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities may then be traded.

SECTION 14. AMENDMENT OR DISCONTINUANCE.

(a) General Rule . The Board shall have the right to amend, suspend or terminate the Plan at any time and without notice. Except as provided in Section 3, any increase in the aggregate number of shares of Stock that may be issued under the Plan shall be subject to the approval of the Company’s stockholders. In addition, any other amendment of the Plan shall be subject to the approval of the Company’s stockholders to the extent required by any applicable law or regulation. The Plan shall terminate automatically 20 years after its initial adoption by the Board, unless (a) the Plan is extended by the Board and (b) the extension is approved within 12 months by a vote of the stockholders of the Company.

(b) Impact on Purchase Price . This Subsection (b) shall apply in the event that (i) the Company’s stockholders during an Offering Period approve an increase in the number of shares of Stock that may be issued under Section 3 and (ii) the aggregate number of shares to be purchased at the close of such Offering Period exceeds the number of shares that remained available under Section 3 before such increase. In such event, the Purchase Price for each share of Stock purchased at the close of such Offering Period shall be the lower of:

(i) The higher of (A) 85% of the Fair Market Value of such share on the last trading day before the commencement of the applicable Offering Period or (B) 85% of the Fair Market Value of such share on the last trading day before the date when the Company’s stockholders approve such increase; or

 

7


(ii) 85% of the Fair Market Value of such share on the last trading day in such Offering Period.

SECTION 15. DEFINITIONS.

(a) “ Board ” means the Board of Directors of the Company, as constituted from time to time.

(b) “ Code ” means the Internal Revenue Code of 1986, as amended.

(c) “ Committee ” means a committee of the Board, as described in Section 2.

(d) “ Company ” means Selectica, Inc., a Delaware corporation.

(e) “ Compensation ” means (i) the total compensation paid in cash to a Participant by a Participating Company, including salaries, wages, bonuses, incentive compensation, commissions, overtime pay and shift premiums, plus (ii) any pre-tax contributions made by the Participant under section 401(k) or 125 of the Code. “Compensation” shall exclude all non-cash items, moving or relocation allowances, cost-of-living equalization payments, car allowances, tuition reimbursements, imputed income attributable to cars or life insurance, severance pay, fringe benefits, contributions or benefits received under employee benefit plans, income attributable to the exercise of stock options, and similar items. The Committee shall determine whether a particular item is included in Compensation.

(f) “ Corporate Reorganization ” means:

(i) The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization; or

(ii) The sale, transfer or other disposition of all or substantially all of the Company’s assets or the complete liquidation or dissolution of the Company.

(g) “ Eligible Employee ” means any employee of a Participating Company whose customary employment is for more than five months per calendar year and for more than 20 hours per week. The foregoing notwithstanding, an individual shall not be considered an Eligible Employee if his or her participation in the Plan is prohibited by the law of any country that has jurisdiction over him or her or if he or she is subject to a collective bargaining agreement that does not provide for participation in the Plan.

(h) “ Exchange Act ” means the Securities Exchange Act of 1934, as amended.

(i) “ Fair Market Value ” means the price at which Stock was last sold in the principal U.S. market for Stock on the applicable date or, if the applicable date was not a trading day, on the last trading day prior to the applicable date. If Stock is no longer traded on a public U.S. securities market, the Fair Market Value shall be determined by the Committee in good faith on such basis as it deems appropriate. The Committee’s determination shall be conclusive and binding on all persons.

 

8


(j) “ Offering Period ” means a period with respect to which the right to purchase Stock may be granted under the Plan, as determined pursuant to Section 4(a).

(k) “ Participant ” means an Eligible Employee who participates in the Plan, as provided in Section 4.

(l) “ Participating Company ” means (i) the Company and (ii) each present or future Subsidiary designated by the Committee as a Participating Company.

(m) “ Plan ” means this Selectica, Inc. 1999 Employee Stock Purchase Plan, as it may be amended from time to time.

(n) “ Plan Account ” means the account established for each Participant pursuant to Section 8(a).

(o) “ Purchase Price ” means the price at which Participants may purchase Stock under the Plan, as determined pursuant to Section 8(b).

(p) “ Stock ” means the Common Stock of the Company.

(q) “ Subsidiary ” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

 

9

Exhibit 10.38

S ELECTICA , I NC .

1999 E QUITY I NCENTIVE P LAN

A DOPTED N OVEMBER  18, 1999

A MENDED AND R ESTATED D ECEMBER  11, 2002

A MENDED AND R ESTATED A UGUST  1, 2006


TABLE OF CONTENTS

 

     Page

ARTICLE 1. INTRODUCTION

   1

ARTICLE 2. ADMINISTRATION

   1

2.1 Committee Composition

   1

2.2 Committee Responsibilities

   1

2.3 Committee for Non-Officer Grants

   2

ARTICLE 3. SHARES AVAILABLE FOR GRANTS

   2

3.1 Basic Limitation

   2

3.2 Annual Increase in Shares

   2

3.3 Additional Shares

   2

3.4 Dividend Equivalents

   2

ARTICLE 4. ELIGIBILITY

   3

4.1 Incentive Stock Options

   3

4.2 Other Grants

   3

ARTICLE 5. OPTIONS

   3

5.1 Stock Option Agreement

   3

5.2 Number of Shares

   3

5.3 Exercise Price

   3

5.4 Exercisability and Term

   3

5.5 Modification or Assumption of Options

   3

5.6 Buyout Provisions

   4

ARTICLE 6. PAYMENT FOR OPTION SHARES

   4

6.1 General Rule

   4

6.2 Surrender of Stock

   4

6.3 Exercise/Sale

   4

6.4 Promissory Note

   4

6.5 Other Forms of Payment

   4

ARTICLE 7. STOCK APPRECIATION RIGHTS

   4

7.1 SAR Agreement

   4

7.2 Number of Shares

   5

7.3 Exercise Price

   5

7.4 Exercisability and Term

   5

7.5 Exercise of SARs

   5

7.6 Modification or Assumption of SARs

   5

ARTICLE 8. RESTRICTED SHARES

   5

8.1 Restricted Stock Agreement

   5

 

i


8.2 Payment for Awards

   6

8.3 Vesting Conditions

   6

8.4 Voting and Dividend Rights

   6

ARTICLE 9. STOCK UNITS

   6

9.1 Stock Unit Agreement

   6

9.2 Payment for Awards

   6

9.3 Vesting Conditions

   6

9.4 Voting and Dividend Rights

   6

9.5 Form and Time of Settlement of Stock Units

   7

9.6 Death of Recipient

   7

9.7 Creditors’ Rights

   7

ARTICLE 10. PROTECTION AGAINST DILUTION

   7

10.1 Adjustments

   7

10.2 Dissolution or Liquidation

   8

10.3 Reorganizations

   8

ARTICLE 11. CHANGE IN CONTROL

   8

ARTICLE 12. AWARDS UNDER OTHER PLANS.

   9

ARTICLE 13. PAYMENT OF DIRECTOR’S FEES IN SECURITIES

   9

13.1 Effective Date

   9

13.2 Elections to Receive NSOs, Restricted Shares or Stock Units

   9

13.3 Number and Terms of NSOs, Restricted Shares or Stock Units

   9

ARTICLE 14. LIMITATION ON RIGHTS

   9

14.1 Retention Rights

   9

14.2 Stockholders’ Rights

   9

14.3 Regulatory Requirements

   9

ARTICLE 15. WITHHOLDING TAXES

   10

15.1 General

   10

15.2 Share Withholding

   10

ARTICLE 16. FUTURE OF THE PLAN

   10

16.1 Term of the Plan

   10

16.2 Amendment or Termination

   10

ARTICLE 17. LIMITATION ON PAYMENTS

   10

17.1 Scope of Limitation

   10

17.2 Basic Rule

   11

17.3 Reduction of Payments

   11

17.4 Overpayments and Underpayments

   11

17.5 Related Corporations

   12

 

ii


ARTICLE 18. DEFINITIONS

   12

 

iii


S ELECTICA , I NC .

1999 E QUITY I NCENTIVE P LAN

ARTICLE 1. INTRODUCTION.

The Board adopted the Plan on November 18, 1999, effective as of March 9, 2000 (the date of the Company’s initial public offering). The Board amended and restated the Plan on December 11, 2002, and effective August 1, 2006. The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by (a) encouraging Employees, Outside Directors and Consultants to focus on critical long-range objectives, (b) encouraging the attraction and retention of Employees, Outside Directors and Consultants with exceptional qualifications and (c) linking Employees, Outside Directors and Consultants directly to stockholder interests through increased stock ownership. The Plan seeks to achieve this purpose by providing for Awards in the form of Restricted Shares, Stock Units, Options (which may constitute incentive stock options or nonstatutory stock options) or stock appreciation rights.

The Plan shall be governed by, and construed in accordance with, the laws of the State of Delaware (except their choice-of-law provisions).

ARTICLE 2. ADMINISTRATION.

2.1 Committee Composition . The Committee shall administer the Plan. The Committee shall consist exclusively of two or more directors of the Company, who shall be appointed by the Board. In addition, each member of the Committee shall meet the following requirements:

(a) Any listing standards prescribed by the principal securities market on which the Company’s equity securities are traded;

(b) Such requirements as the Internal Revenue Service may establish for outside directors acting under plans intended to qualify for exemption under section 162(m)(4)(C) of the Code;

(c) Such requirements as the Securities and Exchange Commission may establish for administrators acting under plans intended to qualify for exemption under Rule 16b-3 (or its successor) under the Exchange Act; and

(d) Any other requirements imposed by applicable law, regulations or rules.

2.2 Committee Responsibilities . The Committee shall (a) select the Employees, Outside Directors and Consultants who are to receive Awards under the Plan, (b) determine the type, number, vesting requirements and other features and conditions of such


Awards, (c) interpret the Plan, (d) make all other decisions relating to the operation of the Plan and (e) carry out any other duties delegated to it by the Board. The Committee may adopt such rules or guidelines as it deems appropriate to implement the Plan. The Committee’s determinations under the Plan shall be final and binding on all persons.

2.3 Committee for Non-Officer Grants . The Board may also appoint a secondary committee of the Board, which shall be composed of one or more directors of the Company who need not satisfy the requirements of Section 2.1. Such secondary committee may administer the Plan with respect to Employees and Consultants who are not considered officers or directors of the Company under section 16 of the Exchange Act, may grant Awards under the Plan to such Employees and Consultants and may determine all features and conditions of such Awards. Within the limitations of this Section 2.3, any reference in the Plan to the Committee shall include such secondary committee.

ARTICLE 3. SHARES AVAILABLE FOR GRANTS.

3.1 Basic Limitation . Common Shares issued pursuant to the Plan may be authorized but unissued shares or treasury shares. The aggregate number of Options, SARs, Stock Units and Restricted Shares awarded under the Plan shall not exceed (a) 2,200,000 plus (b) the additional Common Shares described in Sections 3.2 and 3.3. The limitations of this Section 3.1 and Section 3.2 shall be subject to adjustment pursuant to Article 10.

3.2 Annual Increase in Shares . As of January 1 of each year, commencing with the year 2001, the aggregate number of Options, SARs, Stock Units and Restricted Shares that may be awarded under the Plan shall automatically increase by a number equal to the lowest of (a) 5% of the total number of Common Shares then outstanding, (b) 1,800,000 Common Shares or (c) the number determined by the Board.

3.3 Additional Shares . If Restricted Shares or Common Shares issued upon the exercise of Options are forfeited, then such Common Shares shall again become available for Awards under the Plan. If Stock Units, Options or SARs are forfeited or terminate for any other reason before being exercised, then the corresponding Common Shares shall again become available for Awards under the Plan. If Stock Units are settled, then only the number of Common Shares (if any) actually issued in settlement of such Stock Units shall reduce the number available under Section 3.1 and the balance shall again become available for Awards under the Plan. If SARs are exercised, then only the number of Common Shares (if any) actually issued in settlement of such SARs shall reduce the number available under Section 3.1 and the balance shall again become available for Awards under the Plan. The foregoing notwithstanding, the aggregate number of Common Shares that may be issued under the Plan upon the exercise of ISOs shall not be increased when Restricted Shares or other Common Shares are forfeited.

3.4 Dividend Equivalents . Any dividend equivalents paid or credited under the Plan shall not be applied against the number of Restricted Shares, Stock Units, Options or SARs available for Awards, whether or not such dividend equivalents are converted into Stock Units.

 

2


ARTICLE 4. ELIGIBILITY.

4.1 Incentive Stock Options . Only Employees who are common-law employees of the Company, a Parent or a Subsidiary shall be eligible for the grant of ISOs. In addition, an Employee who owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company or any of its Parents or Subsidiaries shall not be eligible for the grant of an ISO unless the requirements set forth in section 422(c)(6) of the Code are satisfied.

4.2 Other Grants . Only Employees, Outside Directors and Consultants shall be eligible for the grant of Restricted Shares, Stock Units, NSOs or SARs.

ARTICLE 5. OPTIONS.

5.1 Stock Option Agreement . Each grant of an Option under the Plan shall be evidenced by a Stock Option Agreement between the Optionee and the Company. Such Option shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan. The Stock Option Agreement shall specify whether the Option is an ISO or an NSO. The provisions of the various Stock Option Agreements entered into under the Plan need not be identical. Options may be granted in consideration of a reduction in the Optionee’s other compensation. A Stock Option Agreement may provide that a new Option will be granted automatically to the Optionee when he or she exercises a prior Option and pays the Exercise Price in the form described in Section 6.2.

5.2 Number of Shares . Each Stock Option Agreement shall specify the number of Common Shares subject to the Option and shall provide for the adjustment of such number in accordance with Article 10. Options granted to any Optionee in a single fiscal year of the Company shall not cover more than 330,000 Common Shares, except that Options granted to a new Employee in the fiscal year of the Company in which his or her Service as an Employee first commences shall not cover more than 660,000 Common Shares. The limitations set forth in the preceding sentence shall be subject to adjustment in accordance with Article 10.

5.3 Exercise Price . Each Stock Option Agreement shall specify the Exercise Price; provided that the Exercise Price shall in no event be less than 100% of the Fair Market Value of a Common Share on the date of grant.

5.4 Exercisability and Term . Each Stock Option Agreement shall specify the date or event when all or any installment of the Option is to become exercisable. The Stock Option Agreement shall also specify the term of the Option; provided that the term of an ISO shall in no event exceed 10 years from the date of grant. A Stock Option Agreement may provide for accelerated exercisability in the event of the Optionee’s death, disability or retirement or other events and may provide for expiration prior to the end of its term in the event of the termination of the Optionee’s Service. Options may be awarded in combination with SARs, and such an Award may provide that the Options will not be exercisable unless the related SARs are forfeited.

5.5 Modification or Assumption of Options . Within the limitations of the Plan, the Committee may modify, extend or assume outstanding options or may accept the

 

3


cancellation of outstanding options (whether granted by the Company or by another issuer) in return for the grant of new options for the same or a different number of shares and at the same or a different exercise price. The foregoing notwithstanding, no modification of an Option shall, without the consent of the Optionee, alter or impair his or her rights or obligations under such Option.

5.6 Buyout Provisions . The Committee may at any time (a) offer to buy out for a payment in cash or cash equivalents an Option previously granted or (b) authorize an Optionee to elect to cash out an Option previously granted, in either case at such time and based upon such terms and conditions as the Committee shall establish.

ARTICLE 6. PAYMENT FOR OPTION SHARES.

6.1 General Rule . The entire Exercise Price of Common Shares issued upon exercise of Options shall be payable in cash or cash equivalents at the time when such Common Shares are purchased, except that the Committee at its sole discretion may accept payment of the Exercise Price in any other form(s) described in this Article 6. However, if the Optionee is an Outside Director or executive officer of the Company, he or she may pay the Exercise Price in a form other than cash or cash equivalents only to the extent permitted by section 13(k) of the Exchange Act.

6.2 Surrender of Stock . With the Committee’s consent, all or any part of the Exercise Price may be paid by surrendering, or attesting to the ownership of, Common Shares that are already owned by the Optionee. Such Common Shares shall be valued at their Fair Market Value on the date when the new Common Shares are purchased under the Plan.

6.3 Exercise/Sale . With the Committee’s consent, all or any part of the Exercise Price and any withholding taxes may be paid by delivering (on a form prescribed by the Company) an irrevocable direction to a securities broker approved by the Company to sell all or part of the Common Shares being purchased under the Plan and to deliver all or part of the sales proceeds to the Company.

6.4 Promissory Note . With the Committee’s consent, all or any part of the Exercise Price and any withholding taxes may be paid by delivering (on a form prescribed by the Company) a full-recourse promissory note.

6.5 Other Forms of Payment . With the Committee’s consent, all or any part of the Exercise Price and any withholding taxes may be paid in any other form that is consistent with applicable laws, regulations and rules.

ARTICLE 7. STOCK APPRECIATION RIGHTS.

7.1 SAR Agreement . Each grant of an SAR under the Plan shall be evidenced by an SAR Agreement between the Optionee and the Company. Such SAR shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan. The provisions of the various SAR Agreements entered into under the Plan need not be identical. SARs may be granted in consideration of a reduction in the Optionee’s other compensation.

 

4


7.2 Number of Shares . Each SAR Agreement shall specify the number of Common Shares to which the SAR pertains and shall provide for the adjustment of such number in accordance with Article 10. SARs granted to any Optionee in a single fiscal year shall in no event pertain to more than 330,000 Common Shares, except that SARs granted to a new Employee in the fiscal year of the Company in which his or her Service as an Employee first commences shall not pertain to more than 660,000 Common Shares. The limitations set forth in the preceding sentence shall be subject to adjustment in accordance with Article 10.

7.3 Exercise Price . Each SAR Agreement shall specify the Exercise Price; provided that the Exercise Price shall in no event be less than 100% of the Fair Market Value of a Common Share on the date of grant.

7.4 Exercisability and Term . Each SAR Agreement shall specify the date when all or any installment of the SAR is to become exercisable. The SAR Agreement shall also specify the term of the SAR. An SAR Agreement may provide for accelerated exercisability in the event of the Optionee’s death, disability or retirement or other events and may provide for expiration prior to the end of its term in the event of the termination of the Optionee’s Service. SARs may be awarded in combination with Options, and such an Award may provide that the SARs will not be exercisable unless the related Options are forfeited. An SAR may be included in an ISO only at the time of grant but may be included in an NSO at the time of grant or thereafter. An SAR granted under the Plan may provide that it will be exercisable only in the event of a Change in Control.

7.5 Exercise of SARs . Upon exercise of an SAR, the Optionee (or any person having the right to exercise the SAR after his or her death) shall receive from the Company (a) Common Shares, (b) cash or (c) a combination of Common Shares and cash, as the Committee shall determine. The amount of cash and/or the Fair Market Value of Common Shares received upon exercise of SARs shall, in the aggregate, be equal to the amount by which the Fair Market Value (on the date of surrender) of the Common Shares subject to the SARs exceeds the Exercise Price. If, on the date when an SAR expires, the Exercise Price under such SAR is less than the Fair Market Value on such date but any portion of such SAR has not been exercised or surrendered, then such SAR shall automatically be deemed to be exercised as of such date with respect to such portion.

7.6 Modification or Assumption of SARs . Within the limitations of the Plan, the Committee may modify, extend or assume outstanding SARs or may accept the cancellation of outstanding SARs (whether granted by the Company or by another issuer) in return for the grant of new SARs for the same or a different number of shares and at the same or a different exercise price. The foregoing notwithstanding, no modification of an SAR shall, without the consent of the Optionee, alter or impair his or her rights or obligations under such SAR.

ARTICLE 8. RESTRICTED SHARES.

8.1 Restricted Stock Agreement . Each grant of Restricted Shares under the Plan shall be evidenced by a Restricted Stock Agreement between the recipient and the Company. Such Restricted Shares shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan. The provisions of the various Restricted Stock Agreements entered into under the Plan need not be identical.

 

5


8.2 Payment for Awards . Restricted Shares may be sold or awarded under the Plan for such consideration as the Committee may determine, including (without limitation) cash, cash equivalents, property, full-recourse promissory notes, past services and future services. If the Participant is an Outside Director or executive officer of the Company, he or she may pay for Restricted Shares with a promissory note only to the extent permitted by section 13(k) of the Exchange Act. Within the limitations of the Plan, the Committee may accept the cancellation of outstanding options in return for the grant of Restricted Shares.

8.3 Vesting Conditions . Each Award of Restricted Shares may or may not be subject to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Restricted Stock Agreement. A Restricted Stock Agreement may provide for accelerated vesting in the event of the Participant’s death, disability or retirement or other events.

8.4 Voting and Dividend Rights . The holders of Restricted Shares awarded under the Plan shall have the same voting, dividend and other rights as the Company’s other stockholders. A Restricted Stock Agreement, however, may require that the holders of Restricted Shares invest any cash dividends received in additional Restricted Shares. Such additional Restricted Shares shall be subject to the same conditions and restrictions as the Award with respect to which the dividends were paid.

ARTICLE 9. STOCK UNITS.

9.1 Stock Unit Agreement . Each grant of Stock Units under the Plan shall be evidenced by a Stock Unit Agreement between the recipient and the Company. Such Stock Units shall be subject to all applicable terms of the Plan and may be subject to any other terms that are not inconsistent with the Plan. The provisions of the various Stock Unit Agreements entered into under the Plan need not be identical. Stock Units may be granted in consideration of a reduction in the recipient’s other compensation.

9.2 Payment for Awards . To the extent that an Award is granted in the form of Stock Units, no cash consideration shall be required of the Award recipients.

9.3 Vesting Conditions . Each Award of Stock Units may or may not be subject to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the Stock Unit Agreement. A Stock Unit Agreement may provide for accelerated vesting in the event of the Participant’s death, disability or retirement or other events.

9.4 Voting and Dividend Rights . The holders of Stock Units shall have no voting rights. Prior to settlement or forfeiture, any Stock Unit awarded under the Plan may, at the Committee’s discretion, carry with it a right to dividend equivalents. Such right entitles the holder to be credited with an amount equal to all cash dividends paid on one Common Share while the Stock Unit is outstanding. Dividend equivalents may be converted into additional Stock Units. Settlement of dividend equivalents may be made in the form of cash, in the form of Common Shares, or in a combination of both. Prior to distribution, any dividend equivalents that are not paid shall be subject to the same conditions and restrictions as the Stock Units to which they attach.

 

6


9.5 Form and Time of Settlement of Stock Units . Settlement of vested Stock Units may be made in the form of (a) cash, (b) Common Shares or (c) any combination of both, as determined by the Committee. The actual number of Stock Units eligible for settlement may be larger or smaller than the number included in the original Award, based on predetermined performance factors. Methods of converting Stock Units into cash may include (without limitation) a method based on the average Fair Market Value of Common Shares over a series of trading days. Vested Stock Units may be settled in a lump sum or in installments. The distribution may occur or commence when all vesting conditions applicable to the Stock Units have been satisfied or have lapsed, or it may be deferred to any later date. The amount of a deferred distribution may be increased by an interest factor or by dividend equivalents. Until an Award of Stock Units is settled, the number of such Stock Units shall be subject to adjustment pursuant to Article 10.

9.6 Death of Recipient . Any Stock Units Award that becomes payable after the recipient’s death shall be distributed to the recipient’s beneficiary or beneficiaries. Each recipient of a Stock Units Award under the Plan shall designate one or more beneficiaries for this purpose by filing the prescribed form with the Company. A beneficiary designation may be changed by filing the prescribed form with the Company at any time before the Award recipient’s death. If no beneficiary was designated or if no designated beneficiary survives the Award recipient, then any Stock Units Award that becomes payable after the recipient’s death shall be distributed to the recipient’s estate.

9.7 Creditors’ Rights . A holder of Stock Units shall have no rights other than those of a general creditor of the Company. Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Stock Unit Agreement.

ARTICLE 10. PROTECTION AGAINST DILUTION.

10.1 Adjustments . In the event of a subdivision of the outstanding Common Shares, a declaration of a dividend payable in Common Shares or a combination or consolidation of the outstanding Common Shares (by reclassification or otherwise) into a lesser number of Common Shares, corresponding adjustments shall automatically be made in each of the following:

(a) The number of Options, SARs, Restricted Shares and Stock Units available for future Awards under Article 3;

(b) The limitations set forth in Sections 5.2 and 7.2;

(c) The number of Common Shares covered by each outstanding Option and SAR;

(d) The Exercise Price under each outstanding Option and SAR; or

 

7


(e) The number of Stock Units included in any prior Award that has not yet been settled.

In the event of a declaration of an extraordinary dividend payable in a form other than Common Shares in an amount that has a material effect on the price of Common Shares, a recapitalization, a spin-off or a similar occurrence, the Committee shall make such adjustments as it, in its sole discretion, deems appropriate in one or more of the foregoing. Except as provided in this Article 10, a Participant shall have no rights by reason of any issuance by the Company of stock of any class or securities convertible into stock of any class, any subdivision or consolidation of shares of stock of any class, the payment of any stock dividend or any other increase or decrease in the number of shares of stock of any class.

10.2 Dissolution or Liquidation . To the extent not previously exercised or settled, Options, SARs and Stock Units shall terminate immediately prior to the dissolution or liquidation of the Company.

10.3 Reorganizations . In the event that the Company is a party to a merger or other reorganization, outstanding Awards shall be subject to the agreement of merger or reorganization. Such agreement shall provide for (a) the continuation of the outstanding Awards by the Company, if the Company is a surviving corporation, (b) the assumption of the outstanding Awards by the surviving corporation or its parent or subsidiary, (c) the substitution by the surviving corporation or its parent or subsidiary of its own awards for the outstanding Awards, (d) full exercisability or vesting and accelerated expiration of the outstanding Awards or (e) settlement of the full value of the outstanding Awards in cash or cash equivalents followed by cancellation of such Awards.

ARTICLE 11. CHANGE IN CONTROL.

Unless the applicable agreement evidencing the Award provides otherwise, in the event of any Change in Control, the vesting and exercisability of each outstanding Award shall automatically accelerate so that each such Award shall, immediately prior to the effective date of the Change in Control, become fully exercisable for all of the Common Shares at the time subject to such Award and may be exercised for any or all of those shares as fully vested Common Shares. However, the vesting and exercisability of an outstanding Award shall not so accelerate if and to the extent such Award, in connection with the Change in Control, remains outstanding, or is assumed by the surviving corporation (or parent or subsidiary thereof) or substituted with an award with substantially the same terms by the surviving corporation (or parent or subsidiary thereof). The determination of whether a substituted award has substantially the same terms as an Award shall be made by the Committee, and its determination shall be final, binding and conclusive.

Unless the applicable agreement evidencing the Award provides otherwise, in the event of any Change in Control and in the event that a recipient of an Award experiences an Involuntary Termination within 12 months following such Change in Control, the vesting and exercisability of each outstanding Award held by such recipient shall automatically accelerate, as if the recipient of the Award provided another 12 months of service following such Involuntary Termination.

 

8


ARTICLE 12. AWARDS UNDER OTHER PLANS.

The Company may grant awards under other plans or programs. Such awards may be settled in the form of Common Shares issued under this Plan. Such Common Shares shall be treated for all purposes under the Plan like Common Shares issued in settlement of Stock Units and shall, when issued, reduce the number of Common Shares available under Article 3.

ARTICLE 13. PAYMENT OF DIRECTOR’S FEES IN SECURITIES.

13.1 Effective Date . No provision of this Article 13 shall be effective unless and until the Board has determined to implement such provision.

13.2 Elections to Receive NSOs, Restricted Shares or Stock Units . An Outside Director may elect to receive his or her annual retainer payments and/or meeting fees from the Company in the form of cash, NSOs, Restricted Shares or Stock Units, or a combination thereof, as determined by the Board. Such NSOs, Restricted Shares and Stock Units shall be issued under the Plan. An election under this Article 13 shall be filed with the Company on the prescribed form.

13.3 Number and Terms of NSOs, Restricted Shares or Stock Units . The number of NSOs, Restricted Shares or Stock Units to be granted to Outside Directors in lieu of annual retainers and meeting fees that would otherwise be paid in cash shall be calculated in a manner determined by the Board. The Board shall also determine the terms of such NSOs, Restricted Shares or Stock Units.

ARTICLE 14. LIMITATION ON RIGHTS.

14.1 Retention Rights . Neither the Plan nor any Award granted under the Plan shall be deemed to give any individual a right to remain an Employee, Outside Director or Consultant. The Company and its Parents, Subsidiaries and Affiliates reserve the right to terminate the Service of any Employee, Outside Director or Consultant at any time, with or without cause, subject to applicable laws, the Company’s certificate of incorporation and by-laws and a written employment agreement (if any).

14.2 Stockholders’ Rights . A Participant shall have no dividend rights, voting rights or other rights as a stockholder with respect to any Common Shares covered by his or her Award prior to the time when a stock certificate for such Common Shares is issued or, if applicable, the time when he or she becomes entitled to receive such Common Shares by filing any required notice of exercise and paying any required Exercise Price. No adjustment shall be made for cash dividends or other rights for which the record date is prior to such time, except as expressly provided in the Plan.

14.3 Regulatory Requirements . Any other provision of the Plan notwithstanding, the obligation of the Company to issue Common Shares under the Plan shall be subject to all applicable laws, rules and regulations and such approval by any regulatory body as may be required. The Company reserves the right to restrict, in whole or in part, the delivery of Common Shares pursuant to any Award prior to the satisfaction of all legal requirements relating to the issuance of such Common Shares, to their registration, qualification or listing or to an exemption from registration, qualification or listing.

 

9


ARTICLE 15. WITHHOLDING TAXES.

15.1 General . To the extent required by applicable federal, state, local or foreign law, a Participant or his or her successor shall make arrangements satisfactory to the Company for the satisfaction of any withholding tax obligations that arise in connection with the Plan. The Company shall not be required to issue any Common Shares or make any cash payment under the Plan until such obligations are satisfied.

15.2 Share Withholding . To the extent that applicable law subjects a Participant to tax withholding obligations, the Committee may permit such Participant to satisfy all or part of such obligations by having the Company withhold all or a portion of any Common Shares that otherwise would be issued to him or her or by surrendering all or a portion of any Common Shares that he or she previously acquired. Such Common Shares shall be valued at their Fair Market Value on the date when they are withheld or surrendered.

ARTICLE 16. FUTURE OF THE PLAN.

16.1 Term of the Plan . The amended and restated Plan, as set forth herein, shall become effective on August 1, 2006. The Plan shall remain in effect until it is terminated under Section 16.2, except that no ISOs shall be granted on or after the 10 th   anniversary of the later of (a) the date when the Board adopted the original Plan or (b) the date when the Board adopted the most recent increase in the number of Common Shares available under Article 3 that was approved by the Company’s stockholders.

16.2 Amendment or Termination . The Board may, at any time and for any reason, amend or terminate the Plan. An amendment of the Plan shall be subject to the approval of the Company’s stockholders only to the extent required by applicable laws, regulations or rules. No Awards shall be granted under the Plan after the termination thereof. The termination of the Plan, or any amendment thereof, shall not affect any Award previously granted under the Plan.

ARTICLE 17. LIMITATION ON PAYMENTS.

17.1 Scope of Limitation . This Article 17 shall apply to an Award only if:

(a) The independent auditors most recently selected by the Board (the “Auditors”) determine that the after-tax value of such Award to the Participant, taking into account the effect of all federal, state and local income taxes, employment taxes and excise taxes applicable to the Participant (including the excise tax under section 4999 of the Code), will be greater after the application of this Article 17 than it was before the application of this Article 17; or

(b) The Committee, at the time of making an Award under the Plan or at any time thereafter, specifies in writing that such Award shall be subject to this Article 17 (regardless of the after-tax value of such Award to the Participant).

 

10


If this Article 17 applies to an Award, it shall supersede any contrary provision of the Plan or of any Award granted under the Plan.

17.2 Basic Rule . In the event that the Auditors determine that any payment or transfer by the Company under the Plan to or for the benefit of a Participant (a “Payment”) would be nondeductible by the Company for federal income tax purposes because of the provisions concerning “excess parachute payments” in section 280G of the Code, then the aggregate present value of all Payments shall be reduced (but not below zero) to the Reduced Amount. For purposes of this Article 17, the “Reduced Amount” shall be the amount, expressed as a present value, which maximizes the aggregate present value of the Payments without causing any Payment to be nondeductible by the Company because of section 280G of the Code.

17.3 Reduction of Payments . If the Auditors determine that any Payment would be nondeductible by the Company because of section 280G of the Code, then the Company shall promptly give the Participant notice to that effect and a copy of the detailed calculation thereof and of the Reduced Amount, and the Participant may then elect, in his or her sole discretion, which and how much of the Payments shall be eliminated or reduced (as long as after such election the aggregate present value of the Payments equals the Reduced Amount) and shall advise the Company in writing of his or her election within 10 days of receipt of notice. If no such election is made by the Participant within such 10-day period, then the Company may elect which and how much of the Payments shall be eliminated or reduced (as long as after such election the aggregate present value of the Payments equals the Reduced Amount) and shall notify the Participant promptly of such election. For purposes of this Article 17, present value shall be determined in accordance with section 280G(d)(4) of the Code. All determinations made by the Auditors under this Article 17 shall be binding upon the Company and the Participant and shall be made within 60 days of the date when a Payment becomes payable or transferable. As promptly as practicable following such determination and the elections hereunder, the Company shall pay or transfer to or for the benefit of the Participant such amounts as are then due to him or her under the Plan and shall promptly pay or transfer to or for the benefit of the Participant in the future such amounts as become due to him or her under the Plan.

17.4 Overpayments and Underpayments . As a result of uncertainty in the application of section 280G of the Code at the time of an initial determination by the Auditors hereunder, it is possible that Payments will have been made by the Company which should not have been made (an “Overpayment”) or that additional Payments which will not have been made by the Company could have been made (an “Underpayment”), consistent in each case with the calculation of the Reduced Amount hereunder. In the event that the Auditors, based upon the assertion of a deficiency by the Internal Revenue Service against the Company or the Participant that the Auditors believe has a high probability of success, determine that an Overpayment has been made, such Overpayment shall be treated for all purposes as a loan to the Participant that he or she shall repay to the Company, together with interest at the applicable federal rate provided in section 7872(f)(2) of the Code; provided, however, that no amount shall be payable by the Participant to the Company if and to the extent that such payment would not reduce the amount that is subject to taxation under section 4999 of the Code. In the event that the Auditors

 

11


determine that an Underpayment has occurred, such Underpayment shall promptly be paid or transferred by the Company to or for the benefit of the Participant, together with interest at the applicable federal rate provided in section 7872(f)(2) of the Code.

17.5 Related Corporations . For purposes of this Article 17, the term “Company” shall include affiliated corporations to the extent determined by the Auditors in accordance with section 280G(d)(5) of the Code.

ARTICLE 18. DEFINITIONS.

18.1 Affiliate ” means any entity other than a Subsidiary, if the Company and/or one or more Subsidiaries own not less than 50% of such entity.

18.2 Award ” means any award of an Option, an SAR, a Restricted Share or a Stock Unit under the Plan.

18.3 Board ” means the Company’s Board of Directors, as constituted from time to time.

18.4 Cause ” means the commission of any act of fraud, embezzlement or dishonesty by the recipient of the Award, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Company (or any Parent or Subsidiary), or any other intentional misconduct by such person adversely affecting the business or affairs of the Company (or any Parent or Subsidiary) in a material manner.

18.5 Change in Control ” means:

(a) The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization own immediately after such merger, consolidation or other reorganization 50% or more of the voting power of the outstanding securities of each of (i) the continuing or surviving entity and (ii) any direct or indirect parent corporation of such continuing or surviving entity;

(b) The sale, transfer or other disposition of all or substantially all of the Company’s assets;

(c) A change in the composition of the Board, as a result of which fewer than 50% of the incumbent directors are directors who either:

(i) Had been directors of the Company on the date 24 months prior to the date of such change in the composition of the Board (the “Original Directors”); or

(ii) Were appointed to the Board, or nominated for election to the Board, with the affirmative votes of at least a majority of the aggregate of (A) the Original Directors who were

 

12


in office at the time of their appointment or nomination and (B) the directors whose appointment or nomination was previously approved in a manner consistent with this Paragraph (ii); or

(d) Any transaction as a result of which any person is the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing at least 50% of the total voting power represented by the Company’s then outstanding voting securities. For purposes of this Subsection (d), the term “person” shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude (i) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Parent or Subsidiary and (ii) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company.

A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.

18.6 Code ” means the Internal Revenue Code of 1986, as amended.

18.7 Committee ” means a committee of the Board, as described in Article 2.

18.8 Common Share ” means one share of the common stock of the Company.

18.9 Company ” means Selectica, Inc., a Delaware corporation.

18.10 Consultant ” means a consultant or adviser who provides bona fide services to the Company, a Parent, a Subsidiary or an Affiliate as an independent contractor. Service as a Consultant shall be considered employment for all purposes of the Plan, except as provided in Section 4.1.

18.11 Employee ” means a common-law employee of the Company, a Parent, a Subsidiary or an Affiliate.

18.12 Exchange Act ” means the Securities Exchange Act of 1934, as amended.

18.13 Exercise Price ,” in the case of an Option, means the amount for which one Common Share may be purchased upon exercise of such Option, as specified in the applicable Stock Option Agreement. “Exercise Price,” in the case of an SAR, means an amount, as specified in the applicable SAR Agreement, which is subtracted from the Fair Market Value of one Common Share in determining the amount payable upon exercise of such SAR.

18.14 Fair Market Value ” means the market price of Common Shares, determined by the Committee in good faith on such basis as it deems appropriate. Whenever possible, the determination of Fair Market Value by the Committee shall be based on the prices reported in The Wall Street Journal . Such determination shall be conclusive and binding on all persons.

 

13


18.15 Involuntary Termination ” means the termination of the service of the recipient of the Award which occurs by reason of (a) such recipient’s involuntary dismissal or discharge by the Company for reasons other than Cause or (b) such recipient’s voluntary resignation following (i) a change in his or her position with the Company which materially reduces his or her level of responsibility, (ii) a reduction in his or her level of base salary or (iii) a relocation of such recipient’s place of employment by more than 35 miles, provided and only if such change, reduction or relocation is effected by the Company without the recipient’s consent.

18.16 ISO ” means an incentive stock option described in section 422(b) of the Code.

18.17 NSO ” means a stock option not described in sections 422 or 423 of the Code.

18.18 Option ” means an ISO or NSO granted under the Plan and entitling the holder to purchase Common Shares.

18.19 Optionee ” means an individual or estate who holds an Option or SAR.

18.20 Outside Director ” means a member of the Board who is not an Employee. Service as an Outside Director shall be considered employment for all purposes of the Plan, except as provided in Section 4.1.

18.21 Parent ” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date.

18.22 Participant ” means an individual or estate who holds an Award.

18.23 Plan ” means this Selectica, Inc. 1999 Equity Incentive Plan, as amended from time to time.

18.24 Restricted Share ” means a Common Share awarded under the Plan.

18.25 Restricted Stock Agreement ” means the agreement between the Company and the recipient of a Restricted Share that contains the terms, conditions and restrictions pertaining to such Restricted Share.

18.26 SAR ” means a stock appreciation right granted under the Plan.

 

14


18.27 SAR Agreement ” means the agreement between the Company and an Optionee that contains the terms, conditions and restrictions pertaining to his or her SAR.

18.28 Service ” means service as an Employee, Outside Director or Consultant.

18.29 Stock Option Agreement ” means the agreement between the Company and an Optionee that contains the terms, conditions and restrictions pertaining to his or her Option.

18.30 Stock Unit ” means a bookkeeping entry representing the equivalent of one Common Share, as awarded under the Plan.

18.31 Stock Unit Agreement ” means the agreement between the Company and the recipient of a Stock Unit that contains the terms, conditions and restrictions pertaining to such Stock Unit.

18.32 Subsidiary ” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.

 

15

Exhibit 10.39

S ELECTICA , I NC .

1999 E QUITY I NCENTIVE P LAN :

N OTICE O F S TOCK U NIT A WARD

You have been granted units representing shares of Common Stock of Selectica, Inc. (the “Company”) on the following terms:

 

Name of Recipient:    «Name»
Total Number of Units Granted:    «TotalUnits»
Date of Grant:    «DateGrant»
Vesting Commencement Date:    «VestDay»
Vesting Schedule:    The first «CliffPercent»% of the units subject to this award will vest when you complete «CliffPeriod» months of continuous “Service” (as defined in the Plan) after the Vesting Commencement Date. Thereafter, an additional «IncrementPercent»% of the units subject to this award will vest when you complete each «IncrementPeriod»-month period of continuous Service.

You and the Company agree that these units are granted under and governed by the terms and conditions of the Selectica, Inc. 1999 Equity Incentive Plan (the “Plan”) and the Stock Unit Agreement, both of which are attached to and made a part of this document.

You further agree that the Company may deliver by email all documents relating to the Plan or this award (including, without limitation, prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including, without limitation, annual reports and proxy statements). You also agree that the Company may deliver these documents by posting them on a website maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a website, it will notify you by email.

 

R ECIPIENT :     S ELECTICA , I NC .

 

    By:  

 

      Title:  

 


S ELECTICA , I NC .

1999 E QUITY I NCENTIVE P LAN :

S TOCK U NIT A GREEMENT

 

Payment for Units

   No payment is required for the units that you are receiving.

Vesting

   The units vest in installments, as shown in the Notice of Stock Unit Award. In addition, the units may vest on an accelerated basis pursuant to Article 11 of the Plan. No additional units vest after your Service has terminated for any reason.

Forfeiture

   If your Service terminates for any reason, then your units will be forfeited to the extent that they have not vested before the termination date and do not vest as a result of the termination. This means that any units that have not vested under this Agreement will immediately be cancelled. You receive no payment for units that are forfeited.
   The Company determines when your Service terminates for this purpose.

Leaves of Absence

and Part-Time

Work

   For purposes of this award, your Service does not terminate when you go on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by the Company in writing and if continued crediting of Service is required by applicable law, the Company’s leave of absence policy or the terms of your leave. But your Service terminates when the approved leave ends, unless you immediately return to active work.
   If you go on a leave of absence, then the vesting schedule specified in the Notice of Stock Unit Award may be adjusted in accordance with the Company’s leave of absence policy or the terms of your leave. If you commence working on a part-time basis, then the vesting schedule specified in the Notice of Stock Unit Award may be adjusted in accordance with the Company’s part-time work policy or the terms of an agreement between you and the Company pertaining to your part-time schedule.


Settlement of Units

   Each of your units will be settled on the first Permissible Trading Day (as defined below) that occurs on or after the date when the unit vests. However, each unit must be settled not later than the later of (a) March 15 of the calendar year after the calendar year in which the unit vests or (b) June 15 of the Company’s fiscal year after the fiscal year in which the unit vests.
   At the time of settlement, you will receive one share of the Company’s Common Stock for each vested unit. But the Company, at its sole discretion, may substitute an equivalent amount of cash if the distribution of stock is not reasonably practicable due to the requirements of applicable law. The amount of cash will be determined on the basis of the market value of the Company’s Common Stock at the time of settlement.

Section 409A

   This paragraph applies only if the Company determines that you are a “specified employee,” as defined in the regulations under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), at the time of your “separation from service,” as defined in those regulations. If this paragraph applies, then any units that otherwise would have been settled during the first six months following your separation from service will instead be settled during the seventh month following your separation from service, unless the settlement of those units is exempt from Section 409A of the Code.

Nature of Units

   Your units are mere bookkeeping entries. They represent only the Company’s unfunded and unsecured promise to issue shares of Common Stock (or distribute cash) on a future date. As a holder of units, you have no rights other than the rights of a general creditor of the Company.

No Voting Rights or

Dividends

   Your units carry neither voting rights nor rights to cash dividends. You have no rights as a stockholder of the Company unless and until your units are settled by issuing shares of the Company’s Common Stock.

Units

Nontransferable

   You may not sell, transfer, assign, pledge or otherwise dispose of any units. For instance, you may not use your units as security for a loan.

Beneficiary

Designation

   You may dispose of your units in a written beneficiary designation. A beneficiary designation must be filed with the Company on the proper form. It will be recognized only if it has been received at the Company’s headquarters before your death. If you file no beneficiary designation or if none of your designated beneficiaries survives you, then your estate will receive any vested units that you hold at the time of your death.


Withholding Taxes

   No stock certificates or cash will be distributed to you unless you have made arrangements satisfactory to the Company for the payment of any withholding taxes that are due as a result of the vesting or settlement of this award. These arrangements include payment in cash. With the Company’s consent, these arrangements may also include (a) payment from the proceeds of the sale of shares through a Company-approved broker, (b) withholding shares of Company stock that otherwise would be issued to you when the units are settled, (c) surrendering shares that you previously acquired or (d) withholding cash from other compensation. The fair market value of withheld or surrendered shares, determined as of the date when taxes otherwise would have been withheld in cash, will be applied to the withholding taxes.

Restrictions on

Resale

   You agree not to sell any shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of time after the termination of your Service as the Company may specify.

Employment at Will

   Your award or this Agreement does not give you the right to be retained by the Company or a subsidiary of the Company in any capacity. The Company and its subsidiaries reserve the right to terminate your Service at any time, with or without cause.

Adjustments

   In the event of a stock split, a stock dividend or a similar change in Company stock, the number of your units will be adjusted accordingly, as the Company may determine pursuant to the Plan.

Effect of Merger

   If the Company is a party to a merger, consolidation or reorganization, then your units will be subject to Section 10.3 of the Plan, provided that any action taken must either (a) preserve the exemption of your units from Section 409A of the Code or (b) comply with Section 409A of the Code.

Applicable Law

   This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to their choice-of-law provisions).

The Plan and Other

Agreements

  

The text of the Plan is incorporated in this Agreement by reference.

 

The Plan, this Agreement and the Notice of Stock Unit Award constitute the entire understanding between you and the Company regarding this award. Any prior agreements, commitments or negotiations concerning this award are superseded. This Agreement may be amended only by another written agreement between the parties.


Definition :

  

Permissible Trading

Day

   “Permissible Trading Day” means a day that satisfies each of the following requirements:
  

•        The Nasdaq Global Market is open for trading on that day,

  

•        You are permitted to sell shares of the Company’s Common Stock on that day without incurring liability under Section 16(b) of the Securities Exchange Act of 1934, as amended,

  

•        Either (a) you are not in possession of material non-public information that would make it illegal for you to sell shares of the Company’s Common Stock on that day under Rule 10b-5 of the Securities and Exchange Commission or (b) Rule 10b5-1 of the Securities and Exchange Commission is applicable,

  

•        Under the Company’s written Insider Trading Policy, you are permitted to sell shares of the Company’s Common Stock on that day, and

  

•        You are not prohibited from selling shares of the Company’s Common Stock on that day by a written agreement between you and the Company or a third party.

B Y SIGNING THE COVER SHEET OF THIS A GREEMENT , YOU AGREE TO ALL OF THE

TERMS AND CONDITIONS DESCRIBED ABOVE AND IN THE P LAN .

Exhibit 10.40

S ELECTICA , I NC .

C OMPENSATION P ROGRAM FOR N ON -E MPLOYEE D IRECTORS

E FFECTIVE J ANUARY  2, 2009

 

A. Cash Compensation

 

  1. Board retainer : $20,000 per year, paid in quarterly installments.

 

  2. Committee chair retainer : $10,000 per year ($20,000 per year for the Audit Committee chair), paid in quarterly installments. This includes the chair of a special committee.

 

  3. Committee member retainer (other than chair) : $5,000 per year, paid in quarterly installments. Only the first committee membership counts for this purpose. Special committees are treated like the standing committees (Audit, Compensation and Nominating).

 

  4. Meeting Fees :

 

  (a) $1,000 for each meeting of the full Board attended in person.

 

  (b) $500 for each meeting of the full Board attended by telephone.

 

  (c) $1,000 for each meeting of a special committee attended in person.

 

  (d) $500 for each meeting of a special committee attended by telephone.

 

  (e) No additional compensation for meetings of standing committees.

Meeting fees are paid quarterly, with retainers.

 

B. Equity Compensation

 

  1. Triennial stock option grants: Options to purchase 100,000 shares . The options become exercisable in equal installments on the first three anniversaries of the grant, with immediate full vesting in the event of a change in control. The options will be granted by the Compensation Committee under the 1999 Equity Incentive Plan (the “EIP”) in conjunction with the director’s initial appointment or election to the Board and at three-year intervals thereafter (provided that the director’s service continues). A director who was in office on August 1, 2006, will commence receiving these option grants on the next three-year anniversary of his or her initial appointment or election. A director who took office after August 1, 2006, but before December 15, 2006, commenced receiving these option grants on December 15, 2006.


In the event of a subdivision of the outstanding shares, a declaration of a dividend payable in shares or a combination or consolidation of the outstanding shares (by reclassification or otherwise) into a lesser number of shares, a corresponding adjustment will automatically be made in the 100,000-share number described above. In the event of a declaration of an extraordinary dividend payable in a form other than shares in an amount that has a material effect on the price of shares, a recapitalization, a spin-off or a similar occurrence, the Compensation Committee will make such adjustments as it, in its sole discretion, deems appropriate in the 100,000-share number described above.

 

  2. Annual restricted stock unit grants: Units equivalent to shares with a market value of $25,000 . All of the units vest on the first anniversary of the grant, with immediate full vesting in the event of a change in control. The units will be settled in the form of an equal number of shares on the first permissible trading date after they vest (or a further deferral could be elected). The units will be granted by the Compensation Committee under the EIP in conjunction with each Annual Meeting of stockholders. However, in lieu of a grant in conjunction with the 2006 Annual Meeting of stockholders, a grant was made on December 15, 2006.

 

C. Expenses

The reasonable expenses incurred by directors in connection with attendance at Board or committee meetings will be reimbursed upon submission of appropriate substantiation.

 

2

Exhibit 10.41

S ELECTICA , I NC .

C OMPENSATION P ROGRAM FOR N ON -E MPLOYEE D IRECTORS

E FFECTIVE M AY  20, 2009

 

A. Cash Compensation

 

  1. Board retainer : $45,000 per year, paid in quarterly installments.

 

  2. Audit Committee chair retainer : $10,000 per year, paid in quarterly installments.

 

B. Equity Compensation

 

  1. Triennial stock option grants: Options to purchase 100,000 shares . The options become exercisable in equal installments on the first three anniversaries of the grant, with immediate full vesting in the event of a change in control. The options will be granted by the Compensation Committee under the 1999 Equity Incentive Plan (the “EIP”) in conjunction with the director’s initial appointment or election to the Board and at three-year intervals thereafter (provided that the director’s service continues). A director who was in office on August 1, 2006, will commence receiving these option grants on the next three-year anniversary of his or her initial appointment or election. A director who took office after August 1, 2006, but before December 15, 2006, commenced receiving these option grants on December 15, 2006.

In the event of a subdivision of the outstanding shares, a declaration of a dividend payable in shares or a combination or consolidation of the outstanding shares (by reclassification or otherwise) into a lesser number of shares, a corresponding adjustment will automatically be made in the 100,000-share number described above. In the event of a declaration of an extraordinary dividend payable in a form other than shares in an amount that has a material effect on the price of shares, a recapitalization, a spin-off or a similar occurrence, the Compensation Committee will make such adjustments as it, in its sole discretion, deems appropriate in the 100,000-share number described above.

 

  2. Annual restricted stock unit grants: Units equivalent to shares with a market value of $25,000 . All of the units vest on the first anniversary of the grant, with immediate full vesting in the event of a change in control. The units will be settled in the form of an equal number of shares on the first permissible trading date after they vest (or a further deferral could be elected). The units will be granted by the Compensation Committee under the EIP in conjunction with each Annual Meeting of stockholders. However, in lieu of a grant in conjunction with the 2006 Annual Meeting of stockholders, a grant was made on December 15, 2006.


C. Expenses

The reasonable expenses incurred by directors in connection with attendance at Board or committee meetings will be reimbursed upon submission of appropriate substantiation.

 

2

Exhibit 10.42

LOGO

SELECTICA, INC.

MASTER SOFTWARE LICENSE AGREEMENT

-COVER PAGE-

 

CONTACT INFORMATION

   EFFECTIVE DATE: February 13, 2009
  Licensee: CA, Inc.    AP Contact: ***
  Address: ***    Address: ***
  Address:    Address:
  Contact: ***    Email:
  Email: ***    Phone:
  Phone: ***    Fax:
     P.O. Number:

 

SELECTICA INFORMATION

  
  Acct. Exec:   

***

   AR Contact: ***
  Address:   

***

   Address: ***
  Address:   

***

   Address: ***
  Email:   

***

   Email: ***
  Tel:   

***

   Tel: ***
  Fax:   

***

   Fax: ***

ORDER INFORMATION

a. Software : Selectica Contract Lifecycle Management (CLM) version 3.3.1, including third party software, if any required for specified current functionality.

b. License Type : ***

c. License Term : ***

d. Scope of Use : ***

e. Number and Type of Users : ***

f. Initial Maintenance Period : ***

PRICING

***

Maintenance & Support fees: ***

User License(s): ***

Term Licenses: ***

Total Amount: ***

 

***CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 

Selectica Confidential    1    Final 2 12 09


LOGO

 

LOGO      CA, Inc.

 

By (Name):  

/s/ Richard Heaps

     By (Name):  

/s/ Marc W. Pepe

Name Printed:  

Richard Heaps

     Name Printed:  

Marc W. Pepe

Title:  

CFO

     Title:  

Director

Date:  

2/12/09

     Date:  

2/13/09

 

Selectica Confidential    2    Final 2 12 09


LOGO

SELECTICA, INC.

MASTER SOFTWARE LICENSE AGREEMENT

As of the Effective Date stated on the Cover Page, this Agreement is made and entered into by and between Selectica, Inc., a Delaware Corporation with offices at 1740 Technology Drive Suite 450, San Jose, CA 95110 (“SELECTICA”), and CA, Inc., a Delaware corporation with offices at One CA Plaza, Islandia, NY 11749 (“CUSTOMER”). The Cover Page is attached and incorporated by reference hereto. SELECTICA and CUSTOMER hereby agree as follows:

 

1. DEFINITIONS

Whenever used in this Agreement, the following terms will have the following specified meanings:

 

  1.1 Affiliated Company ” means, as of the date of this agreement, any entities for which CUSTOMER holds greater than a fifty percent (50%) interest (or, by force of law or contract, CUSTOMER is obligated to maintain board control thereof). The term “Affiliated Company” shall mean any additional companies in which CA may acquire or come to hold a fifty percent (50%) interest (or, by force of law or contract, Customer is obligated to maintain board control thereof) provided that the number of total employees of CUSTOMER does not increase by more than fifty percent (50%) from the date of this agreement. Such determination shall be made annually under good faith discussions between the companies and any adjustment to license and/or maintenance fees shall be mutually agreed.

 

  1.2 Authorized End Users ” means CUSTOMER’s employees and independent contractors.

 

  1.3 Confidential Information ” of a party shall mean any information disclosed by that party (the “ Discloser ”) to the other party (the “ Recipient ”) which is marked “confidential,” or “proprietary”, or if disclosed orally, is designated as confidential or proprietary at the time of disclosure, or which should otherwise reasonably be understood by Recipient to be confidential or proprietary to Discloser, including, but not limited to, the non-public terms and conditions of this Agreement and/or the technology and business of the Discloser.

 

  1.4 Documentation ” means SELECTICA’s current user manuals, operating instructions and installation guides generally provided with the Software to end users. The term Documentation also includes: SELECTICA’s responses to Customer’s RFP (including but not limited to, sales brochures marketing materials, any and all responses to CUSTOMER inquiries and requests for clarification, and Software features currently implemented through commercially available third party software (currently only PDF to WORD and WORD to PDF conversion) and provided by SELECTICA) and training materials.

 

  1.5 Software ” means the executable object code for the Selectica and, if applicable, third party software described on the Cover Page attached hereto.

 

2 SOFTWARE DELIVERY, ACCEPTANCE AND LICENSE

 

  2.1 Deliverables. Upon execution of this Agreement, SELECTICA shall make available and deliver to CUSTOMER one reproducible master copy of the Software licensed hereunder to CUSTOMER, in object code form, and one copy of the Documentation, and such other copies as the CUSTOMER may reasonably request. Such availability and delivery, on both a designated server or other internet site shall be considered fulfillment of SELECTICA’s delivery obligations hereunder.

 

  2.2 Acceptance of Software. CUSTOMER’s obligation with respect to Software acceptance is set forth in the terms of the Master Services Agreement and Statement of Work #001 to be executed between CUSTOMER and SELECTICA (hereinafter “Acceptance”). Specifically, Acceptance will be deemed to have occurred when CUSTOMER, in its sole discretion, accepts the Proof of Concept (“POC”) phase as provided in the Statement of Work #001, unless extended by express mutual written agreement.

 

  2.3 Grant. Subject to the terms of this Agreement and payment of all fees, SELECTICA hereby grants CUSTOMER, its Affiliated Companies and Authorized End Users a nonexclusive, world-wide, nontransferable, license (the form of which is described on the Cover Page and further subject to Section 2.4 below) to:

 

  2.1.1 Install and use the Software for its internal use subject to the rights and restrictions set forth on the Cover Page.

 

  2.1.2 Reproduce the Documentation and/or incorporate all or any portion of the Documentation in training materials prepared by CUSTOMER, in each case solely for the use of CUSTOMER, its Affiliated Companies and Authorized End Users and provided that the copyright notices and other proprietary rights legends of SELECTICA are included on each copy of the Documentation and such materials.

 

Selectica Confidential    3    Final 2 12 09


LOGO

 

  2.1.3 Reproduce and make a reasonable number of copies of the Software for disaster recovery, archival and backup purposes.

 

  2.1.4 CUSTOMER may, at no additional cost, transfer the Software to new hardware, site or location owned or leased by CUSTOMER.

 

  2.1.5 CUSTOMER may configure, modify, change, enhance and/or reproduce the Software or Documentation. However, SELECTICA shall retain all rights, title and interest in and to all intellectual property relating to the Software and any modifications, enhancements and derivatives thereto, exclusive of CUSTOMER Confidential Information.

 

  2.4 Restrictions. CUSTOMER, its Affiliated Companies and Authorized End Users shall not:

 

  (a) reverse engineer, disassemble or decompose the Software, except to the extent that such acts may not be prohibited under applicable law;

 

  (b) remove, obscure, or alter any notice of patent, copyright, trade secret, trademark, or other proprietary rights notices present on any Software Documentation;

 

  (c) sublicense, sell, lend, rent, lease, or otherwise transfer all or any portion of the Software or the Documentation to any third party except as may be permitted in Section 9.4 hereof;

 

  (d)

use the Software or the Documentation to provide services to third parties, or otherwise use the same on a “service business” basis provided however, CUSTOMER, Affiliated Companies and Authorized End Users shall have the right to allow 3 rd party customers and other authorized parties to access the Software as part of its normal course of business; and

 

  (e) use the Software, or allow the transfer, transmission, export, or re-export of the Software or any portion thereof in violation of any United States export laws including without limitation the United States Bureau of Industry and Security’s Export Administration Regulations and the regulations of any other United States government agency.

 

  2.5 Proprietary Rights. The Software and Documentation contains valuable patent, copyright, trade secret, trademark and other proprietary rights of SELECTICA. Except for the license granted under Section 2.3, SELECTICA reserves all rights to the Software and Documentation. No title to or ownership of any Software or Documentation or proprietary rights related to the Software or Documentation is transferred to CUSTOMER under this Agreement.

 

  2.6 Protection Against Unauthorized Use. CUSTOMER shall promptly notify SELECTICA of any unauthorized use of the Software or Documentation which comes to CUSTOMER’s attention, without a duty to investigate. In the event of any unauthorized use by any of CUSTOMER or its Affiliated Companies and Authorized End Users, employees, agents or representatives, CUSTOMER shall use reasonable efforts to terminate such unauthorized use and to retrieve any copy of the Software or Documentation in the possession or control of the person or entity engaging in such unauthorized use. SELECTICA may, at its option and expense, participate in any such proceeding and, in such an event, CUSTOMER shall provide such authority, information and assistance related to such proceeding as SELECTICA may reasonably request

 

  2.7 Records. CUSTOMER shall use commercially reasonable efforts to cause each copy it makes of all or any portion of the Software or the Documentation to have the notice of copyright or other proprietary rights legends appearing in or on the Software or the Documentation delivered to CUSTOMER by SELECTICA. CUSTOMER shall keep accurate records of the reproduction and location of each copy; and upon the reasonable request of SELECTICA, but no more than annually, shall provide SELECTICA with copies of such records for the purpose of auditing and verifying CUSTOMER’s compliance with this Agreement.

 

3 COMPENSATION

 

  3.1 License and Other Fees. CUSTOMER will pay SELECTICA the Software License Fee and other fees specified on the Cover Page in accordance with the provisions of this Agreement.

 

  3.2

Payment. Subject to the provisions of this Agreement, fees, charges and other sums payable to SELECTICA under this Agreement will be due and payable net sixty (60) days after receipt of invoice. SELECTICA shall issue an invoice only upon Acceptance of the Software by CUSTOMER and CUSTOMER shall only be obligated to pay on Acceptance. All monetary amounts are specified and shall be paid in the lawful currency of the United States of America. CUSTOMER shall pay all amounts due under this Agreement to SELECTICA at the address set forth

 

Selectica Confidential    4    Final 2 12 09


LOGO

 

 

herein. All fees, charges and other sums payable to SELECTICA under this Agreement do not include any sales, use, excise or other applicable taxes, tariffs or duties (excluding any applicable federal and state taxes based on SELECTICA’s net income), payment of which shall be the sole responsibility of CUSTOMER.

 

4 TERM AND TERMINATION

 

  4.1 Term. The term of this Agreement shall commence on the Effective Date and shall end upon the termination of this Agreement pursuant to Section 4.2.

 

  4.2 Termination.

 

  4.2.1 CUSTOMER may terminate this Agreement, in whole or in part, at any time, for any reason, without penalty or if SELECTICA materially defaults in the performance of or compliance with its obligations of this Agreement, and such default has not been remedied or cured within sixty (60) days after CUSTOMER gives SELECTICA written notice specifying the default.

 

  4.2.2 SELECTICA may terminate this Agreement only if CUSTOMER materially defaults in the performance of or compliance with its obligations under Sections 2.3 (a) and (b), 2.4 or 2.5 of this Agreement, or fails to issue payment when due, and such default has not been remedied or cured within sixty (60) days after SELECTICA gives CUSTOMER written notice specifying the default. Termination is not an exclusive remedy and all other remedies will be available whether or not termination occurs.

 

  4.3 Post Termination.

Upon termination of this Agreement by CUSTOMER as a result of SELECTICA’s uncured breach, the licenses granted under Section 2 will terminate and CUSTOMER shall promptly cease all use of the Software and Documentation and destroy or return to SELECTICA all copies of the Software and Documentation then in CUSTOMER’s possession or control and CUSTOMER shall be entitled to a full refund of all license and maintenance fees paid., with licenses prorated over a 5-year period and maintenance fees limited to any prepaid amounts.

Upon termination of this Agreement by CUSTOMER for convenience after Acceptance of the Software, the licenses granted under Section 2 will terminate and CUSTOMER shall promptly cease all use of the Software and Documentation and destroy or return to SELECTICA all copies of the Software and Documentation then in CUSTOMER’s possession or control. In the event of a termination of the software licenses for convenience, CUSTOMER shall not be entitled to a refund of a license fees and CUSTOMER remains obligated for any license fees due. In the event of termination of Maintenance and Support for convenience or upon assignment to a competitor, CUSTOMER shall be entitled to a pro-rata refund of all maintenance fees paid based on a straight line five (5) year depreciation schedule.

Upon termination of this Agreement by CUSTOMER for convenience before Acceptance of the Software, the licenses granted under Section 2 will terminate and CUSTOMER shall promptly cease all use of the Software and Documentation and destroy (and in writing certify such destruction) or return to SELECTICA all copies of the Software and Documentation then in CUSTOMER’s possession or control and CUSTOMER shall not be liable for any license and/or maintenance fees due.

Upon termination of this Agreement by SELECTICA as a result of CUSTOMER’s uncured breach of Sections 2.3, 2.4 or 2.5, the licenses granted under Section 2 will terminate and CUSTOMER shall promptly cease all use of the Software and Documentation and destroy (and in writing certify such destruction) or return to SELECTICA all copies of the Software and Documentation then in CUSTOMER’s possession or control and CUSTOMER shall not be entitled to a refund of license fees paid. However, CUSTOMER shall receive a pro-rata refund of prepaid, if any, maintenance fees based on a straight line five (5) year depreciation schedule.

 

  4.4 Survival. Upon expiration or termination of the Agreement, the rights and obligations of the parties which by their context, intent and meaning would reasonably be expected to survive the termination or expiration of the Agreement or any part thereof will so survive.

 

5 CONFIDENTIALITY

 

  5.1

Obligations . Recipient shall: (i) not use Discloser’s Confidential Information except for the express purposes of this Agreement; (ii) hold Discloser’s Confidential Information in strictest confidence and shall not disclose Discloser’s Confidential Information to others, except for its employees or agents who require Discloser’s Confidential Information in order to carry out the Recipient’s obligations under this Agreement and who are subject to binding obligations of confidentiality and restricted use at least as protective as those of this

 

Selectica Confidential    5    Final 2 12 09


LOGO

 

 

Agreement; (iii) protect the confidentiality of Discloser’s Confidential Information using at least the same level of efforts and measures used to protect its own confidential information of like importance, and at least commercially reasonable efforts and measures, including without limitation limiting access to Discloser’s Confidential Information commensurate with the express purposes of this Agreement; and (iv) notify Discloser as promptly as practicable of any unauthorized use or disclosure of Discloser’s Confidential Information by Recipient, its employees or agents of which Recipient becomes aware.

The Recipient may disclose Confidential Information in connection with a judicial or administrative proceedings to the extent such disclosure is required under law or a court order, provided that the Discloser shall be given prompt written notice of such proceeding. In addition to any other remedies, the Discloser shall be entitled to seek equitable relief without posting of any bond. Each party’s personnel shall be free to use ideas, concepts, know-how, processes, inventions and techniques acquired in conjunction with this Agreement provided such use does not infringe the other party’s patents or copyrights.

 

  5.2 Exceptions . The obligations of this Section 5 shall not apply to any Discloser’s Confidential Information that: (i) Recipient knew prior to learning it under this Agreement, as demonstrated by written records predating the date it was learned under this Agreement; (ii) is now, or becomes in the future, publicly available information other than by an act or omission of Recipient; (iii) a third party discloses to Recipient, without any confidentiality obligations and without any breach of any direct or indirect obligation of confidentiality to Discloser, as shown by Recipient’s written records contemporaneous with such third party disclosure; or (iv) Recipient independently develops without use of or reference to Discloser’s Confidential Information, as demonstrated by Recipient’s independent written records contemporaneous with such development.

 

  5.3 Trademarks . Except as otherwise set forth in this Agreement, neither party grants the other party any rights to use its trademarks, service marks, or other proprietary symbols or designations.

 

  5.4 Nondisclosure of Agreement. Each party (including subcontractors) shall not disclose the terms of this Agreement or the ongoing business relationship initiated by this Agreement except as required by law or governmental regulation without the other parties prior written consent, except that each party may disclose the terms of this Agreement on a confidential basis to each parties accountants, attorneys, parent organizations and financial advisors and lenders.

 

  5.5 Reference Account. Upon express prior written approval by CUSTOMER , SELECTICA may identify CUSTOMER as a user of the Software and may use CUSTOMER’s logo in marketing activities and press releases, subject to SELECTICA’s compliance with CUSTOMER’s published logo guidelines. CUSTOMER will cooperate with SELECTICA in furnishing non-confidential information about CUSTOMER’s software use for informational and promotional use by SELECTICA.

 

6 WARRANTIES AND REMEDIES

 

  6.1 Warranty: Upon Acceptance of the Software by CUSTOMER, SELECTICA represents and warrants to CUSTOMER that when operated in accordance with the Documentation provided by SELECTICA, the Software, including any Updates, Upgrades and/or Major Releases provided to and used by CUSTOMER, will perform in accordance with the functional specifications set forth in the Documentation for period that CUSTOMER is on active Maintenance and Support for the Software. The warranties herein shall commence after the successful implementation and Acceptance of the Software by CUSTOMER. If the Software fails to comply with the warranty set forth in this Section, CUSTOMER may, at its sole discretion, require SELECTICA to: (i) use reasonable commercial efforts to correct the noncompliance; (ii) replace the Software with a version that complies and performs in accordance with the Acceptance criteria, or; (iii) terminate the license and provide a full refund all of the license and maintenance fees paid by CUSTOMER for such Software in full satisfaction of CUSTOMER’s claims relating to such Warranty noncompliance upon CUSTOMER’s return or certification of destruction of the Software.

 

  6.2 Exclusive Remedy: ANY LIABILITY OF SELECTICA WITH RESPECT TO THE PERFORMANCE OF THE SOFTWARE UNDER ANY WARRANTY, NEGLIGENCE, STRICT LIABILITY OR OTHER THEORY WILL BE LIMITED TO THE REPAIR, REPLACEMENT OR A REFUND OF THE LICENSE AND MAINTENANCE FEE.

 

  6.3 SELECTICA warrants that it has the right, power and authority to enter into this Licence Agreement and that it has full title and authority to provide the licences granted herein to the CUSTOMER to use the Software as contemplated by this Licence Agreement.

 

  6.4 SELECTICA warrants that the Software will not contain any viruses, worms, trojan horses or similar (together (“Viruses”) or malicious code of any sort. If at any time the Software is found to contain any such Viruses or malicious Code caused through proper use of the Software, SELECTICA will use best efforts to promptly remove the Virus or malicious code and restore the CUSTOMER systems to operational readiness.

 

Selectica Confidential    6    Final 2 12 09


LOGO

 

7 INDEMNIFICATION

 

  7.1 SELECTICA agrees to hold CUSTOMER, its Affiliated Companies and Authorized End Users harmless from liability to third parties resulting from infringement of any patent, copyright or trade secret by the Software as used within the scope of this Agreement, and to pay all direct damages and costs, including reasonable legal fees, which may be assessed against CUSTOMER, its Affiliated Companies and Authorized End Users under any such claim or action. SELECTICA shall be released from the foregoing obligation unless CUSTOMER provides SELECTICA with (i) written notice within a reasonable time of the date CUSTOMER first becomes aware of such a claim or action, or possibility thereof; (ii) sole control and authority over the defense or settlement thereof; and (iii) at SELECTICA’s cost and expense, information and assistance to assist with settlement and/or defense of any such claim or action. Without limiting the foregoing, if a final injunction is, or SELECTICA believes, in its sole discretion, is likely to be, entered prohibiting the use of the Software by CUSTOMER as contemplated herein, SELECTICA will, at its sole option and expense, either (a) procure for CUSTOMER the right to use the infringing Software as provided herein or (b) replace the infringing Software with non-infringing, functionally equivalent products, or (c) suitably modify the infringing Software so that it is not infringing; or (d) terminate the license, accept return of the infringing Software and refund to CUSTOMER all of the license and maintenance fees paid therefore. Except as specified above, SELECTICA will not be liable for any costs or expenses incurred without its prior written authorization. Notwithstanding the foregoing, SELECTICA assumes no liability for infringement claims with respect to Software (i) not supplied by SELECTICA, (ii) made solely in accordance to CUSTOMER’s specifications pursuant to a custom code statement of work, (iii) that contains a modification not approved or otherwise required to support the Software, (iv) combined with other products, processes or materials not provided or approved by SELECTICA where the alleged infringement relates to such combination, (v) where CUSTOMER continues allegedly infringing activity after being notified thereof or after being informed of modifications that would have avoided the alleged infringement, where such modifications are provided by SELECTICA at no additional expense,or (vi) where CUSTOMER’s use of the Software is not strictly in accordance with this Agreement. THE FOREGOING PROVISIONS OF THIS SECTION 7 STATE THE ENTIRE LIABILITY AND OBLIGATIONS OF SELECTICA AND THE EXCLUSIVE REMEDY OF CUSTOMER, WITH RESPECT TO ANY ACTUAL OR ALLEGED INFRINGEMENT OF ANY PATENT, COPYRIGHT, TRADE SECRET, TRADEMARK OR OTHER INTELLECTUAL PROPERTY RIGHT BY THE SOFTWARE.

 

  7.2 Each party shall indemnify the other against all damages, fees, fines, judgments, costs and expenses incurred as a result of a third party action alleging a bodily injury or death which arises from the Software hereunder, provided that such liabilities are the proximate result of gross negligence or intentional tortuous conduct on the part of the indemnifying party.

 

8 DISCLAIMER OF WARRANTIES AND LIMITATION OF LIABILITY

 

  8.1 Disclaimer of Warranties. EXCEPT AS SET FORTH IN SECTION 6, SELECTICA MAKES NO WARRANTIES WHETHER EXPRESS, IMPLIED OR STATUTORY REGARDING OR RELATING TO THE SOFTWARE OR THE DOCUMENTATION OR ANY MATERIALS OR SERVICES FURNISHED OR PROVIDED TO CUSTOMER UNDER THIS AGREEMENT. SELECTICA SPECIFICALLY DISCLAIMS ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE SOFTWARE, DOCUMENTATION AND ANY OTHER MATERIALS AND SERVICES PROVIDED BY SELECTICA HEREUNDER, AND WITH RESPECT TO THE USE OF THE FOREGOING. THE SOFTWARE IS NOT DESIGNED OR LICENSED FOR USE IN HAZARDOUS ENVIRONMENTS REQUIRING FAIL-SAFE CONTROLS, INCLUDING WITHOUT LIMITATION OPERATION OF NUCLEAR FACILITIES, AIRCRAFT NAVIGATION OR COMMUNICATION SYSTEMS, AIR TRAFFIC CONTROL, AND LIFE SUPPORT OR WEAPONS SYSTEMS. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, SELECTICA SPECIFICALLY DISCLAIMS ANY EXPRESS OR IMPLIED WARRANTY OF FITNESS FOR SUCH PURPOSES. FURTHER, SELECTICA DOES NOT WARRANT RESULTS OF USE OR THAT THE SOFTWARE IS BUG FREE OR THAT CUSTOMER’S USE WILL BE UNINTERRUPTED.

 

  8.2 Limitation of Liability. EXCEPT FOR DEATH OR PERSONAL INJURY CAUSED BY THE NEGLIGENCE OR WILLFUL CONDUCT OF EITHER PARTY, BREACH OF SECTION 5 OR CLAIMS FOR INFRINGEMENT UNDER SECTION 7, IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY LOSS OF PROFITS, LOSS OF USE, BUSINESS INTERRUPTION, LOSS OF DATA, COST TO RECOVER, OR FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES OF ANY KIND IN CONNECTION WITH OR ARISING OUT OF THE FURNISHING, PERFORMANCE OR USE OF THE SOFTWARE, DOCUMENTATION OR ANY MATERIALS OR SERVICES PERFORMED HEREUNDER, WHETHER ALLEGED AS A BREACH OF CONTRACT OR TORTIOUS CONDUCT, INCLUDING NEGLIGENCE, EVEN IF A PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. SELECTICA’S LIABILITY UNDER THIS AGREEMENT FOR DAMAGES WILL NOT, IN ANY EVENT, EXCEED THREE TIMES THE AMOUNTS PAID AND/OR PAYABLE BY CUSTOMER TO SELECTICA UNDER THIS AGREEMENT FOR THE ITEMS GIVING RISE TO SUCH LIABILITY.

 

Selectica Confidential    7    Final 2 12 09


LOGO

 

9 MISCELLANEOUS

 

  9.1 Notices. Any notice or other communication under this Agreement given by either party to the other will be deemed to be properly given if given in writing and delivered in person, electronically or facsimile, if acknowledged received by return electronic communication or facsimile or followed within one day by a delivered or mailed copy of such notice, or if mailed, properly addressed and stamped with the required postage, to the intended recipient at its address specified in this Agreement. Either party may from time to time change its address for notices under this Section by giving the other party notice of the change in accordance with this Section 9.3.

 

  9.2 Assignment. Neither party may assign this Agreement or any of its rights or obligations under this Agreement without the prior written consent of the other party, which will not be unreasonably refused. However, either party may assign all, but not part, of this Agreement and the Software and Documentation then in its possession or control to the surviving entity in a merger, consolidation or other similar corporate reorganization in which it participates or to the purchaser of all or substantially all of its assets. Notwithstanding the preceding sentence, Vendor may only assign this Agreement to an entity who acquires all of the assets of Vendor provided that such entity is not a CUSTOMER competitor or an entity with which CUSTOMER has been in litigation in the five (5) years prior to such assignment. A “CUSTOMER competitor” means an entity which a reasonable person experienced in the software industry would understand to compete with CUSTOMER. Upon acquisition of SELECTICA by a CUSTOMER competitor, CUSTOMER shall have the right to terminate Maintenance and Support pursuant to Section 4.3 above. CUSTOMER shall have the unrestricted right to assign in whole or in part its rights and obligations under this Agreement Subject to the foregoing, this Agreement is binding upon, inures to the benefit of and is enforceable by the parties and their respective successors and assigns.

 

  9.3 Entire Agreement. This Agreement, along with the Cover Page and any schedules thereto, constitutes the entire agreement, and supersedes any and all prior agreements, between SELECTICA and CUSTOMER relating to the Software, Documentation, and other items subject to this Agreement. No amendment of this Agreement will be valid unless set forth in a written instrument signed by both parties. In the event that any provision of this Agreement is found invalid or unenforceable, it will be enforced to the extent permissible and the remainder of this Agreement will remain in full force and effect. No term or condition contained in CUSTOMER’s purchase order or similar document will apply unless specifically agreed to by SELECTICA in writing, even if SELECTICA has accepted the order set forth in such purchase order, and all such terms or conditions are otherwise hereby expressly rejected by SELECTICA.

 

  9.4 Governing Law and Dispute Resolution. The rights and obligations of the parties under this Agreement shall be governed by and construed under the laws of the State of New York. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall first be subject to good faith negotiation by the parties within sixty (60) days after notice of such controversy or claim is provided to the other party. The parties agree that any action arising under or relating to this Agreement shall lie within the exclusive jurisdiction of the State and Federal Courts located in the Eastern District of New York. The United Nations Convention on Contracts for the International Sale of Goods will not apply to the Agreement. THE PARTIES HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM RELATING TO THIS AGREEMENT.

 

  9.5 Equitable Relief. Each party acknowledges that its failure to comply with the provisions of this Agreement may result in irreparable harm to the other for which a remedy at law would be inadequate. In the event of the breach or threatened breach of this Agreement by a party, the other party shall in addition to monetary damages, be entitled to seek equitable relief in the form of specific performance and/or an injunction for any such actual or threatened breach.

 

  9.6 Force Majeure. Neither party will be liable for, or be considered to be in breach of or default under this Agreement, other than monetary obligations, as a result of any cause or condition beyond such party’s reasonable control including without limitation, acts of God, war, riot, strike, labor disturbance, terrorist act, fire, explosion, flood, IT failures outside of the control of either party, such as internet failures or communication system failures, or shortage or failure of suppliers.

 

  9.7 Source Code Escrow. SELECTICA agrees to deposit the source code for the Software into an escrow account with CUSTOMER who shall retain the source code with its Legal Department located at One CA Plaza, Islandia, NY 11749. SELECTICA shall include in the deposit sufficient technical specifications and supporting documentation necessary to enable an independent, competent computer programmer to understand, maintain, modify, and enhance the Software. SELECTICA shall make the initial deposit of materials thereunder, no later than thirty (30) days after CUSTOMER’s written acceptance of the Software. SELECTICA shall thereafter promptly add to the escrow account the source code for any updates of the Software.

CUSTOMER has the right to withdraw the source code upon the occurrence of any of the following events: (i) any material breach by SELECTICA of its obligations hereunder, or under the Master Services Agreement including

 

Selectica Confidential    8    Final 2 12 09


LOGO

 

any SOW, and the expiration of any applicable cure period; (ii) SELECTICA, whether directly or through a successor or affiliate, ceases to be in business; (iii) SELECTICA is the subject of (A) any bankruptcy, insolvency, or similar proceeding, (B) any assignment by SELECTICA for the benefit of creditors, (C) any other proceeding involving insolvency or protection of or from creditors; or, (D) any merger, acquisition or change of control of SELECTICA. Upon the occurrence of any such events, CUSTOMER shall have the right to utilize such source code for purposes within the scope of use contemplated by this Agreement, including, without limitation, the performance of maintenance and support for the Software. If CUSTOMER elects to withdraw source code pursuant to this section, CUSTOMER will provide SELECTICA ten (10) days advance written notice.

 

  10 . Maintenance and Support Services: Maintenance and support services will be provided pursuant to the terms and conditions set forth in Exhibit A, attached and incorporated herein.

[rest of page blank]

 

Selectica Confidential    9    Final 2 12 09


LOGO

Exhibit A

Maintenance and Support Policies – Ultra Support

 

1. Definitions

 

  a) “Updates” shall mean periodic patches and minor releases, as designated by the “Z” in the release code “X.Y.Z”, designed to correct specific and/or minor errors in the Software and have undergone only a subset of Selectica’s full Quality Assurance and Performance Testing process needed to verify the correction(s).

 

  b) “Upgrades” shall mean periodic scheduled releases of the Software, as designated by the “Y” in the release code “X.Y.Z”, designed to enhance performance, add incremental features and have undergone Selectica’s full Quality Assurance and Performance Testing process designed to provide commercially reasonable assurance that the Upgrade new features and bug fixes perform according to their specifications (normally documented in a “Read Me” or “Release Note” document in electronic or printed form).

 

  c) “Major Releases” shall mean releases that occur no more frequently than annually of the Software, as designated by the “X” in the release code “X.Y.Z”, designed to add major new features and/or algorithms to the Software and have undergone Selectica’s full Quality Assurance and Performance Testing process. Major Releases do not include separately priced new modules introduced as a component of the Software during any release cycle nor do Major Releases include New Products.

 

  d) “New Products” shall mean additional functionality that substantially enhances or extends the ability of the Customer to use the Software or the New Product for its internal business purposes. A “New Product” shall be separately priced and packaged by Selectica and may carry a tradename different than that of the Software or may be designated as a new generation of the Software.

 

  e) “Program Errors” shall mean one or more reproducible deviations in the Software licensed, installed and used by Customer from the applicable specifications shown in the Documentation.

 

2. Support and Incremental Releases to the Software

Subject to the terms and conditions of this Agreement and provided (i) Customer is fully paid-up on all applicable Maintenance and Support and (ii) is not otherwise in material breach of this Agreement, Customer will be entitled to receive online support, phone support, and additional releases (Updates, Upgrades and Major Releases) for the Software specified on the Cover Page, on a when-and-if available basis at no additional charge to Customer. Customer’s IT department (or equivalent department) shall establish and maintain the organization and processes to provide Tier 1Support for the Software directly to Users. Selectica shall provide maintenance and Support services to Customer for program errors not resolved by Customer, Tier 2 Support or upon Customer request, which shall be available to Customer 24 hours per day, 7 days per week, 365 days per year for severity levels 1 -4 below. Selectica Maintenance and Support shall be provided with regard to both production and non-production environments where Selectica software is being used by Customer. However, Non-Production usage is not eligible for Severity 1 Maintenance and Support. Customer shall provide Selectica with the necessary remote access to the Software so that Selectica may, at its option, provide remote diagnostic capability. Selectica does not assure performance of the services described herein if such remote access is not provided when requested. Customer may appoint up to two named technical staff to report problems or performance deficiencies to Selectica. Customer may change the designated technical staff by one day advance notice to Selectica.

 

Selectica Confidential    10    Final 2 12 09


LOGO

Roles and Responsibilities

 

Customer
Delivers

  

Selectica
Delivers

  

Level of Support Definition

X       Tier 1 / Level 1    Level 1 Support includes the initial response to an End User reported incident (and any follow-up response as appropriate), initial information gathering, entitlement and escalation to Level 2.
X       Tier 1 / Level 2    Level 2 Support includes some or all of the following: answering software installation, configuration or usage questions; initial problem and failure information gathering; problem isolation, identification, and/or providing standard fixes and workarounds to known problems; escalating unresolved problems to a Selectica Support Engineer.
   X    Tier 2 / Level 3    Level 3 Support consists of, but is not limited to, problem isolation, identification, and replication; providing standard fixes and workarounds to known problems; providing remedies for both new and known complex problems; escalating unresolved problems or those requiring formal fixes to Selectica sustaining engineering or development teams.

 

3. SUPPORT FOR PROGRAM ERRORS

3.1. As set forth in Section 4(a) herein, Selectica has provided Customer with a telephone number and e-mail address that Customer may use to report Program Errors. For priority 1, Customer agrees to notify Selectica via both telephone and e-mail. Selectica will make diligent efforts to correct significant Program Errors that Customer identifies, classifies and reports to Selectica. If Selectica disagrees with Customer’s classification of a Program Error, the parties will meet and resolve the classification in good faith. Customer will provide sufficient information to enable Selectica to duplicate the Program Error, Unless otherwise expressly or implicitly approved by Selectica, Selectica will not be required to correct any Program Error caused by: (a) incorporation, attachment of a feature, program, or device to the Software, or any part thereof, Selectica; (b) any nonconformance caused by accident, transportation, neglect, misuse, alteration, modification, or enhancement of the Software, unless caused in whole or in part by Selectica; (c) Customer’s failure to provide the Prerequisite Environment for the Software; (d) Customer’s use of the Software for other than the specific purpose for which the Software is intended under the terms of this Agreement; (e) if applicable, Customer’s use of defective media or defective duplication of the Software; or (f) Customer’s failure to incorporate any Maintenance Releases previously released by Selectica which corrects such Program Error. Selectica will use diligent efforts to communicate with Customer about the Program Error, via telephone or e-mail within the following targeted response times,

 

Severity Criteria

  

Description

  

Initial
Response

  

Escalation

1.       Critical – Customer Production Down

 

Non-Production usage shall not receive Severity level 1 Maintenance and Support

  

•     Production System Unavailable or Unusable for Multiple Users

•     Business Operations halted or critical features not functioning

•     Users are not able to complete their daily production operations.

   1 Hour   

•     TSO Manager – 5 Minutes

•     PSO Practice Manager – 1 Minute

•     VP of PSO & VP Engineering – 1 Hour

 

Selectica Confidential    11    Final 2 12 09


LOGO

 

2.       High – Major Feature/Function failure

  

•     Loss of significant functionality

•     Key business operational function(s) cannot be performed on a production system.

•     System is usable, albeit in a reduced fashion

   4 Hours   

•     TSO Manager – 15 Minutes

•     Practice Manager – 1 Hour

•     VP of PSO & VP Engineering – 8 Hours

3.       Medium – Minor Feature/Function failure

  

•     Product does not operate as designed.

•     Minor impact on usage

•     Acceptable workaround deployed

   8 Hours   

•     No Escalation

4.       Low – Minor Problem

  

•     Minor product problem (product usages, bug report, documentation etc.

   40 Hours   

•     No Escalation

Escalation Procedures

During the process of resolving a customer support ticket, the priority may be escalated. This occurs in one of three ways:

 

   

Customer Request

 

   

Time Based

 

   

TSE Escalation

The following table outlines the issue update intervals:

 

Severity Criteria

  

Escalation – Problem Resolution

  

Update Interval

1.      Critical – Customer Production Down

  

TSO Manager – 4 Hours

PSO Practice Manager – 12 Hours

VP of PSO & VP Engineering – 24 Hours

   Every 2 Hours

2.      High – Major Feature/Function failure

  

TSO Manager – 24 Hours

PSO Practice Manager – 24 Hours

VP of PSO & VP Engineering – 24 Hours

   Every 24 Hours

3.      Medium – Minor Feature/Function failure

   TSO Manager – 5 Days    Weekly

4.      Low – Minor Problem

   Fix requested for upcoming releases    No Updates

3.2. Selectica will use diligent efforts to identify defective source code and to resolve each significant Program Error by providing either a reasonable workaround, an object code patch (or equivalent) or a specific action plan for how Selectica will address the problem and an estimate of how long it will take to rectify the defect.

 

Selectica Confidential    12    Final 2 12 09


LOGO

3.3. Selectica agrees to support a given revision of the Software for the shorter of: (a) twelve (12) months from the date such revision is superseded by the next sequential Upgrade; or (b) until such revision is superseded by two (2) sequential Upgrades.

 

4. OTHER MAINTENANCE AND SUPPORT POLICIES

Reporting Problems and Response. Customer shall report problems: (i) via access to Selectica’s secure website at “ www.selectica.com ”, (ii) by email notification to “ support@selectica.com ”, or (iii) by telephone call to 1-866-512-3825. Customer shall designate up to two (2) users who will act as Selectica’s primary contact for reporting problems and being Selectica’s primary contact. Selectica will provide ongoing customer support and will respond to reported problems.

Additional Maintenance and Support Fees. If it is determined that Program errors are due solely to Customer or third party hardware or software, Selectica reserves the right to charge Customer additional technical support fees at its then standard rates for technical support services performed in connection with those Program Errors for service or support provided to CA after Selectica and CA agree that Program Errors are not due to Selectica software. Notwithstanding the foregoing, Selectica has no obligation to perform technical support services in connection with Program Errors resulting from hardware or software not supplied by Selectica.

Reinstatement of Maintenance and Support. If Maintenance and Support lapses for a period less than six (6) months from the renewal date, reinstatement of lapsed Maintenance and Support is subject to payment of the previously contracted rates. If Maintenance and Support lapses for a period greater than six (6) months from the renewal date, reinstatement of lapsed Maintenance and Support is subject to payment of the previously contracted rates plus 10%. However, fees for the annual term following reinstatement shall revert to the previously contracted rate. Any reinstatement of Maintenance and Support is contingent upon Customer upgrading the software to the most current release. If professional services are required to upgrade the software, Selectica and Customer shall execute a mutually agreeable statement of work to effectuate the upgrade.

Renewal of Maintenance and Support: . Selectica shall notify CUSTOMER on or before sixty (60) says prior to the expiration of each annual term and CUSTOMER shall elect whether to renew Maintenance and Support. In the event that CUSTOMER fails to notify Selectica, the Maintenance and Support shall automatically renew for an annual period subject to termination as set forth in this Agreement. Renewal of Maintenance and Support shall be for an annual term at the same rate set forth in the Master License Agreement. During the first five (5) annual terms, Selectica may not increase the rates for Maintenance and Support without the express written consent of Customer.

 

5. INVOICING AND PAYMENT

Maintenance will be invoiced annually in advance per the terms of the Master License Agreement.

 

6. ADDITIONAL ESCALATION TERMS

 

1. Upon request but no more than monthly, Selectica agrees to provide Customer with historical incident related statistics to facilitate staffing and impact assessment. This includes, but is not necessarily limited to incident categories, resolution criteria, volumes of incidents against distributed licenses, and other factors that may help Customer understand and plan for delivery of technical support.

 

2. Upon request but no more than monthly, Selectica agrees to make all reasonable attempts to provide Customer with relative historical incident data to support the development of end user self-service including, raw knowledge, knowledge utilization statistics, and access to online knowledge.

 

3. Selectica agrees to provide and maintain within its reasonable commercial efforts, a Selectica Customer Support advocate within the Selectica Customer Support organization to represent the Customer management team to Selectica Customer Support on issues outside of normal Selectica Software support activities.

 

Selectica Confidential    13    Final 2 12 09


LOGO

 

4. Selectica agrees to notify in writing, and in advance of one year, intentions to discontinue support for any currently supported Selectica Software licensed to Customer.

 

5. Upon request but no more than monthly, Customer and Selectica agree to make any and all reasonable attempts to share or communicate, incident or problem resolution related information that will support future enhancements to the Selectica Software set-up, installation, configuration, help files or make other such reasonable enhancements to support related end user self-service infrastructure, to reduce incident volumes to both Customer and Selectica through the mutual improvement of the end user experience.

 

6. Customer and the Selectica Customer Support advocate agree to conduct, upon the reasonable request of either party, quarterly reviews of the overall effectiveness of the Selectica Customer Support relationship, identify areas for improvement and identify potential training requirements. This includes a review of performance statistics for relevant areas of the relationship provided by a Selectica Customer Support Senior Manager from Customer and Selectica. All available metrics should be used to evaluate the effectiveness of the support relationship including, but not necessarily limited to:

 

   

incident volumes

 

   

incident telephony (ACD or Other) statistics

 

   

Resolution criteria

 

   

Escalation details

 

   

incident or problem details

 

7. Customer and Selectica will redact any confidential customer information with regard to data sharing obligations set forth herein.

 

Selectica Confidential    14    Final 2 12 09

Exhibit 10.43

SETTLEMENT, RELEASE AND LICENSE AGREEMENT

THIS SETTLEMENT, RELEASE AND LICENSE AGREEMENT (“Agreement”) is entered into as of this 5th day of October, 2007 (the “Effective Date”), between Versata Software Inc., a corporation f/k/a Trilogy Software, Inc. existing under the laws of Delaware with its principal place of business at 5001 Plaza on the Lake, Austin, Texas 78746, and Versata Development Group, Inc., corporation existing under the laws of Delaware with its principal place of business at 5001 Plaza on the Lake, Austin, Texas 78746, on the one hand (which together with their Affiliates and their permitted successors and assigns are collectively referred to herein as “Versata”); and Selectica, Inc., a corporation existing under the laws of Delaware with its principal place of business at 1740 Technology Drive, San Jose, California 95110 (which together with its Affiliates and its permitted successors and assigns is collectively referred to herein as “Selectica”), on the other hand.

WITNESSETH

WHEREAS, Versata and Selectica are engaged in a lawsuit, styled Versata Software Inc., et al. v. Selectica, Inc., Civil Action No. 2:06CV444, pending in the United States District Court for the Eastern District of Texas, Marshall Division (the “Civil Action”);

WHEREAS, Versata is the owner of certain patents asserted in the Civil Action, as listed in Exhibit A hereto;

WHEREAS, Selectica desires a license to certain patents, as described herein;

WHEREAS, the Parties desire to exchange mutual general releases by which each Party releases any and all claims, whether known or unknown, against the other Party;

WHEREAS, Selectica acknowledges the validity and enforceability of the Versata Patents asserted in the Civil Action but otherwise denies the claims made by Versata in the Civil Action (except for any allegations expressly admitted by Selectica therein), and Versata denies the counterclaims made by Selectica in the Civil Action (except for any allegations expressly admitted by Versata therein); and

WHEREAS, each of Versata and Selectica, in contemplation of the uncertainties of the disputed Civil Action, respectively desires to compromise and settle the claims or counterclaims alleged in the Civil Action.

NOW, THEREFORE, in consideration of the mutual promises and obligations recited herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Versata and Selectica agree as follows:

1. DEFINITIONS. The following terms used in this Agreement shall have the meanings set forth below:

1.1 An “Affiliate” of, or Entity “Affiliated” with, a specified Entity, is an Entity that directly, or indirectly through one or more intermediaries, Controls or is Controlled by, or is under common Control with, the Entity specified. In the case of Versata, the term “Affiliate” includes, without limitation, Trilogy, Inc., Trilogy Capital Holdings Corporation, Versata Enterprises, Inc. and Trilogy Enterprises Inc.


1.2 “Agreement” means this Settlement, Release and License Agreement.

1.3 “Control” and its derivative terms mean, with reference to a specified Entity, the ownership, directly or indirectly, of more than fifty percent (50%) of the voting stock or other voting or managerial equity interests in such Entity or the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Entity, whether through ownership of voting securities, by contract or otherwise.

1.4 “Covered Fields” shall mean the fields of Configuration, Pricing, Quoting, and Contract Management, including without limitation (i) the selection, configuration, pricing, and/or fulfillment of products and/or services and (ii) the management of procurement, sales, revenue, leasing and/or intellectual property contracts.

1.5 “Entity” means an individual, a corporation, a partnership, an association, a joint-stock company, a trust, or any other incorporated or unincorporated business organization.

1.6 “Infringement” shall mean direct and indirect infringement and infringement under the doctrine of equivalents in any jurisdiction worldwide.

1.7 “Licensee Parties” shall mean, with reference to a Party, the customers, licensees, sublicensees, buyers, vendors, users, distributors, developers, resellers, original equipment manufacturers, original design manufacturers, value-added resellers, suppliers, importers, exporters, retailers, contractors, contract manufacturers, consultants and replicators of products or other items of such Party, but only with respect to and to the extent of such parties’ use or distribution of the products or services of a Party to this Agreement.

1.8 “Patents” shall mean all classes or types of patents and patent applications (along with patents issuing thereon) in any jurisdiction worldwide, including all provisionals, substitutes, renewals, continuations, continuations-in-part, divisionals, foreign counterparts, reissues, oppositions, continued examinations, reexaminations and extensions of any of the foregoing.

1.9 “Parties” means Versata and Selectica, and a “Party” means either of them.

1.10 “Payment Cap” means $7,500,000 (seven million five-hundred thousand US dollars).


1.11 “Purchase,” as used herein, means the sale of the entire business or a portion of the business, of either Party to a purchaser that is not an Affiliate of such Party (a “Purchaser”).

1.12 “Purchaser Products,” as used herein, means (i) the services provided or products existing, manufactured, sold, offered for sale, leased, licensed, or brokered by a Purchaser or its Affiliates prior to or as of the date of a Purchase; and/or (ii) the evolution of such Purchaser’s (or its Affiliates’) prior or existing products or services (as described in subpart (i) of this Section) after a Purchase.

1.13 The “Releases” refer to the releases described in Sections 4.1 and 4.2.

1.14 “Reporting Quarter” shall mean the three month period corresponding to Selectica’s fiscal quarter, currently March 31, June 30, September 30 and December 31.

1.15 “Selectica CPQ Revenue” shall mean all license, maintenance and consulting fees received by Selectica in the field of configuration, pricing and quoting, but excluding any Versata Customer CPQ Revenue. For clarity, the Selectica CPQ Revenue includes, but is not limited to, all maintenance, license and consulting fees received by Selectica following the Effective Date from its existing and future customer base (other than any Versata Customer as to which Versata Customer CPQ Revenue is realized by Selectica), regardless of when the applicable license, consulting and maintenance agreements with such customers became effective.

1.16 “Selectica Patents” as used herein, shall mean (i) all patents, patent applications, and provisional patent applications owned by, assigned to, or otherwise assertable by, or licensed to, Selectica as of the Effective Date (and patents issuing thereon); provided that, in the case of any patents, patent applications, or provisional patent applications that are licensed to Selectica by a third party, such patents, patent applications, and provisional patent applications shall be included in the definition of “Selectica Patents” only if Selectica has the right to grant sublicenses thereunder of the scope specified in Section 3.2 without triggering any royalty or other payment obligation to the licensor thereof; (ii) all patents, patent applications, and provisional patent applications filed by a person other than Selectica or one of its Affiliates (or solely by one or more employees of any of the foregoing), and patents issuing thereon, whether filed before or after the Effective Date, that were assigned or transferred to Selectica or any such Affiliate following the Effective Date; (iii) patent applications and provisional patent applications filed by Selectica or any of its Affiliates (and patents issuing thereon) at or after the Effective Date that have an effective filing date prior to the third anniversary of the Effective Date; and (iv) all parents, provisionals, substitutes, reissues, renewals, continuations, continuations-in-part, divisionals, foreign counterparts, oppositions, continued examinations, reexaminations and extensions of any of such patents, patent applications, and provisional patent applications to which reference is made in clause (i), (ii) or (iii) above owned by, filed by, assigned to or otherwise assertable by Selectica or any of its Affiliates, or successors in interest at any time (i.e. as of, prior to, or after the Effective Date), whether filed before, on or after the Effective Date (and patents issuing thereon).


1.17 “Selectica Products” shall mean (i) as of a particular time, any past or then current product, process, or service existing, manufactured, sold, offered for sale, leased, licensed, or brokered by Selectica and (ii) the evolution of such products, processes, and services in the future, excluding any portion of any product, process, or service both (a) that was not developed and designed by Selectica or developed and designed solely for the benefit of and under the direction of Selectica and additionally (b) in which Selectica does not have an unrestricted, royalty-free ownership or license right. All Selectica Products are limited solely to the Covered Fields.

1.18 “VDG” means Versata Development Group, Inc., a corporation existing under the laws of Delaware with its principal place of business at 5001 Plaza on the Lake, Austin, Texas 78745.

1.19 “Versata Customer” shall mean any customer of Versata that is not a configuration, pricing or quote customer of Selectica as of the time Versata provides Selectica with an Introduction Notice with respect to such customer in accordance with the definition of “Versata Customer CPQ Revenue”.

1.20 “Versata Customer CPQ Revenue” shall mean all license, maintenance and consulting fees received by Selectica in connection with new licenses or service sales after the Effective Date related to its configuration, pricing and quoting products (including successor configuration, pricing and quote products thereto) to a Versata Customer and to whom Versata has made an introduction after the Effective Date. For the purposes of this Agreement, an “introduction” shall be deemed to have been made when; (i) Versata’s CEO or General Counsel, at Versata’s sole discretion, has notified Selectica in writing that a specific Versata Customer introduction may be made (the “Introduction Notice”) pursuant to this Agreement (as of the date of this Agreement, no such notices have been provided by Versata to Selectica); and (ii) subsequent to an Introduction Notice and at the request of Selectica, a written, telephonic, or in-person introduction is initiated by Versata between Selectica and the applicable Versata Customer.

1.21 “Versata Patents,” as used herein, means (i) all patents, patent applications, and provisional patent applications owned by, assigned to, or otherwise assertable by, or licensed to, Versata as of the Effective Date (and patents issuing thereon); provided that, in the case of any patents, patent applications, or provisional patent applications that are licensed to Versata by a third party, such patents, patent applications, and provisional patent applications shall be included in the definition of “Versata Patents” only if Versata has the right to grant sublicenses thereunder of the scope specified in Section 3.1 without triggering any royalty or other payment obligation to the licensor thereof; (ii) all patents, patent applications, and provisional patent applications filed by a person other than Versata or one of its Affiliates (or solely by one or more employees of any of the foregoing), and patents issuing thereon, whether filed before or after the Effective Date, that were assigned or transferred to Versata or any such


Affiliate following the Effective Date; (iii) patent applications and provisional patent applications filed by the Versata or any of its Affiliates (and patents issuing thereon) at or after the Effective Date that have an effective filing date prior to the third anniversary of the Effective Date; and (iv) all parents, provisionals, substitutes, reissues, renewals, continuations, continuations-in-part, divisionals, foreign counterparts, oppositions, continued examinations, reexaminations and extensions of any of such patents, patent applications, and provisional patent applications to which reference is made in clause (i), (ii) or (iii) above owned by, filed by, assigned to or otherwise assertable by Versata or any of its Affiliates, or successors in interest at any time ( i.e. as of, prior to, or after the Effective Date), whether filed before, on or after the Effective Date (and patents issuing thereon).

1.22 “Versata Products” shall mean (i), as of a particular time, any past or then current product, process, or service existing, manufactured, sold, offered for sale, leased, licensed, or brokered by Versata; and (ii) the evolution of such products, processes, and services in the future, excluding any portion of any product, process, or service both (a) that was not developed and designed by Versata or developed and designed solely for the benefit of and under the direction of Versata and additionally (b) in which Versata does not have an unrestricted, royalty-free ownership or license right.

2. COVENANT NOT TO SUE

2.1 Versata’s Covenant not to Sue Selectica. Upon Selectica’s payment of the Lump Sum Amount, Versata for itself and all of its predecessors, officers, directors, partners, employees, attorneys, successors, and assigns (the “ Versata Covenanting Parties ”) hereby covenant not to institute, prosecute or otherwise pursue any suit, action, or claim of any kind (including, without limitation, seeking an injunction), whether known or unknown, against: (i) Selectica, arising from, based upon, or relating to any past, present or future use, infringement, misappropriation, or conversion of any Versata Patents, provided such use, infringement, misappropriation, or conversion occurred within the Covered Fields; and/or (ii) any of Selectica’s Licensee Parties arising from or based upon any past or future use or infringement of such Patents arising out of such Licensee Parties’ use or distribution of a Selectica Product covered by any claim of the Versata Patents in connection therewith, provided such use or infringement occurs within the Covered Fields.

2.2 Selectica’s Covenant not to Sue Versata. Upon Selectica’s payment of the Lump Sum Amount, Selectica, for itself and all of its predecessors, officers, directors, partners, employees, attorneys, successors, and assigns (the “ Selectica Covenanting Parties ”) hereby covenant not to institute, prosecute or otherwise pursue any suit, action, or claim of any kind (including, without limitation, seeking an injunction), whether known or unknown, against: (i) Versata, arising from, based upon, or relating to any past, present or future use, infringement or conversion of the Selectica Patents, and/or (ii) any of Versata’s Licensee Parties arising from or based upon any past or future use, infringement or conversion of such Patents arising out of such Licensee Parties’ use or distribution of a Versata Product covered by any claim of the Selectica Patents in connection therewith.


3. LICENSE GRANTS

3.1 Versata’s Grant of Nonexclusive License to Selectica. Subject to the terms and conditions contained in this Agreement and effective upon payment of the Lump Sum Amount, Versata hereby grants to Selectica a fully paid-up, irrevocable (except as specifically provided herein), nonexclusive, nontransferable (except as set forth in Section 6.1 below), worldwide license under the Versata Patents to make, use, sell, develop, publish, distribute, lease, license, export, import, have made, offer to sell or otherwise transfer any product or service of Selectica covered by any claim of the Versata Patents that is within the Covered Fields, excluding any portion of any product, process, or service both (i) that was not developed and designed by Selectica or developed and designed solely for the benefit of and under the direction of Selectica and additionally (ii) in which Selectica does not have an unrestricted, royalty-free ownership or license right. Versata shall have no obligation hereunder to institute any action or suit against third parties for infringement of any of the Versata Patents or to defend any action or suit brought by a third party which challenges or concerns the validity of any of the Versata Patents. Selectica shall have no right to institute any action or suit against third parties for infringement of any of the Versata Patents. Versata is not required to maintain the Versata Patents in force. Versata provides this license to the Versata Patents to Selectica AS IS, and without warranty of any kind. Versata agrees that the claims of the Versata Patents shall be deemed to be fully exhausted with respect to each product or service provided by Selectica to a Licensee Party of Selectica that is covered by the license granted in this Section 3.1 and that such license extends to each such Licensee Party’s use or distribution of such product or service of Selectica.

3.2 Selectica’s Grant of Nonexclusive License to Versata. Subject to the terms and conditions contained in this Agreement and effective upon payment of the Lump Sum Amount, Selectica hereby grants to Versata a fully paid-up, irrevocable (except as specifically provided herein), nonexclusive, nontransferable (except as set forth in Section 6.1 below), worldwide license under the Selectica Patents to make, use, sell, develop, publish, distribute, lease, license, export, import, have made, offer to sell or otherwise transfer any product or service of Versata covered by any claim of the Selectica Patents, excluding any portion of any product, process, or service that both (i) that was not developed and designed by Versata or developed and designed solely for the benefit of and under the direction of Versata and additionally (ii) in which Versata does not have an unrestricted, royalty-free ownership or license right. Selectica shall have no obligation hereunder to institute any action or suit against third parties for infringement of any of the Selectica Patents or to defend any action or suit brought by a third party which challenges or concerns the validity of any of the Selectica Patents. Versata shall have no right to institute any action or suit against third parties for infringement of any of the Selectica Patents. Selectica is not required to maintain the Selectica Patents in force. Selectica provides this license to the Selectica Patents to Versata AS IS, and without warranty of any kind. Selectica agrees that the claims of the Selectica Patents shall be deemed to be fully exhausted with respect to each product or service provided by Versata to a Licensee Party of Versata that is covered by the license granted in this Section 3.2 and that such license extends to each such Licensee Party’s use or distribution of such product or service of Versata.


3.3 Validity of Licensed Patents.

(a) Selectica stipulates and agrees that the Versata Patents asserted in the Civil Action are valid and enforceable in full and further agrees not to challenge the validity or enforceability of any of the Versata Patents or to affirmatively or intentionally assist any other party in any challenge to the validity or enforceability of such Versata Patents (except that Selectica shall not be prohibited from taking any actions reasonably required in order to respond to legal process or discovery or to comply with any court order or other applicable laws or regulations).

(b) Versata agrees not to challenge the validity or enforceability of any of the Selectica Patents or to affirmatively or intentionally assist any other party in any challenge to the validity or enforceability of any Selectica Patents (except that Versata shall not be prohibited from taking any actions reasonably required in order to respond to legal process or discovery or to comply with any court order or other applicable laws or regulations).

4. MUTUAL GENERAL RELEASES AND DISMISSAL

4.1 General Release by Versata. Upon receipt of the Lump Sum Payment, Versata, on behalf of itself and its Affiliates (including without limitation Joseph A. Liemandt, Trilogy, Inc., Trilogy Capital Holdings Corporation, Versata Enterprises, Inc. and Trilogy Enterprises Inc.), principals, officers, directors, employees, agents, successors and assigns as of the Effective Date, shall and does hereby release and forever discharge Selectica and any parent, subsidiary, or other Affiliated or related corporations or entities, and each of their respective current and former officers, directors, agents, employees, representatives, and attorneys (collectively the “Selectica Released Parties”) from any and all claims, actions, causes of action, suits, damages, duties, rights, obligations, liabilities, adjustments, responsibilities, judgments and demands, known or unknown, at law or in equity, of whatever character in any way that Versata (including its Affiliates) may have against any of the Selectica Released Parties, for any act, omission, reason or event occurring prior to the Effective Date, including, but not limited to, any of the foregoing relating to, based upon, or arising out of, the Lawsuit, any act of past or present Infringement, misappropriation or other violation of any Versata Patent or any trade secret or copyright owned or controlled by Versata prior to or as of the Effective Date, and any claim that would have been within the scope of the license or covenants not to sue granted by Versata in Section 3.1, if occurring after the Effective Date. This release attaches to and is transferred with each product and service provided by Selectica to any Selectica Licensee Party prior to the Effective Date (collectively, the “ Released Selectica Items ”). Versata, on behalf of itself and each other Versata Covenanting Party, covenants not to sue Selectica and each of the Licensee Parties of Selectica on account of any Released Selectica Items. Each Licensee Party of Selectica is intended to be and is a third-party beneficiary of this release, and has standing to enforce the terms of this release without joinder of any other such Licensee Party or Selectica. Nothing in this release shall discharge or otherwise affect the rights, duties and obligations created in this Agreement.

 


4.2 General Release by Selectica. Selectica, on behalf of itself and its Affiliates, principals, officers, directors, employees, agents, successors and assigns as of the Effective Date, shall and does hereby release and forever discharge Versata and any parent, subsidiary, or other Affiliated or related corporations or entities, and each of their respective current and former officers, directors, agents, employees, representatives, and attorneys (collectively the “Versata Released Parties”) from any and all claims, actions, causes of action, suits, damages, duties, rights, obligations, liabilities, adjustments, responsibilities, judgments and demands, known or unknown, at law or in equity, of whatever character in any way that Selectica (including its Affiliates) may have against any of the Released Versata Parties, for any act, omission, reason or event occurring prior to the Effective Date, including, but not limited to, any of the forgoing relating to, based on, or arising out of the Lawsuit, any act of past or present Infringement, misappropriation or other violation of any Selectica Patent or any trade secret or copyright owned or controlled by Selectica prior to or as of the Effective Date, and any claim that would have been within the scope of the license or covenants not to sue granted by Selectica in Section 3.2, if occurring after the Effective Date. This release attaches to and is transferred with each product or service provided by Versata to any Versata Licensee Party prior to the Effective Date (collectively, the “ Released Versata Items ”). Selectica, on behalf of itself and each other Selectica Covenanting Party, hereby covenants not to sue Versata or any Licensee Party of Versata on account of any Released Versata Items. Each Licensee Party of Versata is intended to be and is a third-party beneficiary of this release, and has standing to enforce this release without joinder of any other Licensee Party of Versata. Nothing in this release shall discharge or otherwise affect the rights, duties and obligations created in this Agreement.

4.3 Dismissal of the Civil Action. In connection with the execution of this Agreement, Versata shall direct its counsel to execute and deliver by hand delivery or overnight courier to Selectica’s local counsel Elizabeth L. DeRieux at Brown McCarrol a Stipulation of Dismissal pursuant to F.R.C.P. 41(a) in the form attached here as Exhibit B (the “Dismissal”), dismissing with prejudice all claims and counterclaims made therein and specifying that all costs incurred therein (including attorneys’ and expert fees and expenses) shall be borne solely by the Party incurring such costs. Each of the Parties shall bear its own costs with regard to the Lawsuit, such filings, and this Agreement. No Party shall file the Dismissal until Selectica has completed the transfer of the Lump Sum Amount to Versata in accordance with Section 5.2(a) of this Agreement. Following Selectica’s receipt of confirmation that Versata has received the wire transfer of the Lump Sum Amount in accordance with Section 5.2(a) of this Agreement and that such funds have been credited to Versata, Selectica shall then (and only then) be permitted to file Dismissal in the Civil Action. Versata shall provide Selectica and its counsel electronic and telephonic confirmation of the crediting of such funds within four (4) hours of such crediting, provided that Selectica notifies Lance Jones (512-874-3167 / lance.jones@trilogy.com), Sean Fallon (512-874-4021 / sean.fallon@trilogy.com), and Scott Cole (512-692-8705 / scole@mckoolsmith.com) that the wire has been sent. Such Dismissal shall not be operative and may, under no circumstances be filed, except in accordance with this Section 4.3. If Selectica files the Dismissal in violation of the provisions of this Section 4.3, then any dispute relating thereto shall be resolved in the Court where the Civil Action is pending. The Parties agree that the United States District Court for the Eastern District of Texas, Marshall Division shall have sole and exclusive


jurisdiction over an action for violation of this Section 4.3, and Selectica submits to the jurisdiction of the Eastern District of Texas and consents to venue in such District for such purposes. Selectica further covenants not to initiate any action (for declaratory judgment or otherwise) relating to any dispute regarding this Section 4.3 in any venue or jurisdiction other than the Court in which the Civil Action is pending as of the Effective Date.

4.4 Waiver of Certain Statutory Provisions. Versata and Selectica understand the significance of and, as further consideration for this Agreement, expressly waive any right or benefit that may be available under Section 1542 of the California Civil Code or any similar laws. Section 1542 of the California Civil Code provides:

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.

4.5 Agreement Obligations not Released. The releases contained in sections 4.1 and 4.2 do not release any Party or its Affiliates from its respective obligations under this Agreement or the protective order entered in the lawsuit in the United States District Court for the Eastern District of Texas, captioned Trilogy Software Inc., et al. v. Selectica, Inc., Civil Action No. 2-04-CV-160 TJW, nor do such releases prevent any Party or its Affiliates from enforcing the terms and conditions of this Agreement against any other Party or its Affiliates.

5. SETTLEMENT CONSIDERATION

5.1 Cash Settlement Amount. Versata and Selectica agree that in exchange for the License and the settlement of the Civil Action, Selectica shall make non-refundable payments of Seventeen Million, Five Hundred Thousand U.S. Dollars ($17,500,000.00) (the aggregate amount of such payments being the “Cash Settlement Amount”), when and as provided in Section 5.2.

5.2 Cash Settlement Amount. The Cash Settlement Amount will consist of the following components:

(a) A lump-sum payment of Ten Million Dollars in United States currency ($10,000,000.00 US) (the “Lump Sum Amount”), which shall be paid to Versata within five (5) business days after the date of execution of this Agreement.

(b) Subject to the Payment Cap as set forth in Section 5.2(d) and the minimum quarterly payment obligation set forth in Section 5.3, for each Reporting Quarter beginning with the Reporting Quarter ending December 31, 2007, Selectica shall owe to Versata a periodic payment (hereinafter “Periodic Payment”) equal to ten percent (10%) of the Selectica CPQ Revenue for that quarter. Each Periodic Payment shall be due within ten (10) business days following Selectica’s public release of its financial results for such Reporting Quarter but no later than forty-five (45) days following the last day of such Reporting Quarter.


(c) Subject to the Payment Cap as set forth in Section 5.2(d) and the minimum quarterly payment obligation set forth in Section 5.3, for each Reporting Quarter beginning with the Reporting Quarter ending December 31, 2007, Selectica shall owe to Versata a payment (hereinafter “Versata Customer Joint Sales Payment”) equal to fifty percent (50%) of the Versata Customer CPQ Revenue for that quarter. Each Versata Customer Joint Sales Payment shall be due within ten (10) business days following Selectica’s public release of its financial results for such Reporting Quarter.

(d) Selectica shall have no further obligation to make any Periodic Payments or Versata Customer Joint Sales Payments at such time as the aggregate amount of Periodic Payments and Versata Customer Joint Sales Payments (including any minimum quarterly payments made pursuant to Section 5.3) equals the Payment Cap. If the aggregate amount of Periodic Payments and Versata Customer Joint Sales Payments paid by Selectica to Versata (including any minimum quarterly payments made pursuant to Section 5.3) exceeds the Payment Cap at any time, Versata shall promptly refund to Selectica the amount of the Periodic Payments or Versata Customer Joint Sales Payments made by Selectica (including any minimum quarterly payments made pursuant to Section 5.3) in excess of the Payment Cap.

(e) Selectica agrees to separately track its Selectica CPQ Revenue until such time as all payments have been made to Versata pursuant to Section 5.2. Selectica shall provide a report to Versata each fiscal quarter detailing the Selectica CPQ Revenue. Versata shall have the right to audit the books and records of Selectica and its Affiliates to ensure proper and accurate accounting for the Selectica CPQ Revenue.

(f) Tax Liability and Full Payment to Versata. Each Party shall bear its own tax liability. The Parties agree to cooperate and to complete and provide tax forms and other documents or information reasonably required by applicable tax authorities, in a timely manner upon being supplied such documents or requested for such information by the other Party.

5.3 Nature of the Quarterly Payment; Minimum Quarterly Payment. The payments to be made pursuant to Sections 5.2(b) and 5.2(c) represent staggered payment terms on a payment obligation. Notwithstanding any provision set forth herein to the contrary, until Periodic Payments and Versata Customer Joint Sales Payments (including minimum quarterly payments pursuant to this Section 5.3) have been made by Selectica to Versata in an aggregate amount equal to the Payment Cap, Selectica agrees to make Periodic Payments and Versata Customer Joint Sales Payments each calendar quarter that in the aggregate equal at least $200,000, irrespective of the amount of Selectica CPQ Revenue and Versata Customer CPQ Revenue that is realized by Selectica in respect of such calendar quarter. Selectica agrees and acknowledges that such payments shall not be reduced or eliminated as a result of any findings of invalidity, unenforceability, expiration or other circumstances affecting the Versata Patents.

5.4 Payment Instructions. The Lump Sum Amount and all other payments to be made hereunder shall be made by wire transfer to Versata as follows:

 

Bank Name:  

***

ABA:  

***

Account #  

***

 

***CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.


6. LIMITATION ON RELEASES AND LICENSES

6.1 Transferability Matters.

(a) Except as otherwise provided in this Section 6.1, Versata, on the one hand, and Selectica, on the other hand, may not assign any rights or delegate any duties under this Agreement to any third party without the prior written consent of the other, and any attempted assignment without such consent shall be null and void. Notwithstanding the foregoing or any other provision herein to the contrary, either Party may transfer its rights and obligations hereunder, in whole but not in part, to an assignee pursuant to a Purchase, but in no event shall any license, immunities and other rights following such assignment or transfer apply to or cover any Purchaser Products, subject to the following provisions of this Section 6.1(a). Notwithstanding the foregoing, the license, immunities and other rights granted hereunder shall apply to Selectica Products (which, for purposes this Section 6.1(a), include products, processes and services of only Selectica, Inc. and its then-current Affiliates prior to any such Purchase) and upgrades or enhancements to Selectica Products that existed or were offered for sale as of the date of the Purchase, in the case of a Purchase of Selectica; and to Versata Products (which, for purposes this Section 6.1(a), include products, processes and services of only Versata Software, Inc., Versata Development Group, Inc. and their then-current Affiliates prior to any such Purchase) and upgrades or enhancements to Versata Products or services that existed or were offered for sale as of the date of the Purchase, in the case of a Purchase of Versata. A Purchase shall not immunize Purchaser Products from suit, nor shall a Purchaser obtain any protection under this Agreement for Purchaser Products by consummating a Purchase or by combining or integrating Purchaser Products with any Selectica Products (or with any upgrades or enhancements to said Selectica Products), in the case of a Purchase of Selectica, or by combining or integrating Purchaser Products with any Versata Products (or with any upgrades or enhancements to said Versata Products), in the case of a Purchase of Versata; provided that (i) the license granted by Versata under the Versata Patents in all events shall continue to apply to any Selectica Products (or upgrades or enhancements thereto) that are combined or integrated with any Purchaser Products and (ii) the license granted by Selectica under the Selectica Patents in all events shall continue to apply to any Versata Products (or upgrades or enhancements thereto) that are combined or integrated with any Purchaser Products. Notwithstanding anything to the contrary in this Agreement, (x) Selectica agrees that the release, license, immunities and other rights provided herein may not be assigned or transferred for any purpose, including Purchase, to SAP America, Inc., SAP AG, Sun Microsystems, Inc., or any Affiliates thereof and (y) upon any Purchase or the acquisition of control of either Party by an Entity that was not in control of such Party as of the Effective Date (it being understood that “Party” for the purposes of this clause means Versata Software, Inc., Versata Development Group, Inc. or Selectica, Inc. and not any other Entity), the Selectica Patents and the Versata Patents shall include only those Patents owned or controlled by


the relevant Party and its Affiliates (including any patents issuing on any patent applications pending immediately prior to consummation of the Purchase) immediately prior to consummation of the Purchase or such acquisition of control. Except as expressly set forth above in this Section 6.1(a), a Purchase shall not affect the licenses, immunities and other rights granted to a Party that is subject to a Purchase.

(b) If, after the Effective Date, Selectica or Versata, as the case may be, either: (i) transfers a product line to a third party (a “Product Line Transfer”) or (ii) spins off an Affiliate (either by disposing of it to a third party or in some other manner reducing ownership or control so that the spun-off entity is no longer an Affiliate) (an “Affiliate Spin Off”); then, in the case of a Product Line Transfer, Selectica or Versata, as the case may be, shall have the right to partially assign the license granted hereunder in respect of the relevant product line to the third party to which such product line is transferred (which third-party takes subject to the terms of this Agreement), solely to the extent such license applies to such product line and any upgrades or enhancements thereto, and, in the case of an Affiliate Spin Off, the license granted to such spun-off entity will continue (subject to the terms of this Agreement) as to the products owned by such spun-off Affiliate at the time of the spin-off and any upgrades or enhancements thereto. For purposes of this Section 6.1(b), any unaffiliated third-party to whom a product line is transferred or to whom an Affiliate is spun-off or otherwise disposed of shall be considered a “Purchaser,” and the products and services of the Purchaser existing immediately prior to such transfer or spin-off shall be considered to be Purchaser Products as defined in Section 1.12 of this Agreement. In no event shall any license, immunities and other rights following such Product Line Transfer or Affiliate Spin Off apply to or cover any such Purchaser Products, subject to the following provisions of this Section 6.1(b). Notwithstanding the foregoing, the license, immunities and other rights granted hereunder shall apply to Selectica Products (which, for purposes this Section 6.1(b), include products, processes and services of only Selectica, Inc. and its then-current Affiliates prior to any such Product Line Transfer or Affiliate Spin Off) and Versata Products (which, for purposes this Section 6.1(b), include products, processes and services of only Versata Software, Inc., Versata Development Group, Inc. and their then-current Affiliates prior to any such Product Line Transfer or Affiliate Spin Off) (as the case may be) that existed or were offered for sale as of the date of the Product Line Transfer or Affiliate Spin Off and any upgrades or enhancements thereto. A Product Line Transfer or Affiliate Spin Off shall not immunize Purchaser Products from suit, nor shall a Purchaser obtain any protection under this Agreement for Purchaser Products by consummating a Product Line Transfer or Affiliate Spin Off or by combining or integrating Purchaser Products with any Selectica Products or Versata Products (as the case may be) (or with any upgrades or enhancements thereto); provided that (i) the license granted by Versata under the Versata Patents in all events shall continue to apply to any Selectica Products (or upgrades or enhancements thereto) that are combined or integrated with any Purchaser Products and (ii) the license granted by Selectica under the Selectica Patents in all events shall continue to apply to any Versata Products (or upgrades or enhancements thereto) that are combined or integrated with any Purchaser Products. Notwithstanding anything to the contrary in this Agreement, (x) Selectica agrees that the release, license, immunities and other rights provided herein may not be assigned or transferred for any purpose, including a Product Line Transfer or Affiliate Spin Off, to SAP America, Inc.,


SAP AG, Sun Microsystems, Inc., or any Affiliates thereof and (y) upon any Product Line Transfer or Affiliate Spin Off, the Selectica Patents and the Versata Patents shall include only those Patents owned or controlled by the relevant Party and its Affiliates (including any patents issuing on any patent applications pending immediately prior to consummation of the Product Line Transfer or Affiliate Spin Off) immediately prior to consummation of the Product Line Transfer or Affiliate Spin Off. Except as expressly set forth above in this Section 6.1(b), a Product Line Transfer or Affiliate Spin Off shall not affect the licenses, immunities and other rights granted to a Party that is subject to a Product Line Transfer or Affiliate Spin Off.

6.2 No Grants to Third Parties. Except as stated herein, the releases and licenses, as set forth above, are not intended as and are not the grant of a license or any other rights under either the Versata Patents or the Selectica Patents to any third party, not expressly licensed or released.

6.3 No Sublicense. Neither Selectica nor Versata shall have any right to sublicense any right granted to it hereunder.

6.4 Reservation of Rights. Each Party reserves all rights and licenses not expressly granted to pursuant to this Agreement.

7. REPRESENTATIONS AND WARRANTIES

7.1 General. Each Party warrants and represents to the other that (a) it has the right and power to enter into this Agreement and to settle and dismiss the Civil Action; (b) its execution hereof has been duly authorized by all necessary corporate action of such Party; and (c) it has all requisite legal rights necessary to grant the other Party all releases, licenses and covenants granted to the other Party as set forth above.

7.2 Versata’s Warranties. Versata expressly represents and warrants that (i) it is the sole and exclusive owner of all right, title, and interest in and to the Versata Patents identified on Exhibit A, (ii) it has all rights to license and enforce the Versata Patents, including the right to seek past damages for infringement, to grant releases with respect to infringement of the Versata Patents, and to license the Versata Patents, (iii) it will take no action, including but not limited to granting any license or other rights, under the Versata Patents, Versata’s claims or otherwise, that would conflict with, prevent, or otherwise frustrate the licenses, rights and other benefits granted to Selectica hereunder or the limitations imposed for the benefit of Selectica on the scope of the licenses and covenants granted or made by Selectica hereunder; (iv) there are no liens, conveyances, mortgages, assignments, encumbrances, or other agreements that would prevent, impair, or frustrate the full and complete exercise of the terms and conditions of this Agreement; and (v) it has the full power and authority, and has obtained all third party consents, approvals and/or other authorizations required, to enter into this Agreement (on behalf of itself and each of its Affiliates) and to carry out its obligations hereunder.

7.3 Selectica’s Warranties. Selectica expressly represents and warrants that (i) it is the sole and exclusive owner of all right, title, and interest in and to the Selectica Patents, (ii) it has all rights to license and enforce the Selectica Patents,


including the right to seek past damages for infringement, to grant releases with respect to infringement of the Selectica Patents, and to license the Selectica Patents, (iii) it will take no action, including but not limited to granting any license or other rights, under the Selectica Patents, Selectica’s claims or otherwise, that would conflict with, prevent, or otherwise frustrate the licenses, rights and other benefits granted to Versata hereunder or the limitations imposed for the benefit of Versata on the scope of the licenses and covenants granted or made by Versata hereunder; (iv) there are no liens, conveyances, mortgages, assignments, encumbrances, or other agreements that would prevent, impair, or frustrate the full and complete exercise of the terms and conditions of this Agreement; and (v) Selectica has the full power and authority, and has obtained all third party consents, approvals and/or other authorizations required, to enter into this Agreement (on behalf of itself and each of its Affiliates) and to carry out its obligations hereunder.

8. TERM AND TERMINATION

8.1 Term. This Agreement shall become effective as of the Effective Date. The licenses and covenants granted or made in this Agreement shall remain in full force and effect until the last-to-issue of the Versata Patents and the Selectica Patents have expired and all rights thereunder have ceased to exist. All other rights and obligations under this Agreement shall survive any such expiration.

8.2 Termination due to Breach. If Selectica materially breaches its obligations set forth in Section 3.3(a) or fails to timely make any payment to Versata in breach of Selectica’s payment obligations under Section 5.2, Versata, at its option, may give written notice to Selectica of such breach stating the nature of the breach and that Versata intends to terminate this Agreement if such breach is not cured. If Versata gives any such notice of breach as provided in the immediately proceeding sentence and Selectica does not cure such breach within thirty (30) days after the receipt of such notice, then Versata, subject to compliance with Section 9.9 and 9.10 (as applicable), may terminate this Agreement. If Versata terminates this Agreement prior to Selectica paying Versata the entire Cash Settlement Amount, such termination by Versata will terminate any obligation of Selectica to make any payments under Section 5.2 that have not accrued and become due and payable thereunder prior to such termination.

9. GENERAL PROVISIONS

9.1 Non-warranty. Nothing in this Agreement shall be construed as a warranty or representation that making, using or selling of products by or for the either Party will be free from infringement of any patents other than the Versata Patents and Selectica Patents.

9.2 Successors, Subsidiaries, and Assigns. Except as otherwise provided herein, this Agreement shall be binding upon and shall inure to the benefit of Versata and Selectica, and their respective agents, representatives, subsidiaries, successors, trustees, heirs and assigns. Each Party shall advise every such successor, trustee, heir or assign, of the rights of the other Party pursuant to this Agreement, and shall further advise that such successor, trustee, heir or assign to the Versata Patents or Selectica Patents (or any of them individually) or this Agreement, takes such patents subject to the rights granted hereunder.


9.3 Agreement Obligations Not Released. The Releases are not intended to release any of the Parties from their respective obligations created by this Agreement or to prevent any Party from enforcing the terms of this Agreement against the other.

9.4 Entire Agreement. Each of the Parties acknowledges that no person has made any promise, representation or warranty whatsoever, express or implied, not contained herein concerning the subject matter hereof, to induce the execution of this instrument, and each signatory hereby acknowledges that such signatory has not executed this instrument in reliance upon any such promise, representation or warranty. This Agreement constitutes the entire agreement between the parties and supersedes all prior negotiations, representations or agreements between the parties, either written or oral, on the subject hereof. This Agreement may be amended only by written instrument designated as an amendment to this Agreement and executed by the Parties hereto or their respective successors, heirs or assigns.

9.5 Names and Trademarks. Nothing contained in this Agreement shall be construed as conferring any rights to use in advertising, publicity, or other marketing activities any name, trademark, or other designation of either Party hereto, including any contraction, abbreviation, or simulation of any of the foregoing, and each Party hereto agrees not to use the existence of this Agreement in any marketing activity, whether public or private.

9.6 Third Party Actions. Nothing contained in this Agreement shall be construed as (a) creating an obligation to bring or prosecute actions or suits against third parties for infringement, or to secure and/or maintain any of its intellectual property rights or (b) limiting the rights that a party has outside the scope of this Agreement.

9.7 Effective Date. This Agreement will become effective upon the exchange of facsimile copies of the required signatures and such faxed copies shall be binding and effective as if they were original signatures. The parties will thereafter exchange formal signed originals of this Agreement for their permanent records.

9.8 Bankruptcy. All licenses and releases granted under this Agreement are deemed to be, for the purpose of Section 365(n) of the U.S. Bankruptcy Code, licenses of rights to intellectual property as defined under Section 101 of the U.S. Bankruptcy Code, as amended. The Parties agree that, as licensees of such rights under this Agreement, they shall each retain and may exercise all of their rights and elections under the U.S. Bankruptcy Code, as amended.

9.9 Dispute Resolution. Except as provided herein, no civil action with respect to any dispute, claim or controversy arising out of or relating to this Agreement, including without limitation any uncured breach of the Agreement, may be commenced, and no attempted termination of this Agreement pursuant to Section 8.2 shall become effective, until the procedures set forth in this Section have been followed. First, the


respective Chief Executive Officers of the Parties shall meet in person in an attempt to resolve any dispute upon the written request of a Party setting forth the subject matter of the dispute and the relief request. Second, if the matter is not resolved within forty-five (45) days of the written request, the matter shall be submitted to JAMS for mediation by either Party providing to JAMS and the other Party a written request for mediation, setting forth the subject of the dispute and the relief requested. The Parties will cooperate with JAMS and with one another in selecting a mediator from JAMS panel of neutrals, and in scheduling the mediation proceedings. The parties covenant that they will participate in the mediation in good faith, and that they will share equally in its costs. All offers, promises, conduct and statements, whether oral or written, made in the course of the mediation by any of the Parties, their agents, employees, experts and attorneys, and by the mediator and any JAMS employees, are confidential, privileged and inadmissible for any purpose, including impeachment, in any litigation or other proceeding involving the Parties, provided that evidence that is otherwise admissible or discoverable shall not be rendered inadmissible or non-discoverable as a result of its use in the mediation. Either Party may seek equitable relief prior to the mediation to preserve the status quo pending the completion of the mediation process. Except for such an action to obtain equitable relief, neither Party may commence a civil action with respect to the matters submitted to negotiation between the Chief Executive Officers or the mediation until thirty (30) days after the completion of the initial mediation session. The provisions of this Clause may be enforced by any Court of competent jurisdiction, and the prevailing party in any such dispute regarding this Clause shall be entitled to an award of all costs, fees and expenses, including attorneys’ fees.

9.10 Versata’s Rights in the Event of Non-Payment by Selectica. If, for any reason, Selectica fails to make timely payment, Versata shall have the right (in addition to all other remedies available to it) to enforce this Agreement and Selectica’s payment obligations by instituting an action in the United States District Court for the Eastern District of Texas, Marshall Division, subject to compliance with the provisions of Section 9.9. The Parties agree that the United States District Court for the Eastern District of Texas, Marshall Division shall have sole and exclusive jurisdiction over an action for failure to make timely payment in breach of this Agreement. In the event Selectica fails to timely make the Cash Settlement Amount, it submits to the jurisdiction of the Eastern District of Texas and consents to venue in such District. Selectica further covenants not to initiate any action (for declaratory judgment or otherwise) relating to any payment dispute in any venue or jurisdiction other than in the United States District Court for the Eastern District of Texas, Marshall Division.

9.11 Attorneys’ Fees. In the event of litigation for breach of this Agreement, the prevailing party shall recover its attorneys’ fees, court costs, and other related expenses (including, if applicable, document discovery costs, expert witness fees and expenses, and other similar expenses) associated with such litigation.

9.12 Applicable Law. This Agreement shall be governed by and construed in accordance with the federal patent laws of the United States and the laws of the State of Delaware without regard to principles of conflicts of law.


9.13 Use of Patented Technology

(a) Versata shall have no liability for any claim, loss, cost, damage (consequential or otherwise), or expense of any kind or nature caused in whole or in part, directly or indirectly, by Selectica’s use of any technology or rights licensed herein. Selectica shall be solely responsible for each of its own applications and uses and for the consequences thereof. Versata is not obligated to defend, protect, or indemnify Selectica, nor, except as set forth herein, is Versata liable to Selectica for not defending, protecting, or indemnifying it, against infringement or claims of infringement of any patent, copyright or trademark or other intellectual property rights owned or claimed to be owned by any third party.

(b) Selectica shall have no liability for any claim, loss, cost, damage (consequential or otherwise), or expense of any kind or nature caused in whole or in part, directly or indirectly, by Versata’s use of any technology or rights licensed herein. Versata shall be solely responsible for each of its own applications and uses and for the consequences thereof. Selectica is not obligated to defend, protect, or indemnify Versata, nor, except as set forth herein, is Selectica liable to Versata for not defending, protecting, or indemnifying it, against infringement or claims of infringement of any patent, copyright or trademark or other intellectual property rights owned or claimed to be owned by any third party.

9.14 Confidentiality

(a) Subject to Section 9.14(b), Selectica and Versata shall keep all terms and conditions of this Agreement strictly confidential, and Selectica and Versata shall not now or hereafter disclose such terms and conditions to any third party except: (i) with the prior written consent of the other Party, (ii) as may be required by applicable law, regulation or order of a governmental authority of competent jurisdiction, including without limitation the reporting and disclosure requirements of The NASDAQ Stock Market or the Securities and Exchange Commission, (iii) during the course of litigation so long as the disclosure of such terms and conditions is subject to the same restrictions as is the confidential information of the other litigating parties, such restrictions are embodied in a court-entered protective order limiting disclosure to outside counsel only for use in the subject litigation and, to the extent reasonably practical, such disclosing Party provides the other Party written notice at least ten (10) business days prior to such disclosure, or (iv) in confidence to the professional legal and financial counsel representing such Party but only with respect to such Party’s legal or financial obligations relating to this Agreement, and not for use in any other litigation or licensing efforts or negotiations. With respect to the foregoing (ii), such disclosing Party shall, to the extent legally permissible and reasonable, provide the other Party with prior written notice of such applicable law, regulation or order and, at the request of the other Party, use reasonable efforts to limit the disclosure of the terms and conditions of this Agreement, and to obtain a protective order or other confidential treatment.

(b) No Party shall disclose the amounts of the Lump Sum Amount, any Periodic Payment, any Versata Customer Joint Sales Payment, or the Payment Cap, individually or in any combination, except (i) with the prior written consent of the other


Party; or (ii) as may be required by applicable law, regulation or order of a governmental authority of competent jurisdiction, including without limitation the reporting and disclosure requirements of The NASDAQ Stock Market or the Securities and Exchange Commission. With respect to the foregoing (ii), such disclosing Party shall, to the extent legally permissible and reasonable, provide the other Party with prior written notice of such applicable law, regulation or order and, at the request of such other Party, use reasonable efforts to limit the disclosure of the amounts of Initial Payment, any Periodic Payment, any Versata Customer Joint Sales Payment, or the Payment Cap, individually or in any combination, and to obtain a protective order or other confidential treatment.

(c) Versata acknowledges that, pursuant to the Securities Exchange Act of 1934 and the rules and regulations thereunder, Selectica is required to file this Agreement with the Securities and Exchange Commission and that no assurances can be given that the Securities and Exchange Commission will permit any portion of this Agreement, as filed therewith, to be redacted and subject to any confidential treatment.

9.15 No Public Announcement. The parties may make a single press release substantially in the form and content of Exhibit C . Any other text to be included in a Party’s press release, if any, must be approved in advance by the other Party. Otherwise, no Party nor its Affiliates shall issue a press release or make any other public statement regarding this Agreement or the settlement of the Lawsuit, except with respect to each Party’s various public reporting obligations and in accordance with Section 9.14. In the context of private discussions with potential licensees or purchasers of the Versata Patents, Versata may privately state or confirm the fact that the Lawsuit has been settled and Selectica, its Related Parties and Licensee Parties are licensees, and Selectica, its Related Parties and Licensee Parties may do the same. In the context of private discussions with any Licensee Party or Released Party, the Parties may inform such Licensee Party or Released Party of the rights and obligations applicable to such Licensee Party or Released Party hereunder.


IN WITNESS WHEREOF , the Parties have caused their duly authorized officers to execute this Agreement as of the Effective Date.

 

Versata Software, Inc. Versata Development

Group, Inc. and Versata (as defined herein):

     Dated this October 5 , 2007
By:  

/s/ Joseph A. Liemandt

    
  Joseph A. Liemandt     
  Assistant Secretary     
Selectica Inc. and Selectica (as defined herein):      Dated this October 5 , 2007
By:  

/s/ Robert Jurkowski

    
 

Robert Jurkowski

    
 

CEO & Chairman

    

 


EXHIBIT A — VERSATA PATENTS-IN-SUIT

The following United States Patent Nos.:

5,515,524

5,708,798

6,002,854


EXHIBIT B — FORM OF STIPULATION OF DISMISSAL


IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF TEXAS

MARSHALL DIVISION

 

Versata Software, Inc., f/k/a Trilogy    §   
Software, Inc.; and Versata Development    §   
Group, Inc., f/k/a Trilogy Development    §   
Group, Inc.    §   
   §   
Plaintiffs,    §   
   §   
v.    §    CIVIL ACTION NO. 2:06-CV-444 (TJW)
   §   
Selectica, Inc.,    §   
   §    JURY TRIAL DEMANDED
Defendant.    §   

STIPULATION OF DISMISSAL PURSUANT TO F.R.C.P. 41(a)(1)(ii)

WHEREAS, Plaintiffs Versata Software, Inc., f/k/a Trilogy Software, Inc. and Versata Development Group, Inc., f/k/a Trilogy Development Group, Inc. (collectively “Versata”) and Defendant Selectica, Inc (“Selectica”) have entered into an agreement to settle the claims asserted in the above-captioned action on certain terms and conditions set forth in their agreement;

NOW, THEREFORE, Versata and Selectica, pursuant to Rule 41(a)(l)(ii) of the Federal Rules of Civil Procedure, through the signature of their counsel, stipulate herein

\\

\\

\\

\\

\\

\\

\\

\\\


to dismiss this action with prejudice, including all claims and counterclaims. Each party agrees to bear its own attorneys fees and expenses incurred in this action.

D ATED : October     , 2007.

Respectfully submitted,

 

M C K OOL S MITH , P.C.            

 

   

 

By:   Sam Baxter     By:  

Lead Attorney

Texas State Bar No. 01938000

505 E. Travis, Suite 105

P.O. Box O

Marshall, Texas 75670

Telephone: (903) 927-2111

Telecopier: (903) 927-2622

sbaxter@mckoolsmith.com

Peter J. Ayers

Texas State Bar No. 24009882

payers@mckoolsmith.com

Laurie L. Gallun

Texas State Bar No. 24032339

lgallun@mckoolsmith.com

300 W. 6th Street, Suite 1700

Austin, Texas 78701

Telephone: (512) 692-8700

Facsimile: (512) 692-8744

   

S. Calvin Capshaw

ccapshaw@mailbmc.com

State Bar No. 03783900

Elizabeth L. DeRieux

ederieux@mailbmc.com

State Bar No. 05770585

Andrew W. Spangler

aspangler@mailbmc.com

State Bar No. 24041960

BROWN McCARROLL LLP

1127 Judson Road, Suite 220

Longview, TX 75601-5157

P.O. Box 3999

Longview, TX 75606-3999

Telephone: (903) 236-9800

Facsimile: (903) 236-8787

ATTORNEYS FOR PLAINTIFFS VERSATA SOFTWARE, INC. AND VERSATA DEVELOPMENT GROUP, INC.    

David A. Segal

CA State Bar No. 166635

Gibson, Dunn & Crutcher LLP

4 Park Plaza

Irvine, California 92615

Telephone: (949) 451-3873

Facsimile: (949) 475-4662

dsegal@gibsondunn.com

      ATTORNEYS FOR DEFENDANT SELECTICA, INC.


CERTIFICATE OF SERVICE

I hereby certify that all counsel of record who are deemed to have consented to electronic service are being served this     th day of October, 2007, with a copy of this document via the Court’s CM/ECF system per Local Rule CV-5(a)(3). Any other counsel or record will be served by electronic mail, facsimile transmission, and/or first class mail on this same date.

 

 

Elizabeth L. DeRieux


IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF TEXAS

MARSHALL DIVISION

 

Versata Software, Inc., f/k/a Trilogy    §   
Software, Inc.; and Versata Development    §   
Group, Inc., f/k/a Trilogy Development    §   
Group, Inc.    §   
   §   
Plaintiffs,    §   
   §   
v.    §    CIVIL ACTION NO. 2:06-CV-444 (TJW)
   §   
Selectica, Inc.,    §   
   §    JURY TRIAL DEMANDED
Defendant.    §   

STIPULATED ORDER OF DISMISSAL

The parties have jointly moved the Court, pursuant to Rule 41(a) of the Federal Rules of Civil Procedure, to enter an Order dismissing with prejudice all claims brought in this Civil Action by the parties.

IT IS HEREBY ORDERED, in accordance with Federal Rule of Civil Procedure 41(a)(2), as follows:

All claims brought by Versata Software, Inc. (f/k/a Trilogy Software, Inc.) and Versata Development Group, Inc. (f/k/a Trilogy Development Group, Inc.) in this Civil Action, are dismissed with prejudice.

All claims and counterclaims brought by Selectica, Inc. in this Civil Action are dismissed with prejudice.

Each party shall bear its own attorneys’ fees and costs that it has accrued in relation to all claims and all counterclaims in this action.


EXHIBIT C

JOINT PRESS RELEASE

SELECTICA AND VERSATA SOFTWARE ANNOUNCE SETTLEMENT OF PATENT

LITIGATION AND DEVELOPMENT OF JOINT MARKETING RELATIONSHIP

San Jose, Calif. – October X, 2007 – Selectica Inc. (NASDAQ: SLTC) and Versata Software, Inc. (formerly known as Trilogy Software, Inc.) announced today that they have reached an amicable settlement of a patent lawsuit pending in the United States District Court for the Eastern District of Texas since 2006. As part of the settlement, Versata will license the asserted patents together with others to Selectica for the life of the patents, and Selectica will pay to Versata an undisclosed sum in royalties. All claims made in the litigation will be dismissed with prejudice. The parties have agreed that the resolution of this lawsuit does not constitute an admission of liability.

In addition, Selectica and Versata entered into a joint marketing arrangement focused on revitalizating and growing the configuration and pricing market. Specifically, Versata will have the opportunity to market Selectica’s configuration, pricing and quoting (CPQ) solution to Versata’s installed customer base. Selectica and Versata will share in the license and services revenue generated through the joint marketing efforts.

“We are very pleased to resolve our patent litigation and turn an adversarial relationship into a strategic relationship that we believe can help accelerate our growth in the future,” said Robert Jurkowski, Chairman and Chief Executive Officer of Selectica. “As part of the continued servicing of our CPQ installed base over the past few years, we have continually developed enhancements to our core CPQ technology. As a result, we believe that our product will be an attractive complement to Versata solutions. Most important, the joint marketing relationship with Versata will require minimal ongoing investment on our part, while providing meaningful revenue opportunities.”


“We are excited to transition our focus on this matter to growing the CPQ market,” said Randy Jacops, Chief Executive Officer of Versata Enterprises, Inc. parent company of Versata Software, Inc. “Our industry-leading solutions, backed by over 100 issued and in-process patents, and our relentless focus on customer success ensure robust solutions for all of our customers. The Versata-Selectica alliance, backed by a comprehensive intellectual property portfolio, will enable us to offer innovations and solutions unavailable from other competitors. We look forward to presenting the CPQ solutions to our customers and other companies looking for a world-class solution proven to drive significant business value.”

Selectica’s CPQ solution allows companies to effectively price and sell complex, configured products and services. Leveraging constraint-based technology, Selectica’s CPQ solution enables customer to easily set-up, modify and maintain pricing rules for configure-to-order products, resulting in opportunities for enhanced revenues, improved profit margins, and higher customer satisfaction.

With over a decade of use in Fortune 500 companies worldwide, Versata’s solutions and industry-specific customizations have set a standard for configuration capability. In addition to interactive product selection and configuration capabilities, Versata’s product portfolio also includes complex pricing, product multi-sourcing, and other solutions to drive effective enterprise and internet sales and marketing processes.

About Selectica, Inc.

Selectica (NasdaqGM: SLTC - News) provides its customers with software solutions that automate the complexities of enterprise contract management and sales configuration lifecycles. The company’s high-performance solutions underlie and unify critical business functions including sourcing, procurement, governance, sales and revenue recognition. Selectica has been providing innovative, enterprise-class solutions for the world’s largest companies for over 10 years and has generated substantial savings for its customers. Selectica customers represent leaders in manufacturing, technology, retail, healthcare and telecommunications, including: ABB, Ace Hardware, Bell Canada, Cisco, Covad Communications, General Electric, Fireman’s Fund Insurance Company, Hitachi, International Paper, Juniper Networks, Levi Strauss & Co., Rockwell Automation, Tellabs, and 7-Eleven. Selectica is headquartered in San Jose, CA. For more information, visit the company’s Web site at www.selectica.com.

About Versata Enterprises, Inc.

With a global presence covering 45 countries, Versata Enterprises solves the most complex business problems for the world’s largest organizations. Versata Enterprises comprises a number of leading enterprise solution providers, including Versata, Inc., Artemis International Solutions Corporation, and the pending Gensym Corporation acquisition, in addition to Nextance, Inc. Versata distinguishes itself in the software industry by focusing on customer priorities as driven by value delivered. Versata’s market-leading Customer Success Program ensures customer involvement in product decisions and business


priorities and provides a twice-yearly opportunity for customers to score Versata’s performance against commitments. Versata’s world-class engineering capability ensures substantive and valuable product releases, thereby ensuring customer success. Versata also offers customers the opportunity to leverage Versata’s global efficiency by offering a menu of services to help customers lower the cost of technology services across the enterprise. Versata’s relentless focus on customer priorities, coupled with an unmatched global engineering capability, ensures Versata customers benefit from continuous innovation and repeatable value propositions. Further information is available at http://www.versata.com.

 

Contact:

     Tony Rossi, Financial Relations Board for Selectica
     213-486-6545, trossi@financialrelationsboard.com

Forward Looking Statements

The statements contained in this release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, including statements regarding Selectica’s and its customers’ expectations, beliefs, hopes, intentions or strategies regarding the future and expectations regarding performance improvements or increases in sales attributable to Selectica’s existing and new products. All forward-looking statements included in this release are based upon information available to Selectica as of the date hereof, and Selectica assumes no obligation to update any such forward-looking statement. Actual results could differ materially from current expectations. Factors that could cause or contribute to such differences include, but are not limited to, (i) market and customer acceptance of new products of Selectica, including the on-demand contract management and sales execution products and the applications developed with business partners, (ii) the success of the ongoing restructuring of Selectica’s operations, (iii) the conclusions resulting from the independent review of the Company’s past stock option granting practices, (iv) the inability of the Company to avoid delisting from The Nasdaq Stock Market due to non-compliance with Marketplace rules, (vi) potential regulatory inquiries and litigation relating to the review of past stock granting practices and the related restatement of the Company’s financial statements and (vii) other factors and risks discussed in Selectica’s Annual Report on Form 10-K for the fiscal year ended March 31, 2007 and in other reports filed by Selectica with the Securities and Exchange Commission.

Exhibit 10.44

SELECTICA, INC.

SUMMARY OF BOARD CO-CHAIR COMPENSATION ARRANGEMENT

On August 1, 2008, the Board of Directors (the “Board”) of Selectica, Inc. (the “Company”) determined to compensate Jim Thanos and Brenda Zawatski, the Co-Chairs of the Board, at the rate of $250 per hour, subject to a maximum of eight hours per day, for time spent assisting the Company on operational matters beyond the time spent discharging their normal duties as directors of the Company.

EXHIBIT 21.1

SELECTICA, INC.

SUBSIDIARIES

 

COUNTRY OR REGION    OFFICIAL NAME
FOREIGN SUBSIDIARIES:   
Australia    Selectica Australia Pty Ltd.
Canada    Selectica Canada, Inc.
France    Selectica France SARL
Germany    Selectica GmbH
Japan    Selectica Japan, K.K.
Mexico    Selectica Mexico S. de R.L. de C.V.
Sweden    Selectica Scandinavia AB
U.S. SUBSIDIARIES:   
Delaware    LoanMarket Resources, Inc.
Delaware    Wakely Acquisition Corp.

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements (Form S-8 No.’s 333-56576, 333-64246, 333-32666, 333-103622, 333-116449, 333-122708 and 333-126306) of our report dated July 7, 2009, with respect to the consolidated financial statements of Selectica, Inc., included in the Annual Report (Form 10-K) for the two year period ended March 31, 2009.

 

/s/ Armanino McKenna LLP
San Ramon, California
July 7, 2009

EXHIBIT 31.1

SELECTICA, INC.

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Brenda Zawatski, certify that:

 

1) I have reviewed this annual report on Form 10-K of Selectica, Inc;

 

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 8, 2009

 

/s/    B RENDA Z AWATSKI        

Brenda Zawatski
Co-Chair

EXHIBIT 31.2

SELECTICA, INC.

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Jim Thanos, certify that:

 

1) I have reviewed this annual report on Form 10-K of Selectica, Inc;

 

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 8, 2009

 

/s/    J IM T HANOS        

Jim Thanos

Co-Chair

EXHIBIT 31.3

SELECTICA, INC.

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Richard Heaps, certify that:

 

1) I have reviewed this annual report on Form 10-K of Selectica, Inc;

 

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 8, 2009

 

/s/    R ICHARD H EAPS        

Richard Heaps
Chief Financial Officer

EXHIBIT 32.1

SELECTICA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Selectica, Inc. (the “Company”) on Form 10-K for the year ended March 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brenda Zawatski, Co-Chair of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: July 8, 2009

 

/s/    B RENDA Z AWATSKI        

Brenda Zawatski
Co-Chair

EXHIBIT 32.2

SELECTICA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Selectica, Inc. (the “Company”) on Form 10-K for the year ended March 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jim Thanos, Co-Chair of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: July 8, 2009

 

/s/    J IM T HANOS        

Jim Thanos

Co-Chair

EXHIBIT 32.3

SELECTICA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Selectica, Inc. (the “Company”) on Form 10-K for the year ended March 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Heaps, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: July 8, 2009

 

/s/    R ICHARD H EAPS        

Richard Heaps
Chief Financial Officer